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Abstract 
Staphylococcus aureus is a major opportunistic pathogen and a common cause 
of hospital- and community-acquired infections. Furthermore, infections of 
livestock animals by S. aureus results in billion dollar losses to agriculture 
producers annually. Over the last five decades antibiotic resistance has 
dramatically increased in S. aureus and highly pathogenic strains have emerged 
that threaten human and animal health. Characterization of highly pathogenic 
strains and novel transcriptional mechanisms and pathways is of utmost 
importance as it will provide a critical evolutionary understanding of the 
transcriptional changes that led to the emergence of successfully infectious S. 
aureus strains and may identify novel targets for antibacterial development.  
The overarching goal of research described in this thesis was to 
characterize and understand how novel cis- and trans-acting factors affect gene 
expression in S. aureus. To that end, the work and data presented investigate 
the effect of promoter based single nucleotide polymorphisms (SNPs) of the hla 
gene, encoding α-toxin, on gene transcription and gene product expression. The 
cis-acting SNPs increased the binding affinity of the promoter to the trans-acting 
transcription factor SarZ. Furthermore, the S. aureus RF122 strain had increased 
transcriptional expression of several positive regulators and decreased 
transcription of negative regulators of hla, which resulted in a dramatic increase 
in α-toxin expression and likely contributes to the increased mastitis 
pathogenesis of RF122.  
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 Additionally, the essentiality of the yhcSR two-component system was 
confirmed in the hospital-acquired methicillin resistant S. aureus WCUH29 strain. 
The YhcSR TCS was identified to transcriptionally activate the lacABCDE and 
opuCABC operons involved in cellular metabolism and osmoregulatory 
mechanisms, respectively. In an effort determine if a relationship existed 
between YhcSR and pathogenesis, studies revealed that the YhcSR TCS 
transcriptionally regulated, in a positive manner, the sspABC and crtOPQMN 
operons, encoding exported proteases and staphyloxanthin biosynthesis, which 
contribute to the survival of S. aureus in human blood. The data indicate that the 
YhcSR TCS system is an essential trans-acting global regulator in S. aureus. 
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Chapter 1 : Introduction 
1.1 Infections 
In 1881, Sir Alexander Ogston reported the observation of micrococci in 
the pus of an infected surgical site on a knee while investigating the cause of 
blood poisoning (1). We now know the organism described was Staphylococcus 
aureus, a commensal and opportunistic pathogen. S. aureus infects tens of 
thousands of people annually in the US (2, 3). Methicillin-resistant S. aureus 
(MRSA) accounts for more than 60% of all hospital-acquired S. aureus infections 
(4–6). MRSA has increasingly spread beyond healthcare facilities and emerged 
as a community-acquired (CA) pathogen causing minor skin and soft tissue 
infections and severe invasive diseases, including necrotizing pneumonia and a 
sepsis syndrome (2, 3, 7). In the US, treating MRSA infections in hospitalized 
patients costs an estimated $3.2 - $4.2 billion annually and is estimated to be the 
causative agent of an estimated 18,650 American deaths annually (7). S. aureus 
produces an array of innate immune inhibiting factors to promote its own survival 
within a host (8), many of which are controlled by central key transcriptional 
regulatory systems (9–12). Understanding the regulatory network of S. aureus is 
important to our understanding of how S. aureus initiates and maintains an active 
infection. This knowledge will provide new insights staphylococcal infection and 
may provide novel targets for innovative treatments against this persistent threat 
to human health. 
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1.2 The bacterium  
Staphylococcus aureus is a member of the low G+C Gram-positive 
firmicute phylum. The S. aureus cell is 0.5-0.6 μm in diameter and replicates by 
asexual binary fission, but the coccal daughter cells do not separate from each 
other, resulting in grape-like clusters when viewed under a microscope. The 
metabolism of S. aureus has been studied for approximately a century, beginning 
with the laborious task of determining the minimal components required to 
sustain aerobic cell growth (13). This breakthrough was followed shortly 
thereafter with the discovery of the minimal components for S. aureus anaerobic 
cultivation (14) and the individual systems essential for minimal medium growth 
have been investigated (15). S. aureus maintains complete Embden-Meyerhof-
Parnas (glycolytic), pentose phosphate, and tricarboxylic acid (TCA) cycles, 
providing the bacterium the ability to synthesize all macromolecules from 13 
basic biosynthetic intermediates; however, S. aureus often shows autotrophy for 
several amino acids through an as yet unknown mechanisms (16). S. aureus 
preferentially catabolizes glucose, but has catabolic genes for galactose and 
lactose utilization as well (17). Glycolytic and pentose phosphate cycle enzymes 
are expressed at high levels in the presence of excess glucose while TCA cycle 
enzymes are suppressed (18–21). Glycolysis produces two molecules of 
pyruvate for every one molecule of glucose consumed and reduces two 
molecules of NAD+ to NADH, which are shuttled to the electron transport 
pathway for re-oxidation. Pyruvate is further oxidized to acetyl-CoA and CO2 
during aerobic growth, producing acetate and additional ATP (22, 23). Proteome 
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analysis suggests much of the cellular ATP is produced via substrate level 
phosphorylation when S. aureus is cultured in rich media (22, 24).  
As a facultative anaerobe, S. aureus regenerates NAD+ for glycolysis by 
dissimilatory nitrate reduction or fermenting several sugars and amino acids to 
maintain redox balance in the bacterial cell. For energy supplementation or in the 
absence of an alternative terminal electron acceptor, S. aureus relies on mixed-
acid and butanediol fermentation to recycle NAD+/NADH during anaerobic 
growth. Metabolite analysis of S. aureus cultured in a complex medium indicates 
S. aureus primarily consumes glucose, arginine and threonine, while ethanol, 
lactate and ornithine mainly accumulate as a result of fermentation. The pyruvate 
dehydrogenase complex and enzymes of the tricarboxylic acid cycle are down-
regulated to prevent excess NADH production in the absence of oxygen (24, 25).  
1.3 The niche 
S. aureus is most frequently isolated from the anterior nares of the human 
nasal cavity, but the bacterium can be isolated from a range of areas on the skin 
and mucous membranes of humans and animals (26). S. aureus nasal carriage 
rates vary depending on a multitude of factors including age, gender, ethnicity 
and genetics, but at any point in time, S. aureus can be isolated from 20-30% of 
the human population (26–29). Isolation of S. aureus from the anterior nares is 
associated with a higher rate of subsequent isolation at other points on the body. 
A multi-center study found the endogenous S. aureus strain was identical to the 
isolated bacteremia causing S. aureus isolate in greater than 80% of patients 
(29). This conclusion highlights the well-documented observations that carriage 
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of S. aureus is a risk factor for subsequent nosocomial infections (30), as often 
the patient’s first line of defense – the skin – is breached in some manner (26). 
The practice of screening for S. aureus and decolonizing, typically by application 
of mupirocin to the nasal cavity, if the bacterium is detected has been promoted 
as an effective means to reducing nosocomial infections, but the benefits and 
outcomes of decolonization have been mixed when scientifically controlled and 
studied (31–33). 
1.4 Genetic diversity 
As a species, S. aureus is classically differentiated from other closely 
related bacterial species by the formation of golden circular colonies and testing 
positive in the catalase assay. The availability of inexpensive and fast DNA 
sequencing analysis has led to an exorbitant amount of detailed genetic and 
evolutionary data published revealing immense genetic diversity within S. aureus 
(34–43). Collectively, published genomic analyses revealed the average S. 
aureus genome to be ~2.8 Mb, but the species has widespread variation among 
isolates, with as much as ~20% of the genetic content considered dispensable 
(37). This genetic variability is centered around antibiotic resistance and 
virulence factor acquisition, commonly encoded on mobile genetic elements and 
phages (35, 41). Genetic variability is strictly limited to these factors; single 
nucleotide polymorphisms within the core genome have been shown to have 
dramatic effects of virulence and gene expression (38, 44, 45). Additionally, at 
least two examples of a large recombination event, replacing 10% and 20% of 
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the S. aureus chromosome, have been documented, leading to pandemic clonal 
linages (46). 
Much of the evolutionary genetic analysis for S. aureus has focused on 
emergence and development of antibiotic resistance as well as strain and clonal 
expansion of methicillin-resistant S. aureus (MRSA) strains. The genetic 
determinant for methicillin resistance is encoded by the mecA gene carried on 
the staphylococcal cassette chromosome (SCCmec). The gene product is an 
alternative penicillin binding protein, PBP2a. This protein has reduced affinity, 
relative to the endogenously encoded PBP2, for a broad spectrum of β-lactam 
antibiotics, allowing for continued cell-division in their presence (47–51). The 
origin of methicillin resistance is not presently clear. Evidence suggests the origin 
of mecA may have originated in the methicillin-susceptible Staphylococcus sciuri, 
but evidence is lacking on how this normal physiological functioning protein 
evolved to give rise to β-lactam resistance in S. aureus (52). What is clear, 
however, is methicillin-resistance has arisen independently multiple times in S. 
aureus and is the result of horizontal gene transfer of SCCmec from MRSA to 
methicillin-susceptible S. aureus progenitor strains (53). 
On a broad scale, three groups of S. aureus lineages can be defined: 
livestock associated (LA-MRSA), healthcare-associated (HA-MRSA), and 
community-associated (CA-MRSA). The emergence of LA-MRSA is of great 
concern as zoonotic infections between caretakers and animals have been 
documented and genetic analyses of LA-MRSA isolates suggest they contribute 
significantly to the overall burden of MRSA infections (54). Interestingly, genetic 
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analysis of LA-MRSA isolates indicates the progenitor was likely a human 
methicillin sensitive S. aureus (MSSA) strain. This strain likely rapidly adapted to 
livestock, even losing human-specific immune modulators, but gaining resistance 
to methicillin and tetracycline, two antibiotics associated with feedstock (55–57). 
The commercial development of penicillin as a tool to fight Gram-positive 
bacterial infections was dramatic and immediate, but the overuse and misuse of 
the drug was its downfall. Within four years of the antibiotic’s introduction, 
penicillin-resistant infections were reported (26, 58). The introduction of 
methicillin to treat penicillin-resistant S. aureus infections was short lived as well. 
Just two years after its licensing for use in England, the first isolate of MRSA was 
reported in 1961. By 1968, MRSA had been reported in the United States (39). 
Since then a common theme has emerged; a new antibiotic is introduced, and 
within a short period of time, resistant isolates arise. The genome of S. aureus is 
highly plastic, but conjugation and transduction are not solely responsible for the 
development of drug-resistant strains. S. aureus is also capable of developing 
resistance during the course of an infection, resulting from point mutations in the 
core genome (43). HA-MRSA infections often form at the site of surgical incisions 
or repeated skin breaks (often occurring in diabetics or dialysis patients) due the 
repeated administration of antibiotics over a long period of time (7, 59). 
In the last two decades, MRSA has moved from being a strictly hospital-
associated infection to an infection regularly acquired in community settings. 
These CA-MRSA strains were initially thought to be the result of “escaping” HA-
MRSA strains, but genetic analyses of these isolates revealed they have minimal 
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genetic relatedness to their HA-MRSA counterparts. Most notably, CA-MRSA 
strains carry smaller, distinct SSCmec elements and are often Panton-Valentine 
Leukocidin (PVL) positive (60). The mere presence of PVL does not explain the 
global expansion of CA-MRSA and is likely related to the diverse genetic 
backgrounds and antibiotic susceptibilities of CA-MRSA strains (61). It has been 
suggested the emergence of CA-MRSA has been a complex and progressive 
evolutionary development of distinct non HA-MSSA strains which gained 
virulence factors and antibiotics, going unnoticed by medical professionals for 
many years (62). While invasive infections are possible, CA-MRSA infections 
more commonly result in purulent skin and soft tissue infections. 
1.4.1 Single nucleotide polymorphisms  
A single nucleotide polymorphism (SNP) is a variation in the DNA 
sequence at the same site between two isolates of the same biological species. 
Synonymous SNPs are silent and have a minimal role in the evolution of the 
organism, as they do not alter the expression level or primary protein sequence; 
however, SNPs may be useful for genetic typing of the species and evolutionary 
analyses (63). Non-synonymous SNPs may alter the expression level of genes if 
they occur in regulatory regions (called eSNPs). Alternatively, if non-synonymous 
SNPs occur in the coding region of a gene, they may result in missense or 
nonsense mutations.  
Identifying and classifying isolates of S. aureus are common laboratory 
practices and are important epidemiologically to determine colonality and prevalence 
of isolates, as well as follow outbreaks (64). Several molecular techniques utilize 
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SNPs to group isolates of S. aureus: multi-locus sequence typing; pulsed field gel 
electrophoresis; and PCR coupled with sequencing-based assays, such as SCCmec, 
spa, coa and agr typing (65–70). Additionally, genetic analysis has shown SNPs have 
a prominent role in the development of antibiotic resistance (71–73). For example, 
SNPs within the mprF gene and rpoB result in resistance to daptomycin and 
rifampicin, respectively (74, 75). On a large scale, SNPs are useful for high-resolution 
epidemiological surveillance of S. aureus outbreaks (76–78). 
Bacterial genomes are not static and whole-genome sequencing has 
revealed SNPs to be the largest source of genetic diversity with a bacterial species. 
Additionally, SNPs are often the result of individual environmental experiences 
exerting positive selection forces on individual genomes that lead to adaptive 
changes (79–81). SNPs within promoter regions can affect virulence factor 
expression (82) and may even dictate host specificity (83). For example, an SNP 
present within the promoter region of the thermostable direct haemolysin gene of 
Vibrio parahaemolyticus up-regulates haemolysin expression (84). SNPs contribute 
to the strain-specific characteristics of S. aureus and other bacteria, acting as 
endogenous sources of experimental genetic variation with the end result to enhance 
fitness (77, 85, 86). 
The rate and level of transcription of a gene is affected by several factors, 
including the promoter affinity for DNA-dependent RNA polymerase and the presence 
of transcription factors. Bacteria possess only one RNA polymerase (RNAP) which is 
responsible for all transcription within the cell. An RNAP is capable of initiating 
transcription by itself, but must be associated with a sigma factor, which is responsible 
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for DNA sequence recognition, to create a holo-RNAP capable of extended 
transcription (87). An archetypal bacterial promoter consists of a pair of 
hexanucleotide consensus motifs, termed the -10 (TTGACA) and -35 boxes 
(TATAAT), separated by a ~17 bp spacer and is recognized by the housekeeping 
sigma factor, termed σA in Gram-positive bacteria (88). This archetypal promoter is 
the most efficient promoter of gene transcription, but SNPs within the consensus 
motifs alter RNAP’s affinity for the promoter, reducing the rate of transcription, 
providing the first level of transcriptional regulation (89). 
DNA-binding transcription factors (TF) are proteins which regulate the 
expression of genes in response to an internal or external stimuli. They bind cis acting 
TF binding sites and, much like RNAP and sigma factors, SNPs within the cis acting 
elements alter the binding site from the optimal consensus sequence of the respective 
TF and dictate the affinity of the TF for DNA. The SNPs subsequently alter the 
efficiency of the TF to regulate transcription via interaction with RNAP (90).  
In experiments described in chapter two, the differential expression hla, 
encoding α-toxin, between bovine and human isolates of S. aureus is linked to the 
presence of SNPs in the hla promoter region that increase the DNA-binding affinity 
of the activating SarZ TF, leading to hyperproduction of α-toxin. 
1.5 Two-component signal transduction systems 
S. aureus possesses many genes that allow the organism to sense and 
adapt to ever-changing environmental conditions. At least 16 operons encode 
two-component signal transduction systems (TCSs) in S. aureus (17), with 14 
conserved in all sequenced genomes (91). These TCSs sense environmental 
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conditions and manipulate cellular responses accordingly. Cellular responses 
frequently result in increased resistance to antibiotics (73, 92); regulated 
expression of accessory genes critical for infection (45, 93–97); and necessary 
metabolic changes (98–101). 
A prototypical TCS consists of a dimerized sensor histidine kinase (HK) 
which responds to a specific environmental cue(s) by transautophosphorylating 
and subsequently transferring the phosphate to a cognate response regulator. 
Phosphorylation of the response regulator activates the effector function of the 
protein. The effector function ultimately leads to modulation of gene expression 
within the TCS regulon, mediating the cellular response to the environmental cue 
(102–105). A detailed structural analysis of the many subclasses of TCSs can be 
reviewed in Mascher et al. (106) and M.Y. Galperin (107). 
 At least 16 operons encode two-component signal transduction systems 
(TCSs) in S. aureus (17), with 14 conserved in all sequenced genomes (91), 
which sense environmental conditions and manipulate cellular responses 
accordingly. Many TCSs have been investigated and their roles within the S. 
aureus are well understood as identified in Table 1-1. Typically the loss of a TCS 
is not lethal to the bacterium under in vitro growth conditions, but it may alter the 
normal gene expression and/or phenotype of the cell. There are two known 
exceptions to the non-essentiality of S. aureus TCSs, the walKR (vicRS, yycGF) 
TCS and yhcSR TCS, which have been shown to be indispensable for bacterial 
cell viability. The walKR system is a major regulator of cell wall metabolism within 
the S. aureus cell (108). Independently, the genes controlled by WalKR are not 
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essential (109, 110); WalKR positively regulates at least five major genes 
involved in cell wall metabolism and the deletion of walKR likely leads to a 
synergetic loss of cell wall metabolism enzymes that results in cell death (108). 
Recently, novel inhibitors have been identified for the WalKR system and 
continued research will determine if these chemicals will be therapeutically 
beneficial (111–115). 
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Table 1-1 Two-component systems of Staphylococcus aureus 
TCS 
Gene(s) or locus 
namesa Function Reference(s) 
1 agrCA 
quorum sensing and accessory gene 
regulation (116) 
2 saeRS 
exo-protein regulation and innate 
immune evasion 
(45, 117, 
118) 
3 arlRS virulence and biofilm regulation (119, 120) 
4 graRS 
vancomycin resistance and SOS 
response (92, 121) 
5 vraRS 
vancomycin resistance and 
peptidoglycan remodeling enzymes (122) 
6 lytRS programmed cell death and autolysis (123, 124) 
7 ssrAB (shrAB) 
anaerobic growth and TSST-1 
regulation (125, 126) 
8 nreBC 
dissimilatory nitrate reduction 
regulation (101, 127) 
9 walKR (yycFG) 
cell wall metabolism regulation; 
essential (108) 
10 yhcSR (airSR) 
aerobic/anaerobic growth and 
exported protein regulation; essential 
(100, 128–
130) 
11 kdpDE extracellular K+ sensing (98) 
12 hhsRS heme sensing and detoxification (131) 
13 braSR bacitracin resistance associated (132) 
14 SA0216-SA2015 unknown  
15 SA1158-SA1159 unknown  
16 SA1516-SA1515 unknown; phoP/phoR-like  
a Loci numbers based on Staphylococcus aureus N315 sequence (17) 
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The majority of response regulators are helix-turn-helix DNA-binding 
transcription factors and their effector function is transcriptional regulation (102, 
107). In cases of transcriptional activation the response regulator binds an 
upstream binding site and facilitates loading of the holo-RNAP on the promoter 
via interaction with the alpha C-terminal domain of the RNAP complex. 
Alternatively, the response regulator binding site may overlap the -35 motif, in 
which case the response regulator directly binds the sigma factor in the holo-
RNAP facilitating transcription initiation (87). AgrA binding to the region between 
the P2 and P3 of the divergent RNAII and RNAIII promoters is an example of a 
third mechanism of positive regulation, whereby response regulator binding 
induces a conformational change in the DNA and increases access to the 
promoter so the holo-RNAP can bind the promoter elements (133). In studies 
described in chapters 4-6, positive transcriptional regulation of the lacABCDE, 
opuCABCD, sspABC, and crtOPQMN by the YhcSR TCS is presented.   
1.6 Thesis rationale and goals 
Alpha-toxin is an important virulence factor for many types of S. aureus 
infections in humans and animals (134, 135). Infections by S. aureus impose 
enormous financial burdens on human public health services and animal 
agriculture producers. The emergence of a hyper-producing alpha-toxin sub-type 
of S. aureus poses a public health risk and impacts the financial interests of 
animal producers. The goal of chapter 2 was to identify the mechanism(s) that 
are responsible for the up-regulation of alpha-toxin in the S. aureus RF122 strain.  
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Two-component signal transduction systems are the second largest family 
of transcription factors in S. aureus (91), with prominent roles in metabolism, 
cellular division, and virulence factor production. These systems are a critical part 
of the intricate genetic regulatory system in S. aureus. While most of the TCSs 
have been studied, some extensively, a handful remain to be characterized. One 
of these, the yhcSR TCS, is of special interest because it was found to be 
essential in the S. aureus RN4220 laboratory strain, making it a potential new 
target for novel antibiotic development. The goal of this section of the dissertation 
is to verify the essentiality of yhcSR in clinical isolates of MRSA, identify the 
underlying mechanism of essentiality through characterization of inducible 
mutants and identification of regulated genes, and determine if yhcSR had a role 
in pathogenesis.  
1.7 Summary of thesis 
The underlying mechanisms of hyper-production of alpha-toxin (hla) in S. 
aureus RF122 are three-fold. At least four known positive transcriptional 
regulators - sarZ, arlS, saeS, and agrA - and one negative transcriptional 
regulator, rot, are up-regulated and down-regulated, respectively, compared to 
the low alpha-toxin producing strain, WCUH29. Additionally, the positive 
regulator SarZ has a higher binding affinity for the RF122 hla promoter, which 
may be related to the presence of SNPs located in the upstream promoter region 
of all alpha-toxin hyper-producing strains isolated in this study. The differential 
expression of trans transcriptional factors and the presence of cis transcriptional 
elements that promote up-regulation cumulatively result in an eight-fold increase 
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in hla transcription relative the low alpha-toxin expressing S. aureus WCUH29 
strain ultimately leading to a dramatic increase of the effector toxin, alpha-toxin in 
S. aureus RF122. 
As a continuation of work published in 2005 (128), the essentiality of the 
yhcSR TCS was confirmed in the HA-MRSA strain WCUH29 and yhcS antisense 
RNA was shown to inhibit growth of the CA-MRSA strain 923 and MSSA strain 
Newman, suggesting it is essential in those strains as well. In collaboration with a 
former post-doctoral associate, YhcSR was found to promote the transcription of 
the lacABCDE and opuCABC operons involved in lactose catabolism and cellular 
osmotic maintenance. Heterologous expression of these genes during depletion 
of yhcSR by antisense RNA could partially restore growth to S. aureus, 
suggesting they may be linked to yhcSR essentiality. As neither operon contains 
genes which were essential individually, it is possible the essential nature of 
yhcSR is linked to its global regulatory role. My work, and that of others (136, 
137), indicate the YhcSR TCS is involved in regulation of a variety of cellular 
pathways and it is possible that the cumulative dysregulation of all these 
pathways during depletion of yhcSR results in cell death.  
Lastly, I show the YhcSR TCS system transcriptional promotes expression 
of two virulence factor operons involved in innate immune system evasion. The 
first is the protease operon, sspABC. The proteases encoded by this operon 
SspA (V8 Protease) and SspB (Staphopain B) perform a variety of functions such 
as cleaving Protein A from the bacterial cell-wall (138) to proteolytically cleaving 
and inactivating complement factors (139) and antibody (140) to suppress innate 
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immune system recognition of S. aureus. The overproduction of YhcR promotes 
survival of S. aureus WCUH29 in heparinized human whole blood via up-
regulation of the SspAB proteases which degrade opsonins and prevent 
phagocytosis. The second virulence factor positively regulated by YhcSR is 
staphyloxanthin, a golden carotenoid, produced by the crtOPQMN biosynthetic 
operon. Staphyloxanthin is important for protection against reactive oxygen 
species produced by phagocytic cells. The overproduction of YhcR increased 
staphyloxanthin production resulting in increased tolerance to hydrogen peroxide 
and enhanced S. aureus survival in whole blood. Elimination of staphyloxanthin 
production in the background of YhcR overproduction completely eliminated 
enhanced survival of S. aureus in human blood. Taken together, YhcSR 
transcriptionally regulates two virulence factor operons involved in anti-
phagocytosis and immune evasion, directly linking this novel essential TCS to the 
pathogenesis of S. aureus.  
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Chapter 2  : Identification of Single Nucleotide 
Polymorphisms Associated with Hyperproduction of 
Alpha-toxin in Staphylococcus aureus 
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2.1 Overview 
The virulence factor α-toxin (hla) is needed by Staphylococcus aureus in 
order to cause infections in both animals and humans. Although the complicated 
regulation of hla expression has been well studied in human S. aureus isolates, 
the mechanisms of hla regulation in bovine S. aureus isolates remain undefined. 
In this study, we found that many bovine S. aureus isolates, including the RF122 
strain, generate dramatic amounts of α-toxin in vitro compared with human 
clinical S. aureus isolates, including MRSA WCUH29 and MRSA USA300. To 
elucidate potential regulatory mechanisms, we analyzed the hla promoter regions 
and identified predominant single nucleotide polymorphisms (SNPs) at positions -
376, -483, and -484 from the start codon in α-toxin hyper-producing isolates. 
Using site-directed mutagenesis and hla promoter-gfp-luxABCDE dual reporter 
approaches, we demonstrated that the SNPs contribute to the differential control 
of hla expression among bovine and human S. aureus isolates. Using a DNA 
affinity assay, gel-shift assays and a null mutant, we identified and revealed that 
an hla positive regulator, SarZ, contributes to the involvement of the SNPs in 
mediating hla expression. In addition, we found that the bovine S. aureus isolate 
RF122 exhibits higher transcription levels of hla positive regulators, including 
agrA, saeR, arlR and sarZ, but a lower expression level of hla repressor rot 
compared to the human S. aureus isolate WCUH29. Our results indicate α-toxin 
hyperproduction in bovine S. aureus is a multifactorial process, influenced at both 
the genomic and transcriptional levels. Moreover, the identification of 
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predominant SNPs in the hla promoter region may provide a novel method for 
genotyping the S. aureus isolates. 
 
2.2 Introduction 
S. aureus is an important pathogen capable of causing both animal and 
human infections such as pneumonia, endocarditis, toxic shock syndrome and 
bovine mastitis. The continuous increase of infections associated with both 
hospital- and community-acquired methicillin resistant Staphylococcus aureus 
(HA-MRSA and CA-MRSA) has caused serious public health concerns (141). 
The ability of this organism to cause a wide variety of infections partially depends 
on the coordinated and regulated expression of multiple cell- and surface-
associated virulence factors (142, 143) and exported proteins including various 
proteases and toxins (144).  
Alpha-toxin plays a critical role in the modulation of S. aureus–induced 
cytotoxicity in Jurkat T-lymphocytes, human peripheral blood lymphocytes, 
monocytes (145) and epithelial cells (146), even though multiple virulence factors 
are required for the bacterium to induce apoptosis in endothelial cells (147). 
Alpha-toxin can interact specifically with surface receptors of the host cells, form 
functional transmembrane pores, and selectively release ions, and/or leads to the 
activation of cell signaling pathways, thus inducing apoptosis and/or necrosis in 
various cell types (148–152). Recently, we demonstrated that α-toxin can interact 
with α5β1-integrin to interfere with S. aureus adhering to and internalizing into 
human lung epithelial cells (A549) (153). The interaction of α-toxin with α5β1-
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integrin contributes to the cytotoxicity of α-toxin that is required for S. aureus to 
induce apoptosis and death of the epithelial cells (146). However, the role played 
by α-toxin depends on the stage and/or type of infection and the quantities 
produced. It has been demonstrated that α-toxin is an important virulence factor 
in experimental brain abscesses and pneumonia (154–156) and intraperitoneal 
infection (157, 158), whereas the overproduction of α-toxin significantly reduces 
virulence in experimental endocarditis (159).  
Alpha-toxin expression is up-regulated in the stationary growth phase in 
vitro (116) and at later stages of animal infection (160, 161). The expression of α-
toxin is simultaneously regulated by different regulators, which have been well-
documented and reviewed elsewhere (116, 162). The expression of α-toxin is 
positively regulated by various global regulators, including two-component signal 
transduction systems such as the accessory gene regulator (Agr) (116, 163), the 
staphylococcal accessory protein effector (SaeRS) (117, 164), ArlRS (165, 166) 
and transcriptional regulators Mgr (167) and SarZ (168–170). In contrast, the 
homologues of staphylococcal accessory regulator (SarA), including Rot and 
SarT, repress the expression of α-toxin (171, 172). The role of SarA in 
modulating hla transcription is controversial: SarA affects hla expression in both 
an agr-dependent and agr-independent manner (161, 173). In addition, it has 
been revealed that hla transcription is affected by additional factors, including the 
alternative sigma B factor (σB) and environmental stimuli (174, 175). 
Alpha-toxin also serves as a virulence factor in S. aureus-induced mastitis 
(176, 177). It has been found that significant increases in milk antibodies to α- 
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and β-toxins are present in cows with chronic staphylococcal mastitis (178), and 
that many S. aureus isolates from the mammary gland of dairy cows produce α-
toxin (179). The comparative genomic analysis of human and bovine S. aureus 
isolates suggests that a unique mechanism may be involved in the pathogenicity 
of bovine S. aureus isolates (152) and that some bovine S. aureus isolates 
generate dramatic amounts of α-toxin (135). However, the mechanism of 
hyperproduction of α-toxin in some bovine S. aureus isolates remains undefined.  
In the present study, we compared the expression profiles of exported 
proteins between bovine S. aureus isolates and human clinical S. aureus 
isolates. We found hyperproduction of α-toxin in many bovine S. aureus isolates 
and investigated potential mechanisms of up-regulation of hla using site-direct 
mutagenesis, transcriptional promoter-reporter fusion, and quantitative RT-PCR 
approaches. Our results indicate α-toxin hyperproduction in bovine S. aureus is a 
multifactorial process, influenced at both the genomic and transcriptional levels. 
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2.3 Materials and methods 
2.3.1 Bacterial strains, plasmids and growth media.  
The bacterial strains and plasmids used in this study are listed in Table 2-
1. The human S. aureus strains were obtained from the Network on Antimicrobial 
Resistance in Staphylococcus aureus or references indicated. The bovine S. 
aureus isolates were obtained from geographically diverse animals that received 
care at the University of Minnesota’s Veterinary Diagnostics Laboratory. The S. 
aureus cells were cultured in Trypticase soy broth (TSB) at 37˚C with shaking. E. 
coli strains were grown in Luria-Bertani (LB) medium. Transformants containing 
recombinant plasmids were selected on LB agar containing ampicillin (100 µg/ml) 
for E. coli and TSA containing chloramphenicol (10 µg/ml) for S. aureus.  
2.3.2 SDS-PAGE analysis of exported proteins.  
The supernatants were collected from the overnight cultures of S. aureus 
isolates in TSB medium by centrifugation at 3900 x g. The exported proteins 
were precipitated from an equal volume of supernatant using ethanol as 
described (157). The exported protein profiles were detected by a sodium 
dodecyl sulfate (SDS)-12% polyacrylamide gel electrophoresis (PAGE) and 
Coomassie Blue staining.  
Statistical analysis. Data are the means ± standard errors of the means from 
three experiments. The symbol “*” indicates a significant difference (P ≤ 0.05) 
using an unpaired t test.  
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2.3.3 Construction and detection of promoter-gfp-lux dual reporter fusions.  
In order to further confirm the transcriptional regulation of hla expression, 
we created hla promoter-gfp-lux dual reporter constructs as previously described 
(117). The gfp-lux dual reporter fusion system was provided courtesy of Philip Hill 
(180). An approximate 1kb upstream region of hla was amplified from both 
WCUH29 chromosomal DNA and RF122 chromosomal DNA by PCR, 
respectively, using the primers listed in Table 2-2, digested with EcoRI and XmaI, 
and ligated into the upstream region of the promoterless gfp-lux of pCY1006, 
which was digested with the same enzymes. The resulting recombinant plasmids 
pXL1107 and pXL1207 were electroporated into S. aureus RN4220, then into 
both WCUH29 and RF122, resulting in S. aureus strains SaRN1107, SaRN1207, 
SaWH1107, SaWH1207, SaRF1107 and SaRF1207. The lux expression was 
monitored until early stationary phase in TSB with an appropriate antibiotic at 
37°C with a Chiron luminometer. The relative light units (RLU) were calculated 
(bioluminescence intensity/optical density at 600nm). For western blot analysis of 
Gfp expression in different hla promoter-gfp fusions in RF122, a 1:100 dilution of 
an overnight culture was grown and the same number of bacterial cells was 
harvested from cultures at an optical density of 1 at 600 nm by centrifugation. 
The whole cell lysates were prepared, and the same volume of lysate was loaded 
on 12% SDS-PAGE and probed by rabbit anti-Gfp antiserum using western blot 
assay. The density of the reaction band in equal area was scanned and 
calculated using ImageJ software.  
25 
 
2.3.4 Site-directed mutagenesis.  
To determine whether hla transcription is modulated by single nucleotide 
polymorphisms (SNPs) in the RF122 hla promoter, site-directed mutations were 
generated by PCR using the pXL1207 as a template and the QuikChange site-
directed mutagenesis kit (Stratagene, La Jolla, CA) according to the 
manufacturer's instructions except that primer extension was allowed to continue 
for 8 min. The primers used for site-directed mutagenesis are listed in Table 2-2. 
The mutations were confirmed by DNA sequencing of the region containing the 
mutation. The reformed plasmids were designated pXL1307, pXL1407 and 
pXL1507, and electroporated into RN4220, then into WCUH29 and RF122. The 
resulting S. aureus strains were named SaRN1307, SaRN1407, SaRN1507, 
SaWH1307, SaWH1407, SaWH1507, SaRF1307, SaRF1407 and SaRF1507. 
 The chromosomal DNA from each bovine mastitis S. aureus isolate listed 
in Table 2-1 was purified and the promoter region of hla from each isolate was 
obtained by PCR using the same primer listed in Table 2-2. The PCR products 
were purified and sequenced; the DNA sequences were deposited in GenBank 
(accession #HQ592340 to HQ592346). 
2.3.5 DNA affinity purification of hla promoter region binding proteins.  
In order to identify regulators associated with SNPs, we utilized 
Dynabeads M-280 strepavidin coated paramagnetic beads (Invitrogen, Carlsbad, 
CA) to identify DNA-binding proteins according to the manufacturer’s protocol. A 
265 bp PCR fragment spanning the RF122 hla promoter SNP region was PCR 
amplified using the primers RF122-phla217for and phlarev482 listed in Table 2-2 
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and purified using a PCR cleanup kit (Promega, Madison, WI). Approximately 9 
μg of purified biotinylated hla promoter region was mixed with the beads. The 
mixtures were incubated at room temperature for 30 minutes with occasional 
gentle mixing. The beads were washed and resuspended in Protein Binding 
Buffer (10 mM Tris–HCl pH 7.5, 50 mM NaCl, and 1 mM DTT), then mixed with 
500 μg of total cytoplasmic protein of RF122. The reaction mixtures were 
incubated at room temperature for 30 minutes with gentle, occasional swirling. 
The extra protein supernatant was removed and the beads were washed with 
Protein Binding Buffer to remove nonspecific binding proteins before being 
resuspended in 28 µl of Elution Buffer (10 mM Tris–HCl pH 7.5, 10% glycerol, 1 
M NaCl, and 1 mM DTT) and incubated at room temperature for 30 minutes with 
occasional vortexing. A portion of the cytoplasmic protein fraction, washes, and 
elutes from the beads were detect by SDS-PAGE and visualized by Coomassie 
Blue staining. 
2.3.6 Construction of sarZ null mutant in RF122 strain.  
Construction of sarZ null mutant in RF122 isolate was performed by phage 
transduction as described (170). Dr. Adhar Manna provided us with a sarZ 
mutant of RN6390 (AM1090). A phage Ф80α lysate of AM1090 was prepared to 
infect bovine S. aureus isolate RF122 to create a sarZ null mutant of RF122, 
which was confirmed by diagnostic PCR and DNA sequencing of the flanking 
regions of sarZ. This null mutant was designated as BSasarZ. The different hla-
promoter-gfp-lux reporter fusions pXL1107, pXL1207, pXL1307, pXL1407, and 
pXL1507, were each electroporated into BSasarZ. The resulting S. aureus 
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strains were named BSasarZ1107, BSasarZ1207, BSasarZ1307, BSasarZ1407, 
and BSasarZ1507. 
2.3.7 Cloning, expression, and purification of recombinant SarZ protein.  
The sarZ coding region was obtained by PCR using sarZ specific primers 
(sarZNdeIfor1 and sarZXhoIrev) listed in Table 2-2 from S. aureus and cloned 
into NdeI and XhoI sites of the E. coli expression vector pET24b. The 
recombinant DNA (pETsarZ) was confirmed by PCR and DNA sequencing and 
transformed into E. coli strain BL21. The transformants were incubated until mid-
log phase (OD600nm = ~0.4); followed by induction of sarZ expression by adding 
IPTG (final concentration 1mM). The His-tagged SarZ protein expression and 
purification were conducted as described (128). The purity of purified His-tagged 
SarZ protein was evaluated in a 12% SDS-PAGE followed by Coomassie Blue 
staining. 
2.3.8 Gel shift assays.  
The primers (Phla217for and Phlarev428) used for gel shift analysis are 
listed in Table 2-2. A 265 bp DNA fragment of hla promoter upstream region 
encompassing the SNPs was obtained by PCR using either RF122 chromosomal 
DNA or WCUH29 chromosomal DNA as a template. The amplified DNA 
fragments were purified and labeled with Digoxigenin using the DIG GEL Shift 
Kits (Roche, Madison, WI) according to the manufacturer’s protocol. The DNA-
binding and electrophoresis were performed as described (170). Briefly, the 
purified PCR products were labeled with Digoxigenin using terminal transferase 
(Roche, Madison, WI). The interaction of SarZ with DNA was conducted in a 10μl 
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reaction mixture containing 0.03pmol DIG-labeled DNA, 1μg of poly-(dI–dC), 
25mM NaH2PO4 (pH 8.0), 50mM NaCl, 2 mM MgCl2, 1mM DTT, 10% glycerol 
and increasing amount of SarZ protein. An unlabeled DNA fragment of the 
promoter region as a specific competitor was added into the reaction with 100-
fold excess to the labeled probe. After incubation at 25 oC for 20 min, the 
reaction mixtures were analyzed by 5% native PAGE.         
2.3.9 RNA purification and quantitative RT-PCR analysis (qPCR).  
Overnight cultures of S. aureus (WCUH29 and RF122) were incubated in 
TSB medium and grown to the mid-exponential phase of growth (OD600nm ~0.5) 
at 37°C with shaking. Cells were harvested by centrifugation at 3900 x g, and the 
RNA was isolated by the RNAPrep Kit (Promega, Madison, WI) according to the 
manufacturer's instructions. Contaminating DNA was removed with the TURBO 
DNA-free Kit (Ambion, Austin, TX) and the RNA yield was determined 
spectrophotometrically at 260nm. The integrity of the purified RNA was analyzed 
by electrophoresis in 1.2% agarose-0.66 M formaldehyde gels. The 23S and 16S 
rRNA bands were clear without any obvious smearing patterns.  
The first strand cDNA was synthesized using reverse transcriptase 
SuperScript III (Invitrogen, Carlsbad, CA). For each RNA sample, duplicate 
reactions of reverse transcription were performed in order to determine the levels 
of DNA contamination; there was also a control without reverse transcriptase. 
PCR reactions were set up in triplicate by using the SYBR Green PCR Master 
Mix (Bio-Rad, Hercules, CA). Real-time sequence-specific detection and relative 
quantification were performed with the Stratagene Mx3000P Real Time PCR 
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System. Relative quantification of the product was calculated using the 
Comparative CT method, as described for the Stratagene Mx3000P system. The 
housekeeping gene 16S rRNA was used as an endogenous control (117). All 
samples were analyzed in triplicate and normalized against 16S rRNA gene 
expression.  
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Table 2-1 Bacterial strains and plasmids  
Strain Description Source 
RN4220 laboratory S. aureus strain (rsbU-) (181) 
WCUH29 human clinical MRSA isolate NCIMB40771 
COL human MRSA isolates NARSA 
NRS105-
NRS384    
human MRSA isolates NARSA 
MW2 and 
USA300   
human clinical MRSA isolate (182) 
RF122 bovine mastitis S. aureus isolate (47) 
BSasarZ sarZ mutant of RF122 with sarZ::ermC     This study 
BSa12-Bsa110 bovine mastitis S. aureus isolates 
CVM Dia. 
Lab.  
SaRN1107 RN4220 carrying pXL1107 This study 
SaRN1207 RN4220 carrying pXL1207 This study 
SaRN1307  RN4220 carrying pXL1307 This study 
SaRN1407 RN4220 carrying pXL1407 This study 
SaRN1507 RN4220 carrying pXL1507 This study 
SaWH1107 WCUH29 carrying pXL1107 This study 
SaWH1207 WCUH29 carrying pXL1207 This study 
SaWH1307 WCUH29 carrying pXL1307 This study 
SaWH1407 WCUH29 carrying pXL1407 This study 
SaWH1507 WCUH29 carrying pXL1507 This study 
SaRF1107 RF122 carrying pXL1107 This study 
SaRF1207 RF122 carrying pXL1207 This study 
SaRF1307 RF122 carrying pXL1307 This study 
SaRF1407 RF122 carrying pXL1407 This study 
SaRF1507 RF122 carrying pXL1507 This study 
BSasarZ1107 BSasarZ carrying pXL1107 This study 
BSasarZ1207 BSasarZ carrying pXL1207 This study 
BSasarZ1307 BSasarZ carrying pXL1307 This study 
BSasarZ1407 BSasarZ carrying pXL1407 This study 
BSasarZ1507 BSasarZ carrying pXL1507 This study 
Plasmids  Description Source 
pCY1006   
Shuttle vector carrying agr promoter-gfp-lux 
reporter, derives from pSB2019, CmR, AmpR 
31 
pXL1107   WCUH29 hla promoter-gfp-lux reporter This study 
pXL1207   RF122 hla promoter-gfp-lux reporter This study 
pXL1307   RF122 (T→G) hla promoter-gfp-lux reporter This study 
pXL1407   
RF122 (TC→AT) hla promoter-gfp-lux 
reporter 
This study 
pXL1507   
RF122 (T→G/TC→AT) hla promoter-gfp-lux 
reporter This study 
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Table 2-2 Oligonucleotide sequences 
Sa0660RT For 5’-CATTGCTATTAGCGATGAAGGTATTGG-3’ 
 Rev 5’-CTGCTTACACTGATTTTTGCGTTATTTTGTTG-3’ 
Sa1246RT For 5’-ATGATAACACAGTGAGAGTTGAACC-3’ 
 Rev 5’-CTAACCCTTTGAAATCTTGCGTTG-3’ 
Sa1583RT  For 5’-TCAGCGAGATTGAAAGCGAATAC-3’ 
 Rev 5’-CTGTCCATTTCTTTAAGCGTCATAG-3’ 
Sa1844RT  For 5’-GTGAAATTCGTAAGCATGACCCAGTTG-3’ 
 Rev 5’-TGTAAGCGTGTATGTGCAGTTTCTAAAC-3’ 
Sa2174RT For 5’- TGGAACACTGACACCATTAC 
 Rev 5’- CTGATGCTTCTCGTTCTGAA 
Sa1007RT For 5’-CAACTGATAAAAAAGTAGGCTGGAAAGTGAT-3’ 
 Rev 5’-CTGGTGAAAACCCTGAAGATAATAGAG-3’ 
16S rRNART  For 5’-CTGTGCACATCTTGACGGTA-3’ 
 Rev 5’-TCAGCGTCAGTTACAGACCA-3’ 
  
PhlaT-Gfor 5’-GTTAATTTTTATTTAATAGTTAATTAATTGATTTA-3’ 
PhlaT-Grev 5’-TAAATCAATTAATTAACTATTAAATAAAAATTAAC-3’ 
PhlaTC-ATfor 5’-GATATTTCTATGTAATGGCAAAATTTATTCCCG-3’ 
PhlaTC-ATrev 5’-CGGGAATAAATTTTGCCATTACATAGAAATATC-3’  
PhlaForEcoRI 5’-ATGAATTCTTTAATCCCATATCACATTT-3’  
PhlaRevXmaI  5’-TACCCGGGTTTCATCATCCTTCTATTTT-3’ 
Phla217for 5’-BiosgGCCTCTAACTAAAAACCTAC-3’ 
Phlarev482 5’-GTAATCGATTACAATATAAAAATAC-3’ 
Sa2174NdeIfor1 5’-TTCATATGATGTATGTAGAAAACAGCTATC-3’  
Sa1274ZXhoIrev 5’-TTCTCGAGCTTTCTGTCGGAATAGTC-3’ 
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2.4 Results 
2.4.1 Hyperproduction of α-toxin in bovine mastitis S. aureus isolates, 
including RF122. 
The comparative genomic analysis of human and bovine S. aureus isolates 
suggested that a unique mechanism may be involved in the pathogenicity of 
bovine S. aureus isolates (183). Numerous studies have demonstrated that 
staphylococcal exported proteins, especially toxins, are important virulence 
factors in bovine mastitis (178, 179). To examine whether human and bovine S. 
aureus isolates produce distinct levels of toxins, we conducted hemolytic assays 
using a sheep blood agar plate. The supernatants from the overnight cultures of 
human isolates, WCUH29 and COL strains, had dramatically less hemolytic 
activity compared to that of bovine isolate RF122 (Fig. 2-1A). To further 
determine whether there are different exported protein profiles between human 
and bovine S. aureus isolates, we chose human clinical isolates, including 
WCUH29, different strains of MRSA and twelve bovine S. aureus isolates, 
including the RF122 strain, to compare their exported proteins using SDS-PAGE. 
None of the human isolates produced dramatic amounts of α-toxin (Fig. 2-1B). In 
contrast, seven bovine strains, including RF122, exhibited extremely high levels 
of α-toxin production (Fig. 2-1C), although five bovine strains produced α-toxin at 
levels similar to the human isolates (Fig. 2-1D). To further confirm the identity of 
the over-expressed protein, we conducted a MALDI mass spectrometry assay 
and identified that the highly expressed protein is α-toxin (data not shown). 
Furthermore, qPCR analysis identified that RF122 has an 8-fold higher level of 
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hla transcript compared to WCUH29, suggesting the up-regulation of α-toxin is at 
the transcription level (Table 2-3).   
 
Figure 2-1 Hemolytic analysis and SDS-PAGE of the expression profiles of 
exported proteins. (A) Hemolytic analysis on Sheep Blood Agar. SDS-PAGE 
analysis of the expression profiles of the exported proteins. (B) Human S. aureus 
isolates, Lane 1, WCUH29; Lane 2, NRS105; Lane 3, NRS194; Lane 4, NRS 
237; Lane 5, NRS243; Lane 6, NRS248; Lane 7, NRS384; Lane 8, MW2(956); 
Lane 9, USA300(1371); M, Precision Plus Protein Standard. (C) Alpha-toxin 
hyper-producing bovine mastitis S. aureus isolates. Lane 1, RF122; Lane 2, 
BSa39; Lane 3, BSa55; Lane 4, BSa60; Lane 5, BSa67; Lane 6, BSa68; Lane 7, 
BSa74; Lane 8, BSa97. M, Precision Plus Protein Standard. (D) Bovine mastitis 
S. aureus isolates. Lane 1, RF122; Lane 2, BSa12; Lane 3, BSa22; Lane 4, 
BSa28; Lane 5, BSa83; Lane 6, BSa110. M, Precision Plus Protein Standard. 
Arrow indicates α-toxin. 
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Table 2-3 Comparison of gene expression by qPCR analysis between the 
RF122 and WCUH29 strains 
ORF (N315)  Gene      Fold change (RF122/WCUH29) 
Sa1007  hla 8 
Sa2174  sarZ 3 
Sa1246  arlS 4 
Sa0660  saeS 8 
Sa1844  agrA 32 
Sa1583  rot -2 
16SrRNA   0 
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2.4.2 Identification of single nucleotide polymorphisms (SNPs) in the hla 
promoter region.  
To elucidate the potential mechanisms involved in up-regulating hla 
expression in the bovine S. aureus isolate RF122, we performed alignment 
analyses of hla promoter region based upon the published S. aureus genomes in 
the NCBI genome database. We found that the DNA sequences of hla promoter 
region are almost identical among the human S. aureus isolates (Fig. 2-2A). 
However, several nucleotides of the hla promoter region of bovine RF122 in the 
positions -484, -483 and -376 from the start codon are different from those of 
human isolates (Fig. 2-2A). To further investigate whether these differences exist 
in other human and bovine isolates, we isolated the chromosomal DNA from 
these isolates and the hla promoter region was amplified by PCR for sequencing. 
The DNA sequencing results showed that among seven α-toxin over-expressing 
S. aureus isolates, six isolates possess the same hla promoter DNA sequence as 
RF122 (Fig. 2-2B), indicating that these bovine isolates have predominant SNPs 
in the hla promoter region. In contrast, the hla promoter sequences of the five α-
toxin hypoproduction strains were identical to the human S. aureus isolates (Fig. 
2-2B). In addition, the DNA sequences of hla promoter region from eight human 
isolates were identical to the published human isolates (data not shown). 
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Figure 2-2 Alignments of bovine and human S. aureus hla promoters.  
Structural alignments with homologues of the hla promoter region from 
sequenced bovine and published human S. aureus genomes. The symbol “–” 
represents the upstream region from the start codon of hla. The boxed nucleotide 
represents the major nucleotides of difference between bovine S. aureus isolates 
and the human S. aureus isolate. (A) Human S. aureus isolates (B) Bovine 
mastitis S. aureus isolates. 
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2.4.3 The SNPs in the hla promoter region affects hla transcription.  
The identification of predominant SNPs in the hla promoter region led us 
to hypothesize that the SNPs may be associated with the modulation of hla 
transcription. To test this possibility, we created both the human and bovine S. 
aureus hla promoter-gfp-luxABCDE dual reporter constructs in the human isolate 
WCUH29 and determined the hla expression levels by measuring 
bioluminescence intensity. The dual reporter construct carrying the RF122 hla 
promoter showed a significantly higher level of hla transcription than the dual 
reporter construct carrying the WCUH29 hla promoter (Fig. 2-3). The data 
suggests that the predominant SNPs in the RF122 hla promoter region are likely 
involved in the transcriptional modulation of hla expression. 
To confirm this finding, we first performed site-directed mutations in the 
hla promoter region using the RF122 hla promoter-gfp-luxABCDE dual reporter 
construct. The site mutations were confirmed by DNA sequencing. Then, we 
determined the impact of the nucleotide mutations on growth and hla expression 
by monitoring lux expression levels in the WCUH29 strain. The mutations in the 
hla promoter region had no impact on growth (data not shown). However, the 
nucleotide mutations in either -376 (T→G) or -484 and -483 (TC→AT) in the 
RF122 hla promoter region significantly decreased the reporter gene expression 
level compared to that of the parental promoter (Fig. 2.3). Furthermore, the 
double mutations (T→G/TC→AT) in the RF122 hla promoter region dramatically 
diminished the reporter gene expression, which was comparable to the construct 
carrying the WCUH29 hla promoter (Fig. 2-3). 
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Figure 2-3 Influence of SNPs hla promoter-luxABCDE reporters on 
bioluminescence intensity of S. aureus WCUH29.  
The maximal light intensity values are given as relative light units (RLU). The 
symbol “*” indicates a significant difference (P ≤ 0.05) between SaWH1207 and 
all other strains. 
 
To further confirm the role of the SNPs of the hla promoter region in 
controlling the hla over-expression in RF122 strain, we electroporated the above 
hla promoter-gfp-lux dual reporter constructs into the RF122 strain and examined 
the impact of the site-directed mutations in the hla promoter region on reporter 
gene expression. Surprisingly, no bioluminescence signal was detectable in the 
cultures of these strains. However, we found that the introduction of either the 
RF122 hla promoter-gfp-lux dual reporter or either of the single (T→G, TC→AT) 
mutated hla promoter-gfp-lux dual reporters into the RF122 strain either 
eliminated or severely reduced endogenous hla expression, respectively, 
indicating that dominant-negative effects occurred in the strains (Fig. 2-4A, lane 
2, 3 and 4). In contrast, the introduction of the WCUH29 hla promoter-gfp-lux 
reporter and the double mutated (T→G/TC→AT) RF122 hla promoter-gfp-lux 
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reporter did not have an appreciable effect on endogenous hla expression (Fig. 
2-4A, lane 5 and 6). In addition, we determined the impact of the SNPs of hla 
promoter region on reporter gfp expression using a western blotting assay. An 
intense band of Gfp was exhibited in the whole cell lysates of the reporter 
construct carrying the wild-type RF122 hla promoter; contrastingly, either no 
band or a weak band of Gfp was detected in the whole cell lysates of constructs 
carrying either the WCUH29 hla promoter or the double (T→G/TC→AT) mutated 
RF122 hla promoter (Fig. 2-4B). Both the T→G and the TC→AT mutations in the 
RF122 hla promoter led to a 2- to 3-fold decrease of gfp expression (Fig. 2-4B). 
Taken together, the above data demonstrate that the SNPs in the hla promoter 
region participate in the modulation of hla expression in the bovine S. aureus 
RF122 isolate. 
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Figure 2-4 Impact of hla promoter reporter and nucleotide mutations on 
alpha-toxin and GFP expression in RF122 strain. 
(A) SDS-PAGE analysis of hla expression of the S. aureus RF122 strain carrying 
different hla promoter-gfp fusions (Phla-fusions). Lane 1, RF122 control; Lane 2, 
SaRF1207 (RF122 Phla-fusion); Lane 3, SaRF1307 (G-376 mutated RF122 
Phla-fusion); Lane 4, SaRF1407 (AT-484-483 mutated RF122 Phla-fusion); Lane 
5, SaRF1507 (G-376 AT-484-483 mutated RF122 Phla-fusion); Lane 6, 
SaRF1107 (WCUH29 Phla-fusion); Lane 7, WCUH29 control. M, Precision Plus 
Protein Standard. (B) Western blot analysis of GFP expression from different 
Phla-fusions in RF122. Lane 1, SaRF1507; Lane 2, SaRF1307; Lane 3, 
SaRF1407; Lane 4, SaRF1207; Lane 5, SaRF1107. Black triangle indicates the 
increase of intensity of reaction band. (C) SDS-PAGE analysis of alpha-toxin 
expression of the S. aureus RF122 sarZ null mutant (BsasarZ). Lane 1, RF122 
control, Lane 2, BsasarZ control, Lane3, BSasarZ1107; Lane 4, BSasarZ1207; 
Lane 5, BSasarZ1307; Lane 5, BSasarZ1407; Lane 7, BSasarZ1507; M, 
Precision Plus Protein Standard. (D) Western blot analysis of Gfp expression 
from different Phla-fusions in BSasarZ. Lane 1, RF122 wild-type control; Lane 2, 
BSasarZ1107; Lane 3, BSasarZ1207; Lane 4, BSasarZ1307; Lane 5, 
BSasarZ1407; Lane 6, BSasarZ1507. (E) Hemolytic assay on Sheep Blood Agar.  
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2.4.4 SarZ is associated with the SNPs in the regulation of hyperproduction 
of α-toxin.  
In order to identify regulators that are involved in the SNPs’ regulation, we 
employed DNA affinity purification using a biotinylated RF122 hla promoter 
region oligonucleotide bound to Dynabeads M-280 Strepavidin coated 
paramagnetic beads. The cytoplasmic proteins of RF122 specifically binding to 
the hla promoter region oligonucleotide were eluted from the beads and 
separated by SDS-PAGE (data not shown). To determine the identity of hla 
promoter region binding proteins, we employed MALDI mass spectrometry 
assays and revealed SarZ and Mgr bound to the hla promoter region of RF122 
(data not shown).  
To confirm whether SarZ protein is associated with the SNPs in the 
modulation of hla expression genetically, we constructed a sarZ null mutant in 
the RF122 strain by phage transduction. The sarZ null mutant, BSasarZ, was 
confirmed by diagnostic PCR and DNA sequencing. The five individual hla 
promoter-gfp-lux reporter vectors were introduced into BSasarZ by 
electroporation. First, we examined how the loss of SarZ affected the 
endogenous hla expression by using a Sheep Blood Agar hemolysis assay and 
SDS-PAGE and found that the sarZ null mutation abrogates the α-toxin hyper-
production phenotype of RF122 (Fig. 2-4C and E). Furthermore, the sarZ 
mutation eliminated the dominant-negative effects of the RF122 hla promoter-
gfp-lux dual reporter (Fig. 2-4C) compared to the wild-type strains (Fig. 2-4A). 
Next, we determined the impact of SarZ on reporter gfp expression using a 
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western blotting assay. In contrast to the RF122 wild-type strain (Fig. 2-4B), no 
obvious difference of gfp expression was revealed in the whole cell lysates of 
sarZ mutants carrying the WCUH29 hla promoter, the single (T→G or TC→AT) 
mutated RF122 hla promoter, the double (T→G/TC→AT) mutated RF122 hla 
promoter or the wild-type RF122 hla promoter (Fig. 2-4D). 
To further confirm the specific effect of SarZ and identify binding affinity 
differences, we performed gel-shift assays. The PCR products were purified and 
labeled using DIG. The recombinant His-tagged SarZ protein was purified from 
E. coli, and was shown to be more than 95% pure as detected by SDS-PAGE 
(Fig. 2-5A). The gel-shift assays showed that the addition of as little as 100 ng of 
SarZ protein could retard the electrophoretic mobility of RF122 hla promoter 
region DNA (Fig. 2-5B), whereas approximately 500 ng of SarZ was required to 
retard the electrophoretic mobility of the WCUH29 hla promoter region DNA (Fig. 
2-5C). The shifted complexes of DNA-SarZ protein exhibited predominant bands 
when the amounts of SarZ for both hla probes was increased, whereas addition 
of excess amounts of the same, but unlabeled, hla promoter region (specific 
competitor) eliminated the electrophoretic mobility shift (Fig. 2-5B and C). These 
results indicate that the RF122 hla promoter binding affinity of SarZ is higher than 
for the WCUH29 hla promoter region.  
To examine whether the overproduction of α-toxin is also attributable to 
different levels of SarZ between human and bovine isolates, we performed real-
time RT-PCR. We found that in the RF122 strain the transcriptional level of sarZ 
was 3-fold higher than that of the WCUH29 strain (Table 2-3). Taken together, 
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the above results suggest that the SNPs’ regulation of hla expression may 
function through SarZ directly. Furthermore, it suggests the high level of α-toxin 
in the RF122 strain is a result of an increased transcription level of sarZ and 
increased binding affinity for the RF122 hla promoter by SarZ, leading to an α-
toxin hyper-producing phenotype. We did not investigate the impact of Mgr, 
because the DNA-binding motif (GTTG, (168)) of Mgr is outside the SNPs region 
in the hla promoter region.  
 
Figure 2-5 Gel-shift analysis of His-SarZ protein binding to the SNP 
containing region of the hla promoter. Lanes 1 to 5 correspond to 0, 0.1, 0.5, 
1.25 and 1.75μg, respectively, of purified His-SarZ (A) mixed with DIG-labeled 
hla promoter region of RF122 (B) and WCUH29 (C). Lane 6, the mixture of 
1.75μg of purified His-SarZ protein with DIG-labeled hla probe and 100-fold 
excess of unlabeled specific competitor DNA. Head arrow represents the first 
detected mobility shift of each hla promoter region.
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2.4.5 Involvement of agr, arlRS, saeRS and rot in the modulation of 
hyperproduction of α-toxin in the bovine S. aureus isolate RF122. 
It is well known that different regulators, including two-component signal 
regulators, such as agr, saeRS, and arlRS systems, and transcriptional 
regulators such as sarA family proteins, such as rot, coordinately regulate hla 
expression (116, 162). Building off of our previous finding that RF122 has a 
higher sarZ transcript level, we hypothesized the hyper-production of α-toxin may 
also be attributable to differential expression of these regulators between the 
bovine S. aureus RF122 and the human S. aureus WCUH29. To address this 
question, we examined the transcriptional levels of selected hla regulators using 
qPCR. The real-time RT-PCR results are shown in Table 2-3. In the bovine S. 
aureus RF122 strain, the transcriptional levels of hla positive regulator genes agr, 
saeRS and arlRS were higher than those in the human WCUH29 strain, whereas 
the transcriptional level of hla repressor gene rot was lower than that in the 
human WCUH29 strain (Table 2-3). The data suggest that the over-transcription 
of the hla positive regulators agr, arlRS, and saeRS and decreased transcription 
of the hla negative regulator rot also, at least in part, contributes to the α-toxin 
hyper-production phenotype of RF122.   
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2.5 Discussion 
Our studies revealed that the hla promoter region possesses predominant 
SNPs that contribute to the modulation of hla over-expression in some bovine S. 
aureus isolates. Although no specific SNP is identified in the hla promoter region 
of the human S. aureus isolates tested, we cannot exclude the possibility that 
SNPs may exist in the hla promoter region in other human S. aureus isolates. 
Notably, we identified that a known hla transcriptional regulator, SarZ, has a 
higher binding affinity for the SNPs region and contributes to the involvement of 
SNPs in regulating hla expression. Moreover, we revealed that the transcription 
level of sarZ is higher in the bovine S. aureus RF122 strain than in the human 
WCUH29 strain. This suggests that the higher transcription level of sarZ is, at 
least in part, involved in the α-toxin hyper-production phenotype of the RF122 
strain. Importantly, we also demonstrated that the SNPs contribute to the 
regulation of hla regardless of the genetic background, WCUH29 or RF122, in 
that the RF122 hla promoter-gfp-lux dual reporter construct had higher levels of 
expression in both backgrounds compared to the WCUH29 hla promoter-gfp-lux 
dual reporter construct. Additionally, the site-directed mutation of the RF122 
promoter’s SNPs progressively decreased reporter expression in both 
backgrounds (Fig. 2-3 and 2-4B). Our findings are partially supported by a 
previous report that ST151 strains, including the RF122 strain, have elevated 
levels of hla and RNAIII expression (135). Taken together, these findings indicate 
that unique mechanisms may be involved in the up-regulation of hla expression 
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in bovine S. aureus isolates, which in turn may partially contribute to the 
pathogenicity in bovine mastitis.  
DNA sequencing analysis indicates that there are predominant SNPs in 
the hla promoter region of bovine S. aureus isolates, which occur at positions -
376, -483 and -484 upstream, of the hla start codon. In the α-toxin 
hyperproduction isolates, there are apparent nucleotide shifts from G to T and T 
to C at positions -376 and -483, respectively, compared with the α-toxin 
hypoproduction isolates. These nucleotide shifts lead to a decreased binding 
affinity of SarZ (Fig. 2-5), which is consistent with a decreased hla expression 
level of the WCUH29 hla promoter-gfp fusion reporter system (Fig. 2-4B). It has 
been reported that the DNA-binding protein, SarZ, regulates hla expression by 
binding to the hla promoter region (169, 170), and is associated with the 
pathogenicity of S. aureus (169). Furthermore, the introduction of RF122 hla 
promoter-reporter fusion into the RF122 strain led to a dominant-negative effect 
on endogenous hla expression; this effect was eliminated in a sarZ null 
background. Taken together, the above data indicate that the SarZ protein has a 
higher binding affinity for the RF122 hla promoter and is directly involved in 
differential regulation of hla expression through SNPs, which in turn may 
contribute to virulence of some genetically similar bovine S. aureus. Our results 
are similar to previous findings that a single nucleotide (T→C) mutation at 
position -215 bp in the promoter region of the nitrate reductase operon narGHJI 
in Mycobacterium tuberculosis and Mycobacterium bovis leads to differential 
activity of reductase and altered virulence capacity (83); and that in Vibrio 
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cholerae, nucleotide differences at positions -65 and -66 bp in the tcpPH 
(encoding a toxin-coregulated pilus transcriptional activator pair, TcpPH) 
promoter region is not only responsible for determining the classical and EL Tor 
biotypes, but also contributes to differential regulation of virulence gene 
expression through a tcpPH regulator, AphB (82). Although we found that the 
DNA binding motif of Mgr is not located in the SNPs, we cannot exclude the 
possibility that Mgr may contribute to the hyperproduction of α-toxin, because 
sarZ is transcriptionally regulated by Mgr (170).  
It was reported that the ET3 clone is predominant in bovine mastitis S. 
aureus isolates (184) and that different subtypes exhibit different expression 
levels of α-toxin in the ET3 clone (135). The RF122 strain belongs to the ET3 
clone ST151 subtype (135); therefore, it is necessary to determine whether 
bovine S. aureus isolates that possess the predominant SNPs in the hla 
promoter region belong to the common bovine S. aureus clone (ET3) and/or the 
same subtype within the ET3 clone. The results would allow us to evaluate 
whether the identified predominant SNPs of the hla promoter region would be 
useful as a target for molecular diagnosis of S. aureus isolates that posses an α-
toxin hyper-productive phenotype and may cause severe bovine mastitis.       
The agr locus in S. aureus has been examined for its role in the 
expression of exotoxins and cell surface proteins (185). It has been reported that 
variations in α-toxin production of S. aureus isolates from humans and bovines 
were due to variations of the RNA III transcript in agr locus (148, 186). Our data 
also revealed that in the RF122 strain the transcriptional levels of hla positive 
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regulators genes agr, saeR and arlR are higher in the bovine S. aureus RF122 
strain than in the human WCUH29 isolate in the same culture medium; however, 
the transcription level of the hla repressor gene rot is lower in the RF122 strain. 
Although the SNPs are located outside of the hla promoter DNA-binding regions 
(GEEAAN6GTTAA from -405 to -390 or TTTAAN6GTTA from -190 to -175) of 
phosphorylated SaeR (94) and the DNA-binding motif of Mgr (170), to define the 
mechanisms of their regulation is beyond the scope of this study. In addition, we 
found that the impact of SNPs on hla expression in the sigma B deficient strain 
RN4220 (Figure 2-6) is the same as in the sigma B positive strains WCUH29 and 
RF122. Thus, we can exclude the potential effect of sigma B factor on the SNPs’ 
involvement in regulating hla expression, although sigma B factor is associated 
with mediating hla expression (174, 175).  
 
Figure 2-6 Influence of SNPs hla promoter-luxABCDE reporters on 
bioluminescence intensity of S. aureus RN4220. 
The maximal light intensity values are given as relative light units (RLU). The 
symbol “*” indicates a significant difference (P ≤ 0.05) between SaRN1207 and 
all other strains. 
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It was previously reported that the RF122 strain belongs to ST151 (a 
subtype of ET3 clone) (183). Our unpublished data showed that the supernatant 
of RF122 culture is more toxic than the supernatant of WCUH29 using MAC-T 
cells (187). This is consistent with recent findings that among ET3 subtypes, the 
ST151 strain is more virulent in an intramammary gland infection (135). Previous 
studies have also demonstrated that most S. aureus isolates from the mammary 
gland of dairy cows produce α-toxin (179). Significantly higher amounts of 
antibodies against both α- and β-toxins are exhibited in milk isolated from cows 
with chronic staphylococcal mastitis (178), and immunization of animals with 
attenuated α-toxin protects from S. aureus-induced mastitis (188). Taken 
together, the above data suggest that the hyperproduction of α-toxin is a 
probable key factor for S. aureus to cause severe cow mastitis, although we 
cannot rule out the importance of other virulence factors in the pathogenesis of 
bovine mastitis (189).  
In conclusion, we are the first to identify SNPs in the hla promoter region 
that results in the hyperproduction of α-toxin in many bovine S. aureus isolates. 
Importantly, we have identified and demonstrated that the DNA-binding protein 
SarZ has a higher binding affinity for the RF122 hla promoter region containing 
the SNPs and is transcribed at higher levels in the RF122 strain, thus 
contributing to the involvement of SNPs in differential regulation of hla 
expression. In addition, we found that the over-expression of agrA, arlR and 
saeR, and the down-regulation of rot, may partially contribute to the 
hyperproduction of α-toxin in the RF122 strain. 
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Chapter 3 : Characterization of the Staphylococcus 
aureus yhcSR two-component signal transduction 
system
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3.1 Overview 
Two-component signal transduction systems (TCSs) are important for 
adapting gene expression in response to extrinsic stimuli. Staphylococcal TCSs 
have a role in regulating a variety of pathways including cell-wall biosynthesis, 
biofilm development and virulence factor expression. The Staphylococcus aureus 
yhcSR two-component signal transduction system was previously shown to be 
essential in the S. aureus RN4220 laboratory strain and expression of yhcS 
antisense RNA inhibited growth of the HA-MRSA WCUH29 strain. As an 
extension of this previously published work, the yhcSR TCS was found to be 
absolutely essential for aerobic and anaerobic viability of S. aureus WCUH29. 
Furthermore, expression of yhcS antisense RNA in the CA-MRSA 923 and 
MSSA Newman strains inhibited bacterial growth. Additionally, the expression of 
yhcSR was dramatically up-regulated in the absence of oxygen and the 
importance for production of YhcSR in the absence of oxygen was highlighted by 
the inability of S. aureus to perform dissimilatory nitrate reduction during yhcS 
antisense RNA expression. Lastly, the YhcSR TCS may be involved in regulation 
of the cellular division or cell-wall biosynthesis. Depletion of YhcSR resulted in 
slower growth and abnormally large cells. Overproduction of the response 
regulator, YhcR, produced uniformly enlarged cells with possible cell-wall 
thickening as visualized by staining. The YhcSR TCS is essential for S. aureus 
growth and the essentiality is likely related to regulation of cellular metabolic 
pathways.    
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3.2 Introduction 
Staphylococcus aureus possesses many genes that allow the organism to 
sense and adapt to ever-changing environmental conditions. At least 16 operons 
encode two-component signal transduction systems (TCSs) in S. aureus (17), 
with 14 conserved in all sequenced genomes (91). The TCSs sense a variety 
environmental conditions and manipulate cellular responses accordingly. A 
prototypical TCS consists of a dimerized sensor histidine kinase (HK) that 
responds to a specific environmental cue(s) by transautophosphorylating and 
subsequently transferring the phosphate to a cognate response regulator. 
Phosphorylation of the response regulator activates the effector function of the 
protein. The effector function ultimately leads to modulation of gene expression 
within the TCS regulon, mediating the cellular response to the environmental cue 
(102–105). 
The novel yhcSR TCS of S. aureus was found to be essential in a 
laboratory strain of S. aureus and depletion of YhcSR by yhcS antisense RNA 
inhibited growth of the clinically relevant hospital-acquired methicillin-resistant S. 
aureus WCUH29 strain (HA-MRSA) (128). This information was the foundation 
for the continued characterization of this TCS as well as the fact the yhcSR TCS 
appears to be conserved with at least 40% conserved identity in the GAF 
sensory domain of YhcS throughout the Bacilli Class. Definitively, using BLASTP 
analysis, the cysteine residues that are essential for oxygen sensing by YhcS 
(129) are conserved in all identified homologues in the Bacilli Class. This 
conservation suggests the YhcSR TCS is important for oxygen sensing within 
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Bacilli, but more importantly, the YhcSR TCS may be essential in other 
pathogens such as Bacillus anthracis and constitutes a novel target for the 
development of new antibiotics.  
Little was known about the functional role of YhcSR when this work 
began. The only confirmed genes to be regulated by YhcSR were involved in 
dissimilatory nitrate reduction, narGHIJ and nreABC (100) and it provided the 
background for confirming the essentiality and determining the temporal 
expression pattern of yhcSR in S. aureus WCUH29 aerobically and 
anaerobically. As a way to gain insight into the function of YhcSR the cellular 
phenotype of S. aureus YhcR producing and YhcSR deplete cells were studied 
which revealed changes in cellular morphology. 
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3.3 Materials and methods 
3.3.1 Bacterial strains, plasmids and growth media.  
The bacterial strains and plasmids used in this study are listed in Table 3-
1. The S. aureus strains were cultured in trypticase soy broth (TSB) at 37˚C with 
shaking. E. coli strains were cultured in Luria-Bertani (LB) broth. Transformants 
containing recombinant plasmids were selected on LB agar containing 
spectinomycin (100 µg/ml) for E. coli, and trypticase soy agar (TSA) containing 
chloramphenicol (10 µg/ml), tetracycline (5 µg/ml), or erythromycin (5 µg/ml) for 
S. aureus. All plasmids were constructed in E. coli then purified and 
electroporated into S. aureus RN4220 and subsequently electroporated into the 
relevant S. aureus strain. 
3.3.2 Construction of the S. aureus Newman and 923 yhcS antisense RNA 
strain. 
 S. aureus Newman and S. aureus 923 were electroporated with the 
control plasmid, pCY406, or the yhcS antisense RNA plasmid, pCY606.  
Overnight cultures of S. aureus strains were diluted to ~104 CFU/ml with TSB 
containing 5 µg/ml of erythromycin and different concentrations of an inducer 
anhydrotetracycline, (ATc), at concentrations of 0, 100, 250 ng/ml. Cell growth 
was monitored at 37ºC by measuring the optical density at 600 nm (OD600nm) 
every 15 min, with 1 min of mixing before each reading in a BioTek Synergy II 
microplate reader.   
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3.3.3 Construction of S. aureus WCUH29::Pspac-yhcSR (JH312). 
  Using the primers YhcS For pLH1-NotI RBS/YhcR Rev pLH1-BamHI the 
yhcSR operon was obtained by high fidelity PCR, purified, and digested with NotI 
and BamHI (NEB). The plasmid pLH1 was digested with the same enzymes and 
the PCR product was ligated into pLH1 with T4 DNA ligase (Promega). Correct 
insertions were confirmed by diagnostic PCR.  
To create strain JH312, the plasmid p312 was electroporated into S. 
aureus strain CYL557 (190) and transductants were plated on TSA containing 
tetracycline, chloramphenicol, and 100 μM isopropyl β-D-1-thiogalactopyranoside 
(IPTG). Insertion of plasmid p312 into the chromosomal φ11 integration site to 
create strain RN312 was confirmed by diagnostic PCR using the primer sets 
scv4 paired with scv10 and primer scv8 paired with scv9 listed in Table 3-2. After 
confirmation of insertion, one of the RN312 transductants was used to make a 
phage lysate by using S. aureus phage φ11. The phage lysate was then used to 
infect WCUH29 as described (159) and tetracycline resistance was used to 
select for potential transductants. Diagnostic PCR using the primers sets 
scv4/scv10 and scv8/scv9 were used to confirm the transduction event. 
3.3.4 Construction of an in-frame yhcSR deletion plasmid. 
 Using the yhcS/yhcR pKOR1 primers listed in Table 3-2 approximate 1 kB 
DNA regions upstream and downstream of yhcSR was amplified by PCR. Each 
PCR product was gel purified. A 5’ phosphate was attached to the downstream 
segment’s forward primer during oligonucleotide synthesis. Equal molar 
concentrations of upstream and downstream PCR segments were ligated 
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together overnight utilizing the 5’ phosphate on the downstream PCR product. 
Five μl of the ligation reaction was mixed with BP Clonase II, TE buffer, and 
plasmid pKOR1 and incubated overnight at 25°C. The following day the pKOR1 
reaction was transformed using DH10B E. coli with selection on LB agar with 
ampicillin for selection of recombinants (191). DH10B E. coli was grown at 30°C. 
Recombinant plasmids were confirmed by PCR and electroporated into S. 
aureus RN4220 and incubated at the replication-permissive 30°C temperature. A 
RN4220 transformant was cultured at 30°C overnight and the pKOR1-ΔyhcSR 
plasmid was purified from RN4220.  
3.3.5 Deletion of endogenous yhcSR locus. 
After the Pspac-yhcSR segment was transduced into the WCUH29 
chromosome, an attempt was made to delete the endogenous yhcSR operon by 
homologous recombination using the temperature-sensitive plasmid pKOR1 as 
described (191). The pKOR1-ΔyhcSR plasmid was electroporated into wild-type 
S. aureus WCUH29 or JH312 using chloramphenicol (and tetracycline for JH312) 
for selection and incubated at 30°C overnight. A single colony from each of the 
resulting plates was cultured in TSB with appropriate antibiotics at 30°C 
overnight. The following day 5 μl of each overnight culture was used to inoculate 
separate, pre-warmed, TSB with appropriate antibiotics for each strain and 
incubated overnight at 42°C; the plasmid’s non-replication permissive 
temperature. 50 μl of each culture was streaked onto TSA containing the 
appropriate antibiotics and incubated overnight at 42°C. The following day, a 
single large colony from each plate was cultured overnight in TSB at 30°C and 
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subsequently sub-cultured two more times. To induce the second homologous 
recombination event and loss of the pKOR1 plasmid backbone, the third day sub-
culture of each strain was serially diluted to ~10-4 CFU/ml and 50 μl of each 
culture was plated on TSA and TSA containing 200 ng/ml of anhydrotetracycline 
(tetracycline was included for selection of JH312). One set of plates, consisting of 
WCUH29 WT and JH213, was incubated aerobically overnight at 37°C. A second 
set of plates was incubated in an anaerobic COY chamber (O2-free, N2-He mix) 
between 25-30°C for 4 days. Randomly chosen large colonies from the TSA/ATc 
plates were screened by colony PCR using the primer set attB1-yhcS-L-F-
pKOR1/attB2-yhcR-R-R-pKOR1 for aerobic plates and the primer set Yhc KO 
For/Yhc KO Rev for the anaerobically grown plates. See Table 3-2 for primer 
sequences. GoTaq Green PCR mix (Promega) was used for colony PCR 
screening. Colonies were suspended in 10 mM Tris-Cl, pH 7.5 containing 50 
μg/ml lysostaphin and incubated at 37°C for at least 30 minutes to weaken the 
cell wall. One microliter of the suspension was used as the PCR template. 
3.3.6 Construction and monitoring of Pyhc-luxABCDE reporter plasmid. 
The promoter region of yhcSR was obtained and cloned upstream of the a 
promoterless luxABCDE cassette creating plasmid pCY106 (100). The plasmid 
was electroporated into RN4220 and subsequently into WCUH29. The overnight 
culture of S. aureus strain YJ106 was diluted to ~104 CFU/ml with TSB 
containing appropriate antibiotics and in the absence or presence of 5.7 mM 
cysteine as a free oxygen scavenger. The bioluminescence signal and cell 
growth were monitored at 37ºC by measuring the light intensity and optical 
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density at 600 nm (OD600nm) with a BioTek Synergy II spectrophotometer every 
30 min. To eliminate the effect of bacterial growth on light intensity, the relative 
light units (RLU) were calculated (light intensity/OD600nm) from duplicate 
readings at different times during growth. The data represent the mean RLU and 
OD600nm of three independent colonies. 
3.3.7 RNA isolation and purification.  
An overnight culture of S. aureus WCUH29 was inoculated at 1% in TSB 
medium with appropriate antibiotics. Aerobic cultures were grown in an 
Erlenmeyer flask with the medium making up no more than 5% of the total flask 
volume and with vigorous shaking at 37°C. Anaerobic cultures were grown in 
sealed TSB filled Wheaton Serum bottles bubbled with oxygen-free nitrogen, 
autoclaved, and 5.7 mM fresh cysteine was added to remove traces of free 
oxygen. Each culture was grown to an OD600nm of 0.4, collected, and RNA 
extracted. Total RNA was purified from the above culture as described (192). 
Briefly, bacterial cells were harvested by centrifugation, and the RNA was 
isolated by the RNAPrep kit (Promega). Contaminating DNA was removed with a 
DNA-free kit (Ambion), and the RNA yield was determined 
spectrophotometrically at 260nm. The integrity of the RNA was checked by 
formaldehyde agarose electrophoresis and no degradation of the major 23S and 
16S ribosomal RNA was detected. 
3.3.8 Quantitative real-time RT-PCR (qPCR) analysis. 
In order to determine if yhcSR is up-regulated during anaerobic growth 
quantitative real-time reverse transcription (RT) PCR was employed to compare 
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the RNA levels, as described (166, 192). The first strand cDNA was synthesized 
using the SensiFASTTM cDNA Synthesis Kit (Bioline) according to the 
manufacturer’s protocol. 110 ng of total RNA was used for cDNA synthesis. Total 
cDNA was diluted 1:40 for yhcS qPCR and 1:1000 for 16S qPCR. For each RNA 
sample, duplicate reactions of reverse transcription were performed, as well as a 
control without reverse transcriptase, in order to determine the levels of DNA 
contamination. PCR reactions were set up in duplicate by using the PerfeCTa® 
SYBR© Green 2X Fastmix kit (Quanta Biosciences). Real-time sequence-
specific detection and relative quantitation were performed with the Stratagene 
Mx3000P Real Time PCR System. Gene-specific primers were designed to yield 
~100 bp of specific products (Table 3-2). Relative quantification of the product 
was calculated using the Comparative CT method, as described for the 
Stratagene Mx3000P system. The housekeeping gene 16S rRNA was used as 
an endogenous control (166). All samples were analyzed in duplicate and 
normalized against 16S rRNA gene expression.  
3.3.9 Analysis of conversation of nitrate to nitrite in YhcSR-depleted S. 
aureus WCUH29. 
To measure nitrate conversion during yhcS antisense induction, overnight 
cultures of YJ406 and YJ606 were cultured overnight with appropriate antibiotics 
and each strain was washed with PBS and diluted 1:100 in CDM with 20 mM 
sodium nitrate, 5.7 mM cysteine as an oxygen scavenger, and 500 ng/ml of 
inducer, ATc. The conversion of nitrate (NO3) to nitrite (NO2) by S. aureus was 
measured using the Sigma Aldrich Griess Reagent Solution according to the 
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manufacturer’s instructions and compared to empirical determined standard 
curve. The relative nitrite concentration is calculated by dividing the nitrite 
concentration by the OD600nm of the culture at each time point. The data 
represent the mean and standard deviation of 3 independent experiments.  
To create the pKOR1-ΔnreABC plasmid, approximately 1 kb upstream 
and downstream of the nreABC locus was amplified by PCR using primers in 
Table 3-2, ligated together and cloned into the S. aureus allelic replacement 
plasmid, pKOR1 (191) and deletion of nreABC was carried out aerobically and 
confirmed by diagnostic PCR as described previously. To create the 
complementation plasmids, the yhcSR and nreABC operons were PCR amplified 
using primers YhcSOE-for/YhcROE-rev and NreABC-orf-PmeI-F/ NreABC-orf-AscI-
R listed in Table 3-2, digested with AscI and cloned downstream of the TetR 
regulated promoter in the pYH4 shuttle vector digested with PmeI and AscI. Each 
plasmid was subsequently electroporated into S. aureus WCUH29. 
3.3.10 Gram-stain, imaging and cell diameter measurements 
Overnight cultures of each strain were cultured with inducer ATc, 500 
ng/ml for antisense RNA control and JSAS909, and 250 ng/ml of ATc for 
overproduction control and WYhcR. 5 μl of each control and inducible mutant 
strain were Gram-stained using the Fisher Scientific Gram-stain kit according to 
the manufacturer’s protocol. Images were taken at 100X magnification under oil 
immersion using an Olympus BX41 Microscope with an attached Olympus XC30 
top-mounted camera and cellSens Software. The cell diameter of at least 200 
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individual cells from each image were measured using cellSens. Statistical and 
graphing analysis were conducted in Microsoft Excel.   
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Table 3-1 Bacterial strains and plasmids  
Strain Description Source 
DH10B E. coli used for cloning and plasmid 
construction 
Invitrogen 
DB3.1 E. coli used for propagation of plasmid 
pKOR1 
Invitrogen 
RN4220 S. aureus Laboratory strain: rsbU- (181) 
WCUH29 Clinical human S. aureus isolate: rsbU+ (109) 
Newman Methicillin sensitive S. aureus strain with 
plasmid pCY406; Ermr 
This study 
Newman-606 Newman with plasmid pCY606; ErmC This Study 
MRSA923 Community-acquired methicillin resistant S. 
aureus stain with plasmid pCY406; ErmC This Study 
MRSA923-606 MRSA923 with plasmid pCY606; Ermr This study 
JSAS909 WCUH29 containing plasmid pSAS909 
carrying yhcS antisense; Ermr 
(128) 
CYL557 RN4220 that carries pLL2787 which 
encodes the φ11 int gene under the control 
of the IPTG inducible Pspac promoter; Cmr 
(190) 
YJ106 WCUH29 containing plasmid pCY106, Cmr (100) 
RN312 RN4220::Pspac-yhcSR; Tetr This Study 
JH312 WCUH29::Pspac-yhcSR; Tetr This Study 
YJ406 WCUH29 with pCY406; Ermr (100) 
YJ606 WCUH29 with pCY606; Ermr (100) 
WYhcSR WCUH29 with pYhcSR; Ermr This Study 
WNreABC WCUH29 with pNreABC; Ermr This Study 
WCUH29ΔnreABC WCUH29 with in-frame chromosomal 
deletion of nreABC  
This Study 
JHYhcSR WCUH29ΔnreABC with pYhcSR; Ermr This Study 
JHNreABC WCUH29ΔnreABC with pNreABC; Ermr This Study 
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Table 3-2 Plasmids 
Plasmids Description Source 
pCY406 Shuttle vector, derived from pYH4, 
containing luxABCDE; Ermr 
(193) 
pCY606 Shuttle vector, derived from pSAS909, 
containing luxABCDE and yhcS antisense; 
Ermr 
(193) 
pCY106 yhcSR promoter-luxABCDE reporter 
system, Cmr 
(100) 
pYH3 Shuttle vector with a TetR regulated 
inducible promoter; Ermr 
(128) 
pSAS909 pYH3 vector with yhcS antisense RNA 
downstream of TetR ; Ermr 
(128) 
pLH1 The integration vector pLL39 carrying 
Pspac-lacI segment, Tetr 
(194) 
p312 pLH1 with yhcSR cloned downstream of 
the Pspac promoter; Tetr 
This Study 
pYhcSR pYH4 shuttle vector with TetR regulated 
promoter for over-expression of yhcSR; 
Ermr 
This Study 
pNreABC pYH4 shuttle vector with TetR regulated 
promoter for over-expression of nreABC; 
Ermr 
This Study 
pKOR1 E.coli/ S.aureus shuttle vector, permits 
lambda recombination and ccdB selection; 
temperature sensitive in S. aureus; Cmr 
(191) 
pKOR1-ΔyhcSR pKOR1 with flanking yhcSR 
upstream/downstream segments to 
mediate deletion of operon 
This study 
pKOR1-ΔnreABC pKOR1 with flanking nreABC 
upstream/downstream segments to 
mediate deletion of operon 
This study 
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Table 3-3 Oligonucleotide sequences 
Primers Sequence 
YhcS For pLH1-
NotI RBS 
5’-GCGGCCGCAGGAGGTTTAAACTATGGAACAAAGG 
ACGCGAC-3’ 
YhcR-Rev pLH1-
BamHI  
5’-GGATCCCTAAATCAACTTATTTTCCATTGCATAAATTGC-3’ 
scv4 5’-ACCCAGTTTGTAATTCCAGGAG-3’ 
scv10 5’-TATACCTCGATGATGTGCATAC-3’ 
scv8 5’-GCACATAATTGCTCACAGCCA-3’ 
scv9 5’-GCTGATCTAACAATCCAATCCA-3’ 
attB1-yhcS-L-F-
pKOR1 
5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTTTGTACATGT 
ATGGCCAAACAACC-3’ 
yhcS-L-R-pKOR1 5’-ATAAACCTGCGCGATTAATGGATAA-3’ 
yhcR-R-F-pKOR1  5’-Phos-GGATAAAATTCCCCAAACAGAAAG-3’ 
attB2-yhcR-R-R-
pKOR1 
5’-TCACATAATAAGTCTGTTGCGTTATCTAC-3’ 
Yhc KO For 5’-CCTGGTCCAGTCGATGAATTG-3’ 
Yhc KO Rev 5’-CACTTGTTGGTGCATGGTTTG-3’ 
YhcS-RT 
For 5'-GGGTCAGCCATCAAACGTATTTATTTAAC-3' 
Rev 5'-GAAATGAAAGACGTTGAGCCTCAGCA-3' 
16S-RT 
For 5'-CTGTGCACATCTTGACGGTA-3' 
Rev 5'-TCAGCGTCAGTTACAGACCA -3' 
AttB1-pKOR1-
nreKO-L-For 
5’-GGGG ACAAGTTTGTACAAAAAAGCAGGCTGATACGCAA 
AAAGAACGTGGG-3’ 
pKOR1-nreKO-L-
Rev 
5’-CAAATCCTTTCACCTCTTATGCTTAC-3’ 
pKOR-nreKO-R-For 5’Phos-GTGAAAACAGTAGAAGCACATAAGAC-3’ 
AttB2-pKOR1-
nreKO-R-Rev 
5’-GGGGACCACTTTGTACAAGAAAGCTGGGTCGCGTTTAT 
AAACAGCAAGACTTA G-3’ 
NreABC-orf-PmeI-F 5’-GTTTAAACTATGACACCAGAAGCAATAATTGAAG-3’ 
NreABC-orf-AscI-R For 5’-GGCGCGCCCTAAAACTCTAATAATTTCTTTTTC 
AATGCATATTC-3’ 
YhcSOE-for For 5'-AAACTATGAACAAAGTAATATTAGTAG-3' 
YhcROE-rev For 5’-TTGGCGCGCCCTATTTTATAGGAATTGTGAATTG-3’ 
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3.4. Analysis of essentiality and characterization of the S. aureus 
yhcSR two-component system. 
3.4.1 Induction of yhcSR antisense RNA inhibits growth of S. aureus MSSA 
strain Newman and CA-MRSA strain 923. 
It has previously been shown that induction of yhcS antisense RNA results 
in growth inhibition and suggests the yhcSR TCS is essential in a hospital-
associated (HA)-MRSA strain, WCUH29 (100, 128). A recent publication 
suggested the essential nature of YhcSR was strain specific, as their methicillin-
sensitive S. aureus (MSSA) strain Newman yhcS antisense RNA strain had no 
growth defect (129). To investigate this claim, an yhcS antisense RNA plasmid 
was introduced into S. aureus Newman and community-associated (CA)-MRSA S. 
aureus 923 (Fig. 3-1). Contrary to the other authors’ results, S. aureus Newman 
was found to be extremely sensitive to induction of yhcS antisense RNA, with the 
yhcS antisense RNA strain Newman strain yielding poorer growth without 
induction of the yhcS antisense RNA compared to the empty vector control. Strain 
Newman’s growth was severely inhibited with as little as 250 ng/μl of antisense 
RNA inducer, anhydrotetracycline (ATc) in TSB. The authors of the contradicting 
article did not provide evidence that their antisense RNA efficiently reduced yhcS 
mRNA or protein product, thus it is likely that the antisense RNA was ineffective 
and did not work as designed. It was previously demonstrated yhcS mRNA 
knockdown and YhcR protein loss occur during induction of yhcS antisense RNA 
with ATc (128). A similar growth defect was seen in S. aureus 923, but higher 
induction of the yhcS antisense RNA was needed to inhibit growth. The difference 
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in sensitivity to the yhcS antisense RNA between MSSA Newman and the MRSA 
strains may be due individual expression levels of yhcSR within each strain as well 
as inherent genetic differences via the absence of presence of additional mobile 
genetic elements that encode additional regulators which may influence yhcSR 
expression (195, 196). 
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Figure 3-1 Growth of S. aureus Newman and S. aureus 923 with yhcS 
antisense RNA plasmid.  
(A) Growth curves of the control Newman strain and yhcS antisense RNA strain, 
Newman-606 and (B) Growth curves of the MRSA923 control and yhcS 
antisense RNA strain, MRSA923-606, with various concentrations of inducer 
ATc. The growth curves represent one of three repeated experiments.
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3.4.2 The yhcSR operon is essential for S. aureus WCUH29 aerobic and 
anaerobic growth. 
Previously it was demonstrated deletion of the native yhcSR locus is only 
possible when yhcSR is heterologously expressed from another point on the 
chromosome in the highly mutagenized laboratory strain RN4200 (128). Using a 
method similarly used to confirm essentiality of the walKR (yycFG) TCS of S. 
aureus (197) an attempt to delete yhcSR was undertaken aerobically and 
anaerobically to confirm the essentiality of yhcSR during aerobic and anaerobic 
growth in the clinically relevant HA-MRSA strain WCUH29. Deletion of yhcSR 
only occurred in the presence of a heterologously expressed wild-type copy of 
yhcSR (placed in the Φ11 integration site) (Fig. 3-1A) (128, 190). Screening of 
bacteria grown in an anaerobic COY chamber produced similar results, deletion 
of yhcSR could only be obtained in the presence of a second heterologously 
expressed wild-type copy of yhcSR (Fig. 3-1B) indicating the essential nature of 
the yhcSR operon in S. aureus WCUH29. 
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Figure 3-2. The native yhcSR operon can only be deleted when yhcSR is 
heterologously expressed.  
In parallel, pKOR1-ΔyhcSR was electroporated into WCUH29 WT and 
WCUH29::Pspac-yhcSR (JH213) and the pKOR1 deletion protocol was followed. 
Plates were incubated (A) aerobically or (B) anaerobically. (C) Outline of the 
completed WCUH29::Pspac-yhcSRΔyhcSR strain. White arrows indicate the 
placement of PCR primers to detect the presence or absence of the native 
yhcSR locus. Each lane represents a single PCR reaction of a randomly chosen 
colony. (+) represents wild-type WCUH29 genomic DNA used as a positive PCR 
control. 
 
70 
 
3.4.3 Transcriptional analysis of yhcSR expression during oxygen replete 
and deplete conditions. 
 Analysis to confirm the absolute essentiality of yhcSR indicated the 
operon was essential, but it did not provide information about when yhcSR is 
expressed during in vitro culturing. To determine when yhcSR was 
transcriptionally expressed and how anaerobiosis affected the transcription of the 
operon reporter bioluminescence production driven by the yhcSR promoter was 
monitored. A previously constructed PyhcSR-luxABCDE reporter plasmid, 
pCY106, and S. aureus WCUH29 strain, YJ106 (100) was utilized to determine 
the transcription of Pyhc during growth phases and absence of oxygen. To 
produce micro-aerobic culture conditions, the TSB medium was autoclaved and 
cysteine was added to a concentration of 5.7 mM from a freshly prepared stock 
to scavenge free oxygen (198). As seen in Fig. 3-3, the growth rate of the semi-
aerobic YJ106 culture is slower compared to the aerobic culture, but 
bioluminescence expression from the yhcSR promoter is almost 3-fold higher 
suggesting yhcSR is induced under anaerobic conditions. During aerobic growth, 
yhcSR transcription is maximally expressed in the early logarithmic phase of 
growth. In the semi-aerobic culture a similar, but amplified, expression pattern is 
seen with expression of yhcSR being sustained through, at least, the mid-
logarithmic phase of growth. To confirm that yhcSR is expressed at a higher level 
when oxygen concentration is low or absent, qRT-PCR was used to compare the 
mRNA transcript level of yhcS in aerobically and anaerobically grown cultures of 
S. aureus WCUH29.  
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Figure 3-3 Analysis of transcriptional expression of the yhcSR operon 
using a Pyhc-luxABCDE reporter fusion.  
YJ106 in TSB containing appropriate antibiotics and in the absence (blue line, 
red columns) or presence of 5.7 mM cysteine (green line, purple columns). The 
bioluminescence signal and cell growth were monitored at 37ºC by measuring 
the light intensity and OD600nm with a BioTek Synergy II spectrophotometer 
every 30 min. The data represent the mean RLU and OD600nm of three 
independent cultures. 
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The qRT-PCR analysis revealed yhcS mRNA was 16-fold higher in the anaerobic 
culture compared to aerobic culture. Taken together, data show that yhcSR is 
expressed during aerobic and anaerobic growth of S. aureus and that 
transcriptional expression of yhcSR is higher when oxygen is absent from the 
culture. 
3.4.4 Altering the expression level of yhcSR affects S. aureus cell size and 
morphology.  
In an effort to characterize and understand the functional role YhcSR has 
within S. aureus it was investigated how altering the expression level of yhcSR 
affects cells size and morphology. Overnight cultures of induced controls, 
WSASJ909, and WYhcR were Gram-strained and cellular morphology was 
observed under oil immersion and 100X magnification. The Gram-stain revealed 
fairly uniform cocci in grape-like clusters in the control strains; a classic Gram-
stain pattern of S. aureus (Fig. 3-4A and D). Intriguingly, depletion of yhcSR 
mRNA by yhcS antisense RNA produced heterogeneous cell morphology with 
the observation of overly large cells (Fig. 3-4B, black arrows). These cells had 
intact cell walls, as they retained crystal violet, but were 2- to 2.5-times larger in 
diameter than the control cells. Measuring the cell diameter of induced 
WJSAS909 cells revealed a large range in cell diameter, with a portion of the 
cells being similar in diameter to the controls, but a large portion of cells being 
dramatically larger than the control strain (Fig. 3-4C). Overproduction of YhcR 
produced fairly homogenous cellular morphology compared to the control. 
WYhcR cells were uniformly cocci in shape and clustered similarly to the control 
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cells. Visually, there was a noticeable increase in cell diameter in WYhcR cells 
compared to the control (Fig. 3-4D and E). This observation is supported by 
quantitative measurement of WYhcR cell diameter, which are on average 0.2 
microns larger than the control cells (Fig. 3-4F). 
 
Figure 3-4 Altering the expression level of yhcSR affects S. aureus cell size 
and morphology. Gram strains of overnight cultures of (A) antisense RNA 
control strain and (B) yhcS antisense RNA strain, WJSAS909, were induced with 
500 ng/ml of ATc. (D) Overproduction control strain and (E) YhcR overproduction 
strain, WYhcR, were induced with 250 ng/ml ATc. Each respective control and 
mutant strain was processed on the same glass slide. Images taken at 100X 
under oil immersion. Box and Whisker Plot of cell diameter for (C) antisense 
strains and (F) Overproduction strains measured in microns. At least 200 
individual cells were measured for each strain. 
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3.4.5 Depletion of yhcSR decreases the rate of dissimilatory nitrate 
reduction in S. aureus WCUH29. 
The NreBC TCS regulates the nar operon responsible for dissimilatory 
nitrate reduction in S. aureus. It was subsequently identified that YhcSR 
regulates both the nar and nre operons under anaerobic conditions by directly 
binding the respective upstream promoter sequences. Additionally, down-
regulation of yhcSR by antisense RNA led to decreased nar promoter activity as 
established by a promoter-luciferase assay (100). To determine if the decreased 
nar expression resulted in a functional decrease in the amount of nitrate reduced 
to nitrite, the culture nitrite concentration of the CDM medium and growth of S. 
aureus was monitored over time. It was found that induction of yhcS antisense 
RNA led to a functional decrease in conversion of nitrate to nitrite by S. aureus 
when adjusted for optical density (Fig. 3-5A), likely due to decreased nar 
expression. Interestingly, overproduction of YhcSR in an nre deletion background 
did not restore nitrate reduction or enhance growth. Conversion of nitrate to 
nitrite was undetectable in the YhcSR complemented WCUH29ΔnreABC strain 
(Fig. 3-5B). The data suggest YhcSR is an enhancer of nar expression, and likely 
nre due to co-transcription of the nar-nre operons (127, 199), under anaerobic 
conditions and that NreBC is essential for nitrate reduction. As further evidence 
that YhcSR failed to complement the deletion of nreABC, the 
WCUH29ΔnreABC/pYhcSR strain grew at the same rate as the 
WCUH29ΔnreABC/pYH4 strain, which is limited to less energy productive 
fermentative growth.  
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Figure 3-5 YhcSR is important for dissimilatory nitrate reduction but cannot 
complement the loss of nreABC.  
(A) control (pCY406; green line; blue columns), yhcS antisense RNA strain 
(pCY606; purple line; red columns). Induction of yhcS antisense RNA produces a 
functional decrease in the amount of nitrate converted to nitrite in S. aureus 
cultures. Data represents the mean and standard deviation of 3 independent 
experiments. (B) Production of YhcSR in the WCUH29ΔnreABC background fails 
to complement nitrate reduction. Nitrate to nitrite conversion was not detected in 
WCUH29ΔnreABC/pYhcSR (represented by absence of blue columns) and 
growth complementation was not detected (compare pink line to blue line). 
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3.5 Discussion 
In this study, it was determined that the yhcSR TCS is absolutely essential 
for S. aureus WCUH29 growth and expression yhcS antisense RNA in a CA-
MRSA and MSSA strain inhibited growth in a similar manner as observed in 
WCUH29. It is concluded that the yhcSR TCS is extremely important for viability 
and likely to be essential for all strains of S. aureus. This is the first systematic 
analysis of yhcSR using an accepted merodiploid analysis for gene essentiality in 
S. aureus (200). Since the beginning of this work, there have been two articles 
published that dispute the essentiality of yhcSR. The first, published by Sun et al. 
(129) identified YhcS as an oxygen sensor and characterized the phosphorelay 
signal in relation to the absence or presence of oxygen. Sun et al. constructed a 
bursa aurealis transposon insertion mutant in YhcR, but failed to show that the 
transcription or translation of the gene was interrupted and a functional protein 
was not produced. Furthermore, a previous study investigating the role of TCSs 
in biofilm development also failed to recover a yhcSR deletion mutant (201). A 
second bursa aurealis transposon mutant library produced transposon insertions 
in yhcS, but failed to find a single insertional mutation in yhcR from a library of 
nearly 20,000 Tn insertion clones (202). This suggests yhcS may be dispensable 
for growth while the effector gene, yhcR, is the essential gene of the operon, but 
further investigation is necessary to determine the individual essentiality of each 
gene. Furthermore, Sun et al. claim that expression of yhcS antisense RNA does 
not inhibit growth of strain Newman, but again, evidence was not presented to 
show that the yhcS antisense RNA resulted in loss of the yhcSR mRNA or 
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inhibition of translation as was shown to occur for the previously constructed and 
published yhcS antisense RNA strain (128). As seen in Fig. 3-1, strain Newman 
is extremely sensitive to yhcS antisense RNA. While the Sun et al. paper does an 
excellent biochemical analysis of YhcSR, they fail to make a conclusive 
argument for non-essentiality of yhcSR in strain Newman.  
A second, recent publication, reported that YhcSR modulates cell-wall 
synthesis genes (137). The concern with this report is not the claim that YhcSR 
modulates cell-wall synthesis, as they clearly show that YhcR binds the 
promoters of autolysis and cell-wall synthesis controlling genes. Additionally, the 
data presented in this chapter is supportive of this conclusion as it was found that 
altering the expression of yhcSR resulted in cells that appeared unable to divide, 
impacted cellular diameter and possibly cell-wall thickness. The disagreement is 
with their claim of constructing an yhcSR ermC replacement mutant. This is the 
first reported deletion of yhcSR in the absence of a second, ectopically 
expressed copy. While the authors note the controversy about yhcSR 
essentiality, they fail to include any information about the rate at which deletions 
in yhcSR were recovered or if they attempted to construct a deletion in a non-
laboratory, clinically relevant strain of S. aureus. This is of particular interest 
because the S. aureus NCTC 8325 strain used in the report is a common 
laboratory strain and is known to have at least one major genetic defect, the 
absence of a functional rsbU gene which functions in activation of the stress 
induced alternative sigma factor, σB (203). It is possible that the construction of a 
true transposon mutant and gene replacement mutant were created and YhcSR 
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is not produced in the bacterium, making the gene not essential in these strains. 
So far though, supportive evidence of these claims is missing and it is quite 
possible during the construction of each of these mutants one or more 
suppressor mutations developed in the strains. Whole genome sequencing and 
comparative analysis between the parental and mutant strains is necessary to 
ensure this did not occur, followed by verification that the gene product of yhcSR 
is not made, or if it is translated, proteins are not functional in any manner.  
 As previously mentioned, YhcS has been shown to sense oxygen and 
directs YhcR to up-regulate genes necessary for anaerobic growth (129). In 
accordance with this observation and the previous publication indicating that 
YhcSR transcriptional regulates the nar and nre operons, depletion of YhcSR 
resulted in a functional defect in dissimilatory nitrate reduction resulting in a 
reduced growth rate in the presence of nitrate and YhcSR alone cannot 
complement for loss of NreABC, suggesting YhcSR is important for initiating 
transcription of nre-nar and subsequent prolonged production of NreABC is 
needed for nitrate respiration under anaerobic conditions. 
 It is concluded that the yhcSR TCS is essential for growth in all S. aureus 
strains based on the merodiploid analysis and yhcS antisense RNA data. It is 
very likely that YhcSR do regulate the genes identified in the other published 
studies; as results presented in this chapter and the following chapters are 
supportive and complementary to these claims. In the absence of any conclusive 
counter-data on the essentiality of yhcSR, investigations into novel inhibitors of 
the TCS should be undertaken in much the same way they have for the essential 
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WalKR TCS (113–115) as new antimicrobials to combat S. aureus infections are 
desperately needed.
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Chapter 4 : The Essential yhcSR Two-Component 
Signal Transduction System Directly Regulates the 
lacABCDE and opuCABCD Operons of Staphylococcus 
aureus
82 
 
4.1 Overview 
  Our previous studies suggested that the essential two-component signal 
transduction system, YhcSR, regulates the opuCABCD operon at the 
transcriptional level, and the Pspac-driven opuCABCD partially complements the 
lethal effects of yhcS antisense RNA expression in Staphylococcus aureus. 
However, the reason why yhcSR regulon is required for growth is still unclear. In 
this report, we present that the lac and opuC operons are directly transcriptionally 
regulated by YhcSR. Using real-time RT-PCR we showed that the down-
regulation of yhcSR expression affected the transcription of lacA encoding 
galactose-6-phosphatase isomerase subunit LacA and opuCA, encoding a 
subunit of a glycine betaine/carnitine/choline ABC transporter. Promoter-lux 
reporter fusions further confirmed transcriptional regulation of lac by YhcSR. Gel 
shift assays revealed that YhcR binds to the promoter regions of the lac and 
opuC operons. Moreover, the Pspac-driven lacABC expression in trans was able 
to partially complement the lethal effect of induced yhcS antisense RNA. 
Likewise, Pspac-driven opuCABCD expression in trans enhanced growth of S. 
aureus in a high osmotic strength medium during induced yhcS antisense RNA 
expression. Taken together, the above data indicate that the yhcSR system 
directly regulates the expression of lac and opuC operons, which, in turn, may be 
partially associated with the essentiality of yhcSR in S. aureus. These results 
provide a new insight into the biological functions of the yhcSR TCS, a global 
regulatory system. 
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4.2 Introduction 
 The continuing increase of hospital- and community-associated methicillin 
resistant Staphylococcus aureus infections highlights an urgent need for the 
development of alternative potent antibacterial agents (141, 204, 205). The ability 
of this organism to resist current antibiotic therapies and cause infection is 
partially due to the coordinated regulation of gene expression allowing the 
bacteria to survive in different stress conditions. Two-component signal (TCS) 
transduction systems are important sensory units and allow microbial organisms 
to adapt to different niches, as well as play a significant role in pathogenesis and 
biofilm formation for various bacterial species(142, 206–208). Therefore, 
interrupting these critical signaling pathways may provide an alternative strategy 
for the development of novel classes of preventive and/or therapeutic 
antibacterial agents (195). 
 A typical two-component system is composed of a histidine kinase sensor 
and a cognate response regulator responsible for sensing and responding to 
environmental signals by regulating gene expression, respectively (207). In S. 
aureus, at least 16 different two-component signal systems have been identified 
(208), and two TCSs, yycFG and yhcSR (also known as airSR), are required for 
viability (128, 129, 197). The yycFG system, which has orthologs in Bacillus 
subtilis (209) and Streptococcus pneumoniae (210), is the first reported TCS 
regulatory system that is indispensable for cell viability in S. aureus (197). 
Analyses of conditional-lethal yycFG mutants in B. subtilis suggested that this 
system controls the ftsAZ operon that is involved in the process of cell-wall 
84 
 
division (211), as well as endopeptidase-type autolysins including YvcE and LytE 
(196). However, YycFG is not involved in the regulation of ftsZ expression in S. 
pneumoniae and S. aureus, but, modulates the expression of genes involved in 
cell wall metabolism in S. aureus (212), and an essential gene, pcsB, encoding a 
cysteine, histidine-dependent amidohydrolase /peptidase involved in cell wall 
biosynthesis in S. pneumoniae and S. aureus (212–216).  
 We have identified another TCS, yhcSR, which is also required for viability 
of S. aureus (128). However, the reason why yhcSR is required for viability and 
growth is unknown. In order to elucidate the biological functions of yhcSR, we 
examined the effect of yhcSR on gene expression using a microarray assay. Our 
preliminary microarray analysis suggested that the down-regulation of yhcSR 
expression affects the expression of genes associated with a variety of biological 
functions. Recently, we demonstrated that YhcSR positively regulates the 
nreABC and narGHIJ operons which are responsible for dissimilatory nitrate 
reduction under anaerobic growth conditions (100). We have also previously 
published data indicating regulation of the opuCABCD operon by YhcSR and 
showed that plasmid-borne expression of OpuCABCD partially complements the 
lethal effect of induced yhcS antisense RNA (193).  
 In this study, we employed quantitative RT-PCR, promoter-lux reporter 
fusions, and gel-shift technologies and demonstrated that the yhcSR system 
directly regulates the transcription of the lac operon encoding the structural 
genes for lactose and galactose metabolism, and the opuCABCD operon 
encoding a glycine betaine/carnitine/choline ABC transporter(217, 218). 
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Moreover, we found that that the regulation of the lac and opuC operons may 
partially contribute to the essentiality of the yhcSR regulon in S. aureus.  
 
4.3 Material and methods 
4.3.1 Bacterial strains, plasmids and growth media.  
The bacterial strains and plasmids used in this study are listed in Table 
4.1. The S. aureus cells were cultured in Trypticase soy broth (TSB) at 37˚C with 
shaking. E. coli strains were grown in Luria-Bertani (LB) medium. Transformants 
containing recombinant plasmids were selected on LB agar containing ampicillin 
(100µg/ml), chloramphenicol (50µg/ml), or erythromycin (300µg/ml) for E. coli, 
and TSA containing chloramphenicol (10µg/ml) or erythromycin (5µg/ml) for S. 
aureus. The isopropyl-β-D-thiogalactoside (IPTG) was added as 1mM at final 
concentration. Where noted, NaCl (1 M) and choline (1μM) were added to 
chemically defined medium (CDM).  
4.3.2 RNA isolation, purification and qPCR.  
Overnight cultures of S. aureus were inoculated 1:100 in TSB medium and 
grown to the mid-exponential (3 hr) phase of growth. Total RNA was purified from 
the above culture as described (192). Briefly, bacterial cells were harvested by 
centrifugation, and the RNA was isolated by the RNAPrep kit (Promega). 
Contaminating DNA was removed with a DNA-free kit (Ambion), and the RNA 
yield was determined spectrophotometrically at 260nm.  
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4.3.3 Quantitative real-time RT-PCR (qPCR) analysis.  
In order to determine whether the down-regulation of yhcSR expression 
has any impact on the expression of several identified essential genes, we 
employed quantitative real-time reverse transcription (RT) PCR to compare the 
RNA levels, as described (166, 192). The first strand cDNA was synthesized 
using reverse transcriptase with the SuperScript III Platinum Two-Step qRT-PCR 
kit (Invitrogen). For each RNA sample, we performed duplicate reactions of 
reverse transcription, as well as a control without reverse transcriptase, in order 
to determine the levels of DNA contamination. PCR reactions were set up in 
triplicate by using the SYBR Green PCR Master Mix (Strategene). Real-time 
sequence-specific detection and relative quantitation were performed with the 
Stratagene Mx3000P Real Time PCR System. Gene-specific primers were 
designed to yield ~100 bp of specific products (Table 4-2). Relative quantification 
of the product was calculated using the Comparative CT method, as described for 
the Stratagene Mx3000P system. The housekeeping gene 16S rRNA was used 
as an endogenous control (166). All samples were analyzed in triplicate and 
normalized against 16S rRNA gene expression. The experiments were repeated 
at least three times. To determine whether the complementary effect was 
attributed to the over-expression of a Pspac-driven lacABC operon, we also 
utilized the qPCR as the above described. 
4.3.4 Construction of promoter-lux reporter fusions.  
In order to further confirm whether the yhcSR regulatory system 
transcriptionally regulates the expression of lac we created a promoter-lux 
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reporter fusion using the yhcS antisense expression vector, pCY606 as 
described and previously used to build an opuC promoter reporter (193). The 
promoter region of structural lac genes was amplified by PCR respectively using 
the primers (Sa1997proNotFor/ Sa1997proNotrev) listed in Table 4-2, digested 
with NotI and ligated upstream of the promoterless luxABCDE of pCY606, which 
was digested with the same enzymes. The resulting recombinant plasmids 
pMY1997 containing the promoter-lux reporter fusion was transformed into E. coli 
DH10B competent cells and correct orientation and DNA sequence was 
confirmed by PCR, restriction enzyme digestion, and DNA sequencing. The 
plasmid pMY1997 was purified and electroporated into S. aureus RN4220, and 
then into WCUH29, resulting in S. aureus strain, YJ1997. The lux expression was 
monitored during growth in TSB at 37°C with a Chiron luminometer. The relative 
light units (RLU) were calculated (bioluminescence intensity/optical density at 
600nm). Each experiment was repeated at least three times.  
4.3.5 Cloning, expression and purification of YhcR-His tagged fusion 
protein in Escherichia coli.  
In order to differentiate which identified genes are directly regulated by the 
yhcSR regulatory system, we cloned and purified a His-Tagged YhcR response 
regulator protein as described. The yhcR coding region was obtained by PCR 
from S. aureus and cloned into NdeI and XhoI sites of the E. coli expression 
vector pET24b. The recombinant plasmid (pETyhcR) was confirmed by PCR and 
DNA sequencing (data not shown) and transformed into E. coli strain BL21(DE3). 
The transformants were incubated until mid-log phase (OD600nm = ~0.6) 
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followed by induction of yhcR expression by adding IPTG (final concentration 1 
mM). After two hours of incubation, cells were harvested and lysed by sonication. 
The overproduction of YhcR was viewed by SDS-PAGE followed by Coomassie 
Bright Blue staining (data not shown). 
 To purify the YhcR-His tagged protein a 500 ml culture of the BL21 (DE3) 
containing pETyhcR was induced, and the cell pellet was collected and lysed in 
Lysis Buffer (8 M Urea, 0.1 M NaH2PO4, 0.01 M Tris-Cl, pH8.0) by incubation at 
room temperature for 1 h with agitation. The supernatant was collected by 
centrifugation, applied to the Ni-NTA His-Binding Resin, and incubated for 30 min 
with shaking. The resin mixture was loaded onto the column and washed twice 
with washing buffer (8 M urea, 0.1 M NaH2PO4, 0.01 M Tris-Cl, pH6.3). The 
YhcR-His protein was eluted with elution buffer (8 M urea, 0.1 M NaH2PO4, 0.01 
M Tris-Cl, pH5.6). Following Ni-NTA affinity purification the YhcR-His tag protein 
was further purified by size exclusion chromatography using Sephadex-50 
(Sigma). The purified YhcR-His protein was analyzed by SDS-PAGE followed by 
Coomassie Bright Blue staining found to be the correct molecular weight (data 
not shown). The concentration of purified YhcR-His protein was determined by 
the Bradford method. 
4.3.6 Protein phosphorylation in vitro.  
For YhcR phosphorylation in vitro, total of 3 µg of protein was incubated in 
30 µl of phosphorylation buffer [20 mM NaH2PO4 (pH8.0), 10 mM MgCl2, 1 mM 
DTT, 32 mM acetyl phosphate] at 37˚C for 90 min as described (219).  
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4.3.7 Gel mobility shift DNA-binding assay. 
To determine which identified gene(s) are directly regulated by YhcSR, we 
performed gel-shift assays. DNA fragments of the upstream DNA regions of lacA 
(Plac, 397 bp) and opuCA (PopuC, 312 bp) were obtained by PCR using the 
primers listed in Table 4-2. The amplified DNA fragments were purified and 
labeled with digoxigenin using the DIG GEL Shift Kits (Roche) according to the 
manufacture’s protocol. The DNA-binding and electrophoresis were performed as 
described (168, 220). Briefly, the purified PCR products were labeled with 
digoxigenin (DIG) using terminal transferase (Roch). The labeled DNA fragments 
were further purified to remove the redundant DIG-ddUTP and salts. The 
interaction of YhcR-His with DNA was conducted in a 20 μl reaction mixture 
containing 0.2 pmol DIG-labeled DNA, 1 μg of poly-(dI–dC), 25 mM NaH2PO4 
(PH 8.0), 50 mM NaCl, 2 mM MgCl2, 1 mM DTT, 10% glycerol, and different 
concentrations of YhcR-His protein (final concentrations of YhcR-His were 1, 2, 
4, and 6 μM corresponding to 0.5, 1, 2, and 3 μg, respectively). Unlabeled DNA 
fragments of the promoter region as a specific competitor were added into the 
reaction with 100-fold excess to labeled probe. Bovine serum albumin (BSA) was 
used as a nonspecific binding control. The DNA binding reaction was initiated by 
the addition of YhcR-His and incubated at room temperature for 25 min. Samples 
were then loaded directly onto a 5% native polyacrylamide gel 
[acrylamide:bisacrylamide (29:1) in 0.5 x TBE buffer]. Samples were 
electrophoresed for 2 h at 4°C with 7V/cm, and the DNA samples were 
transferred to Nylon membrane via electro-blotting in 0.5 x TBE at 300 mA for 90 
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min at 4°C. After cross-linking of DNA fragments using UV light, the membrane 
was hybridized with anti-digoxigenin-AP antibody and exposed to X-ray film for 4 
hours to achieve the desired signal. 
4.3.8 Construction and characterization of Pspac-driven complementary 
strains.  
 In order to determine whether the modulation of lac by YhcSR is 
involved in the essentiality of YhcSR, we created Pspac-driven lacABC operon 
complement strains respectively within the yhcS antisense expression plasmid. 
Briefly, the 1905 bp PCR fragment of lacABC (sa1995-1997) was amplified using 
the primers Sa1997RBSfor/ Sa1995rev digested with NotI, then cloned into the 
same site of pMY107 as previously described (193). The resulting recombinant 
plasmid carrying the lacABC genes located downstream of the Pspac promoter 
region was obtained, confirmed by PCR and DNA sequencing, and 
correspondingly designated as pMY307. The pMY307 recombinant plasmid was 
electroporated into WCUH29 and resulted in Pspac-driven lacABC genes 
complement strains denoted as YJ307. To examine whether the Pspac-driven 
lacABC genes can complement the inhibitory growth effect of yhcS antisense 
RNA, we titrated the effect of induced yhcS antisense RNA on growth by 
kinetically monitoring the growth of the above complementary strains in TSB 
containing erythromycin (5μg/ml) and different concentrations of inducer, 
anhydrotetracycline (ATc) in a 96-well format using a SpectraMax plus 
Spectrophotometer (Molecular Devices) as previous described (128, 193). This 
experiment was repeated at least three times.  
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Table 4-1 Bacterial strains and plasmids  
Strain Description Source 
DH10B E. coli strain used propagation and construction 
of plasmids 
Invitrogen 
BL21(DE3) E. coli strain allows for overproduction and 
purification of heterologously proteins 
Invitrogen 
RN4220 S. aureus Laboratory strain: rsbU (181) 
WCUH29 Clinical human S. aureus isolate: rsbU+  
YJ2002  WCUH29 containing plasmid pYH3 
(221) 
 
JSAS909 WCUH29 containing plasmid pSAS909 carrying 
yhcS antisense; Ermr (128) 
YJ606 WCUH29 containing plasmid pCY606; Ermr (193) 
YJ1997 WCUH29 containing plasmid pMY1997; Ermr 
This 
study 
YJ107 WCUH29 containing plasmid pMY107; Ermr (193) 
YJ207 WCUH29 containing plasmid pMY207; Ermr (193) 
YJ307 WCUH29 containing plasmid pMY307; Ermr 
This 
study 
   
Plasmids Description Source 
pET24b Vector for overproducing His-tagged proteins, 
Kanr 
Novagen 
pyhcR-24b pET24b derivative for overproduction of YhcR, 
Kanr 
This 
study 
pYH3 Shuttle vector with a TetR regulated inducible 
promoter; Ermr (128) 
pSAS909 pYH3 vector with yhcS antisense RNA 
downstream of TetR ; Ermr (128) 
pCY606 Shuttle vector, derived from pSAS909, 
containing luxABCDE and yhcS antisense; Ermr (193) 
pMY1997 Derived from pCY606, with sa1997 promoter - 
luxABCDE reporter fusion; Ermr 
This 
study 
pMY107 Derived from pCY606, with luxABCDE replaced 
by Pspac promoter region; Ermr (193) 
pMY207 Derived from pMY107, with sa2237operon 
under the Pspac; Ermr (193) 
pMY307 Derived from pMY107, with sa1997operon 
under the Pspac; Ermr 
This 
study 
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Table 4-2 Oligonucleotide sequences 
Primers Sequence 
yhcRforNdeI 5’-GGAATTCCATATGAACAAAGTAATATTAGTAG-3’ 
yhcRrevXhoI 5’-CCGCTCGAGAATCAACTTATTTTCCATTGC-3’ 
sa1997proNotFor 5’-TAGTGCGGCCGCATTAAAAGTATAACTGCATTG-3’ 
sa1997proNotRev 5’-TAGTGCGGCCGCTAATAAGACTCCTTTTTACTTT-3’ 
Sa2237prGSFor416bp 5’-TGCATTATTACAAAAATTCGAC-3’ 
Sa2237prGSRev416bp 5’-AACATAATCATTTCTCCTTCC-3’ 
Sa2237prGSFor312bp 5’-TATGAGTTATCTATTTAGTTGC-3’ 
Sa2237prGSFor210bp 5’-AGTAATCGGTAGAAATTCAAC-3’ 
Sa2237prGSFor172bp 5’-TACTGTTAAGTATTCACATTAC-3’ 
SA1997prGSfor 5’-TTAAAAGTATAACTGCATTG-3’ 
SA1997prGSrev 5’-CATCTGAACCAATAATAATC-3’ 
Pspacfor 5’-TCTAGAGCTGCCTGCCGCGTTTCGGT-3’ 
Pspacrev 
5’-GCTTGAATTCCCGGGCGGCCGCCGCGGCCGGCC 
AATTGTTATCCGCTCACAATTC-3’ 
Sa1997RBSfor 
5’-TAGTGCGGCCGCGGCCGGCCAGGAGGGAGTCTT 
ATT ATGGCGATTATTATTGG-3’ 
Sa1995rev 
5’-TAGTGCGGCCGCGGCCGGCC 
TTACACCTCTAAAACTTCAATTTG-3’ 
SA2237RT 
For 5’-CGTATCGGTGTCGTAAGAGCACT-3’ 
Rev 5’-GCACCACCTTACCTTCTGACAT-3’ 
SA1997RT 
For 5’-TGGTGCAGGTAGCTTTATGGTTG-3’ 
Rev 5’-GCATATCTACGCGGATTTGGTGT-3’ 
SA0222RT 
For 5’-AAGCAGTTAAAGAAGCAGACGAATCTTG-3’ 
Rev 5’-GTTGTGTTGTTTCTTCAGCTTTACCAG-3’ 
SA0959RT 
For 5’-GGATACACCAGGACATGCAGACTT-3’ 
Rev 5’-CTACAACACCCTCTGGACGTGCT-3’ 
SA1044RT 
For 5’-CCTAACACAAGACCGGTACCAGAT-3’ 
Rev 5’-CTTCACAGTGTGCTACGATGGCTT-3’ 
P2290 
For 5’-TGTCGTCTTGAAATACGGCTGT-3’ 
Rev 5’-CTATATTGTTCGGTTTTTAAAAGCAATG-3’ 
SA1269RT 
For 5’-GCCGTCAAGAGAGGCATTTGAAG-3’ 
Rev 5’-CAAGACCACCTGCTCCTACAACAA-3’ 
SA1271RT 
For 5’-GATGCAACGATTGTGATGCCAG-3’ 
Rev 5’-ATTAGGCCACCTCCACCAACTG-3’ 
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4.4 Results 
4.4.1 Identification of essential genes regulated by the essential yhcSR 
system. 
Using a Pspac-regulated yhcSR mutant and a TetR-regulated yhcS 
antisense RNA mutant, we have demonstrated that the down-regulation of 
yhcSR expression causes a lethal effect on bacterial growth (128). In order to 
elucidate the biological functions of the essential yhcSR system in S. aureus, we 
comprehensively examined the effect of conditional knockdown of yhcSR on 
gene expression using regulated antisense RNA technology with the combination 
of microarray analysis. Our preliminary microarray data showed that the down-
regulation of yhcS expression differentially affected expression of various genes, 
including the lac operon encoding the structural genes for lactose and galactose 
metabolism (decreased expression two to five-fold) and opuC encoding a glycine 
betaine/carnitine/choline ABC transporter (decreased expression four to five-
fold), and virulence factors (Table 4-3). To confirm the preliminary results, we first 
selected four down-regulated genes and five up-regulated genes including 
several essential genes and conducted qPCR analysis. For the control strain, 
YJ2002 (WCUH29 carrying pYH3, (221), the addition of inducer (250ng/ml of 
ATc) had no significant influence on the expression of the above selected 10 
genes in both microarray and qPCR assays (data not shown). However, for the 
yhcS antisense RNA expression strain JAS909, the qPCR analysis showed that 
the down-regulation of yhcSR led to a 4-fold decrease of both lacA and opuCA 
expressions, which are consistent with the microarray data (Table 4-3). 
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Interestingly, we found that the down-regulated yhcSR expression significantly 
increased the transcription of several genes encoding virulence factors, including 
coagulase, fibronectin binding protein, and exotoxin, suggesting that the YhcSR 
system may function as a repressor of these virulence factor genes (Table 4-3), 
possibly through regulation of agr and saeR (129).  
 
Table 4-3 qPCR and microarray data of gene expression in mid-log phase 
of growth, using the yhcS antisense RNA strain 
Gene Description 
    Fold Change 
qPCR* 
(control) 
Microarray 
coa staphylocoagulase +4 (0) 5.59 
set15 exotoxin 15 +4 (0) 2.5 
SA0959 GTP-binding elongation factor homolog +2 (0) 2.3 
pyrC dihydroorotase +2 (0) 2.8 
fnbB fibronectin-binding protein homolog +2 (0) 7.29 
SA1269 Blt-like protein -4 (0) -33.4 
SA1271 threonine dehydratase -8 (0) -51.67 
lacA galactose-6-phosphate isomerase -4 (0) -4.89 
opuCA Glycine/betaine/carnitine/choline-ABC transporter -4 (0) -4.39 
qPCR* (control): The number inside parentheses is the fold change of specific genes 
in control strain YJ2002 with versus without ATc. – represents down-regulated gene 
expression during depletion of the yhcSR system; + represents up-regulated gene 
expression during depletion of the yhcSR system 
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4.4.2 Confirmation of transcriptional regulation of lac using a promoter-lux 
reporter fusion system.  
To further confirm whether the yhcSR regulator transcriptionally regulates 
the expression of the lac genes, we created a promoter-lux reporter fusion 
system using the TetR-regulated yhcS antisense expression vector, pCY606. 
The promoter-lux reporter fusion strains (YJ1997) and the parental control strain 
(YJ606) were grown in TSB in the presence of the yhcS antisense RNA inducer 
ATc (200ng/ml) and in the absence of ATc, at 37°C with shaking. 
Bioluminescence intensity and optical density of the cultures were measured at 
different times of growth. No light signal was detected for the control strain YJ606 
with and without inducer, suggesting no detectable leaky luxABCDE transcription 
(data not shown) and expression. However, for the lac promoter-lux fusion 
strains (YJ1997), the light intensity obviously decreased in the early log-phase of 
culture during the induction of yhcS antisense RNA expression with inducer ATc 
(Fig. 4-1). These results, in conjunction with our previous results on opuC (193), 
indicate that the YhcSR system transcriptionally regulates the expression of lac 
operon and opuC operons. 
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Figure 4-1 Analysis of transcriptional regulation of lac operon by the 
YhcSR system using promoter-luxABCDE reporter fusion.  
The impact of the down-regulation of yhcSR on the expression of lac operon was 
determined by monitoring the bioluminescence intensity during growth. The 
overnight cultures of S. aureus strains were diluted to ∼104 CFU/ml with TSB 
containing appropriate antibiotics and in the absence (solid dots ) or presence of 
200 ng/ml of inducer, ATc (solid dashes). Both bioluminescence signals and cell 
growth were monitored at 37°C by measuring the light intensity with a Chiron 
luminometer and optical density at 600 nm (OD600nm) with a SpectraMax plus 
spectrophotometer every 30 min. To eliminate the effect of bacterial growth, the 
relative light units (RLU) were calculated (light intensity/OD600nm) from triplicate 
readings at different times during growth. 
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4.4.3 YhcR directly interacts with the upstream promoter regions of lacA 
and opuCA.  
To examine whether YhcR directly or indirectly regulates the expression of 
these essential genes, we conducted gel shift assays with the upstream regions 
of lacA and opuCA. Gel shift promoter probes containing the 300 to 400 bp 
upstream of the translational start site of the first structural gene of each operon 
were obtained by PCR and labeled with digoxigenin (DIG). Each gel shift assay 
consisted of a DNA probe-only control, the probe incubated with different 
concentrations of YhcR ranging from 1 to 6 μM, the probe plus 100-fold excess of 
unlabeled probe, and the probe with nonspecific protein BSA (2.3 μM).  
The gel shift assays with the upstream region of lacA resulted in obvious 
bands shifted in a dose-dependent manner compared to the probe only and 
nonspecific proteins. Moreover, the addition of excess-unlabeled competitor 
apparently competed with the shifted band (Fig. 4-2A). Furthermore, two 
apparent shifted bands were revealed in the gel shift analysis with the upstream 
region of opuCA probe, suggesting the possible presence of multiple YhcR 
binding sites in the promoter sequence. The excess-unlabeled competitor 
successfully competed with the shifted bands (Fig. 4-2B). These results indicate 
that the YhcR response regulator may directly interact with the upstream regions 
of lacA and opuCA genes. 
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Figure 4-2 Gel-shift mobility analysis of genes regulated by YhcR.  
Different amounts of YhcR were incubated with each DIG-labeled promoter 
probes: Plac (A) and PopuC (B). (–) represents without unlabeled specific 
competitor; (+) represents in the presence of 100-fold excess unlabeled specific 
competitor.
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4.4.4 Expression of lacABC genes in trans partially complements the lethal 
effect of down-regulating yhcSR expression.  
In order to determine whether the direct modulation of the lac operon is 
associated with the essentiality of yhcSR system, we conducted complementary 
experiments using a multi-copy plasmid. The lacABC genes were obtained by 
PCR using a high fidelity pfx DNA polymerase, and cloned downstream of Pspac 
promoter within the yhcS antisense RNA expression vector, pMY107 and labeled 
at pMY307. The recombinant plasmid was electroporated into the laboratory 
strain, RN4220, and subsequently, into the clinical isolate, WCUH29, labeled 
YJ307. The growth of the complementary strain YJ307 and control carrying 
parental plasmid DNA (YJ107) was kinetically monitored with increasing 
concentrations of inducer, ATc. Consistent with our previous findings (128), the 
induction of yhcS antisense expression with the inducer ATc dramatically 
inhibited the growth of the control strain (YJ107) in a dose-dependent manner 
(Fig. 4-3A). In contrast, the expression of the lacABC genes partially restored the 
growth of the yhcS antisense RNA expression strain and shortened the 
differential lag-phase of growth from five to two hours in the presence of 250, 
500, and 750 ng/ml of inducer ATc (Fig. 4-3B). We previously observed similar 
results of partial complementation with the opuC operon (193). 
To exclude the possibility that the above complementation may be 
attributed to the overproduction of the LacABC or OpuCABCD proteins in the 
multi-copy plasmid, we compared the growth between the control strain and each 
complementary strain in the absence of inducer. Without the induction of yhcS 
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antisense RNA expression, the complemented strain carrying the multi-copy 
plasmids of lacABC genes and the opuC operon showed a similar pattern of 
growth as the control strain showed (Fig. 4-3C).  
To determine if the complemented growth effect of the lacABC genes and 
opuC operon on the yhcS antisense RNA lethal function resulted from the Pspac-
driven lacABC genes and opuC operon over-expressions in trans, we performed 
qPCR using lacA, and opuCA specific primers (Table 4-2). Total RNA was 
isolated and purified from log-phase cultures, and cDNA was reverse transcribed. 
The transcriptional levels of lacA and opuCA in the complemented strains (YJ307 
and YJ207) respectively increased 16- and 4-fold than those in the control strain 
(YJ107), suggesting the complemented growth effect seen in the assays was due 
to the Pspac-driven expression of the lacABC genes and opuC operon.  
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Figure 4-3 Complementation of induced yhcS antisense RNA by Pspac-
driven lacABC expression.  
Growth curves of control strain, YJ107 (A), lacABC complemented strain, YJ307 
(B), in TSB containing 5 µg/ml of erythromycin and various concentrations of 
inducer anhydrotetracycline, ATc (in nanograms/milliliter). (C) Represents the 
growth curves of the above strains in the absence of ATc. The overnight cultures 
of S. aureus strains were diluted to ~ 104 CFU/ml. Cell growth was monitored at 
37ºC by measuring the optical density at 600 nm (OD600) every 15 min, with 1 
min of mixing before each reading in a SpectraMax plus spectrophotometer. The 
growth curves represent one of three repeated experiments.
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4.4.5 Expression of opuCABCD genes in trans enhances growth in high 
osmolarity medium during yhcS antisense RNA induction. 
In order to further to demonstrate the link between yhcSR regulation of the 
opuC operon we conducted complementation experiments using an opuC operon 
expressing multicopy plasmid and chemically defined medium in the absence or 
presence of NaCl and the compatible solute, choline. Choline, oxidized in the cell 
to glycine betaine, is one of several osmoprotectants that S. aureus can use to 
shield itself from high osmolarity environments (222, 223). Consistent with 
previous publications regarding S. aureus growth in high osmotic conditions (218, 
223), the addition of NaCl to the CDM dramatically reduced the growth rate of the 
control strain YJ2002. The addition of choline to the CDM improved the growth of 
YJ2002. The presence of ATc had mild effect on the growth of S. aureus in all 
conditions, but the effect was equal across of the growth conditions for YJ2002 
(Fig. 4-4A). The yhcS antisense RNA strain, YJ107 grew similarly to YJ2002 with 
ATc. As expected, induction of yhcS antisense RNA caused a growth defect in 
YJ107, this growth defect was further exacerbated with the addition of NaCl to 
the CDM. Adding choline to the NaCl-CDM allowed YJ107 growth to partially 
recover, similar to YJ2002 in the same medium (Fig. 4-4B). The presence of the 
Pspac-driven opuCABCD genes in YJ207 resulted in S. aureus growing better in 
CDM containing NaCl and ATc, indicating protection of the cells from the high 
salt conditions. This protection may be mediated by OpuC transport of the 
minimal amount of L-proline in the CDM. The presence of the opuCABCD genes 
and the addition of choline to the NaCl-ATc-CDM further enhanced the growth of 
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YJ207 to the point that it grew as well as the YJ207 + ATc (Fig. 4-4C) This 
indicates that the Pspac-driven expression of opuCABCD complemented the loss 
of the yhcSR regulated chromosomal opuCABCD.  
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Figure 4-4 Complementation of induced yhcS antisense RNA by Pspac-
driven opuCABCDE in the presence of NaCl and choline.  
Growth curves of control strain, YJ2002 (A), yhcSR antisense RNA strain, YJ107 
(B), and opuCABCD complemented strain, YJ207 (C) in CDM with 750 ng/ul 
ATc, 1 M NaCl, and 1 μM choline chloride were added where indicated. The 
overnight cultures of S. aureus strains were diluted with CDM containing 
appropriate antibiotics and additives as indicated. Cell growth was monitored at 
37ºC by measuring the optical density at 600 nm (OD600nm) every 15 min, with 1 
min of mixing before each reading in a BioTek Synergy 2 microplate reader. The 
growth curves represent one of three repeated experiments. 
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4.5 Discussion 
Two-component signal transduction systems play important roles in the 
ability of bacteria to adapt to various environments by sensing alterations in their 
surroundings and by altering gene expression (207). With the availability of S. 
aureus genome sequences, at least 16 pairs of two-component signal 
transduction systems have been revealed (224). However, most of them have 
not been functionally explored. Previous work in our laboratory led to the 
identification of a novel essential two-component signal transduction system, 
yhcSR, in S. aureus (128) and demonstrated its role in regulating disimilatory 
nitrate reduction (100). In this study, we investigated two additional target genes 
that are directly regulated by the essential YhcSR system.  
Our results demonstrate for the first time that the novel essential YhcSR 
system directly regulates the expression of lac and opuC operons (225, 226). 
Using microarray approaches, we and other investigators have successfully 
identified genes that are directly and/or indirectly regulated by different regulators 
including two-component signal regulatory systems, such as ArlRS (166), SaeRS 
(117), AgrA and SarA (227), and MgrA (228). In this study, we employed a similar 
approach to identify genes that are modulated by the YhcSR system. Our 
preliminary microarray data showed that the depletion of the YhcSR system 
apparently down-regulates the expression of lac and opuC operons, which were 
confirmed by semi-quantitative RT-PCR analysis. To further confirm whether 
YhcSR is able to regulate the expression of the lac operon at the transcriptional 
level, we performed promoter-lux reporter fusion assays. Consistent with the RT-
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PCR data, the down-regulation of yhcSR expression obviously decreased the 
bioluminescence intensity of the Plac-lux promoter fusion. Taken together, and in 
conjunction with our previous publication (193) the results indicate that the 
essential yhcSR system transcriptionally regulates the lac and opuC operons in S. 
aureus. The different profiles of lux expression in the different promoter-lux 
reporter fusions during different stages of growth suggest that in the early log-
phase YhcR controls lac transcription; in contrast, in the middle and late log-
phases YhcR positively modulates opuC operon expression (193). This finding is 
not surprising since it has been found that the well-studied agr system differentially 
regulates the expression of both cell-wall associated proteins and exported toxins 
in different phases of cell growth (33).  
 In order to elucidate whether the above regulatory effects on the lac and 
opuC operons expression are mediated directly by YhcR or indirectly through 
other regulators, we employed gel shift assays. The upstream promoter regions of 
the lac and opuC operons bound to YhcR-His in a dose-dependent manner. We 
also found that the upstream promoter regions showed multiple shifted bands with 
a low concentration of YhcR, suggesting that these promoter regions may bind 
YhcR as a dimer or at multiple sites. This phenomenon has been observed with 
different regulators, including OmpR, SarA, and SrrA (220, 229, 230). These 
results indicate that YhcR positively mediates the expression of the lac and opuC 
operons by directly binding to their promoter regions.  
In addition, unlike OmpR where binding affinity to its target DNA is 
increased by phosphorylation (229, 231), the phosphorylation of YhcR had no 
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obvious impact on our gel shift assays (data not shown), which is consistent with 
the report of SrrA (230). We cannot dismiss the possibility that the in vitro 
phosphorylation of YhcR in this study is not as effective as expected. It remains to 
be determined whether a phosphorylated YhcR has different binding sites and/or 
affinities in the promoter regions of lac and opuC.  
To address whether the above transcriptional effects of YhcSR on lac 
expression are relevant to the biological function or essentiality of the yhcSR 
system, we conducted complementation experiments by introducing Pspac-driven 
lacABC genes in a multi-copy plasmid. The complementation of the lacABC 
dramatically curtailed the inhibitory effect of the induced yhcS antisense RNA. 
Biochemical evidence indicates YhcSR is an oxygen sensing two-component 
system (129), thus regulation of the lac operon by YhcSR links lactose 
fermentation to the absence of oxygen. The importation and ultimate fermentation 
of lactose provides an additional energy source during oxygen limited periods for 
growth.  
A similar result of partial complementation was observed for Pspac-driven 
opuC operon (193). Additionally, we found that the down-regulation of yhcSR 
expression effectively inhibited bacterial growth in a high osmotic defined medium. 
Complementation with the Pspac-driven opuCABCD enhanced growth of the 
bacteria in the high osmotic medium and supplementation of the high osmotic 
medium with choline restore bacterial growth to that equal of the cells in CDM with 
ATc alone. This indicates full complementation by the Pspac-driven opuCABCD is 
occurring. Further complementation by the Pspac-driven opuCABCD is not seen, 
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nor expected, as the YhcSR TCS is a global regulator and likely controls other, as 
yet unidentified, essential genes. The data indicate that YhcSR is involved in the 
modulation of the transportation of the osmoprotectant choline through direct 
regulation of opuC operon expression. The transport of choline by OpuCABCD 
and their role in osmoprotection has been is well established (218, 232–234). 
In S. aureus, OpuCA interacts with and influences the level of 
phosphorylated TRAP protein, a protein that protects DNA from oxidative stress 
(218, 235). The kinase activity of YhcS is influenced by oxidative stress (such as 
H2O2) (129) and the regulation of opuC by YhcSR is likely part of the overall stress 
response that occurs when S. aureus encounters stressful environmental 
conditions. The up-regulation of multiple stress response pathways likely allows 
the cell to better handle additional environmental insults.  
Structural alignment indicates that YhcS and YhcR are more than 40% 
identical to YhcY and YhcZ in B. subtilis. However, unlike the YycFG system which 
is essential for B. subtilis and S. aureus (197, 209), YhcYZ is dispensable for B. 
subtilis growth (236). The YhcSR system may play different roles in S. aureus 
compared to the YhcHZ system in B. subtilis. In B. subtilis, only a limited set of 
genes are regulated by YhcHZ (237). In contrast, in S. aureus our preliminary 
microarray results showed that more than 80 genes are modulated by YhcSR 
(data not shown). This is also true for the YycFG system because YycF is involved 
in the regulation of the FtsAZ operon in B. subtilis (211), whereas there is no such 
evidence in S. aureus and S. pneumoniae (108, 212, 214–216, 224). 
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Interestingly, our preliminary microarray and qPCR analyses also indicate 
that the essential YhcSR system is probably a repressor of virulence factors 
because the down-regulation of yhcSR expression dramatically increased the 
expression of coagulase, fibronectin binding protein, and exotoxin (Table 3-3), 
possibly through regulation of the agr and sae operons (129). This suggests that 
the YhcSR system may function as a global regulator.
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Chapter 5 :  The YhcSR two-component system 
positively regulates the sspABC operon
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5.1 Overview 
 To date, genes identified to be transcriptionally regulated by the YhcSR 
have been involved in energy production and cellular homeostasis of the cell. It is 
well accepted that the state of cellular metabolism impacts the expression of 
virulence factors in S. aureus. For this reason, experiments to determine if the 
YhcSR TCS is involved in S. aureus pathogenesis were conducted using 
antisense RNA and overproduction plasmids to create inducible mutants of this 
essential TCS. Likely due to growth inhibition, depletion of YhcSR resulted in 
decreased survival of S. aureus while the overproduction of YhcR promoted 
survival of S. aureus in human whole blood. This enhanced survival is linked to 
the direct transcriptional regulation of the sspABC operon, encoding V8 protease 
(SspA), staphopain B (SspB) and staphostatin B (SspC). SspA and SspB are 
known virulence factors which proteolytically digest opsonins and inhibit the 
function of professional phagocytes by cleavage of receptors. Deletion of sspAB 
partially eliminated the YhcR-mediated enhanced survival in human blood. This 
is the first evidence linking the TCS to pathogenesis of S. aureus. 
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5.2 Introduction 
Staphylococcus aureus accounted for approximately 20% of bloodstream 
infections in the U.S. (238). The bacteria gain access to the bloodstream 
commonly from the result of puncture wounds of the skin (239–241), surgical site 
infections, or insertion of central venous lines and catheters (238, 242). Once S. 
aureus enters the bloodstream the bacteria have the ability to enter almost any 
site of the human body (243). S. aureus bloodstream infections often lead to 
septic shock and endocarditis (144). Bacteremia accounted for 75% of invasive 
S. aureus infections identified by the Active Bacterial Core Surveillance program, 
a nationwide observation program of federal and state health officials. Septic 
shock and endocarditis accounted for an additional 10% of invasive infections 
(7).  
The pathogenicity of S. aureus partially relies on the coordinately-
regulated expression of virulence factors that allow the bacterium to evade the 
host immune system and/or promote survival during infection. Similar to other 
bacterial pathogens (244–249), S. aureus has evolved a series of regulatory 
effectors (11, 213, 245, 250, 251) which allow the organism to sense and to 
adapt to changing environmental stimuli and survive within a particular niche by 
modulating specific cellular responses and virulence gene expression. Sixteen 
two-component systems are encoded in the core S. aureus genome, with many 
of them influencing the expression of virulence factors (92, 95–97, 119, 123, 201, 
252–254). Some of these TCSs link cellular metabolism and virulence factor 
expression to the availability of extracellular nutrients, such as KdpDE and 
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HssRS systems that sense extracellular K+ and heme, respectively (98, 250). 
Analysis of YhcSR to date has shown the two-component system to be a sensor 
of oxygen (129) that modulates the expression of pathways responsible for 
dissimilatory nitrate reduction (100), cellular osmotic balance (193) and 
alternative sugar catabolism pathways (99). Importantly, the YhcSR TCS is 
essential for aerobic and anaerobic growth of S. aureus as described in chapter 1 
(128, 130).  
The mechanisms by which S. aureus survives and subverts the vertebrate 
immune system have been studied for many decades. These published studies 
identified many S. aureus produced immune suppression factors and that 
circulating neutrophils and monocytes are key innate cellular components to 
combat infection by S. aureus (255–260). Data presented in this chapter are the 
first evidence that indicate the YhcSR TCS transcriptionally activates expression 
of the sspABC operon, encoding V8 protease (sspA, serine endopeptidase), 
staphopain B (sspB, cysteine endopeptidase) and staphostatin B (sspC, inhibitor 
of Staphopain B). These proteases have been linked to a wide variety of innate 
immune system suppression pathways by their ability to degrade complement 
components (139), induce vascular leakage and promote extracellular matrix 
structural damage (261, 262). In addition, the proteases inhibit neutrophil 
chemotaxis and induce apoptosis of neutrophils or engulfment of neutrophils by 
macrophages (263, 264).  
 Overproduction of YhcR resulted in enhanced survival of S. aureus in 
human blood. Furthermore, the culture supernatants of the YhcR over-producing 
114 
 
S. aureus strain inhibited opsonin mediated phagocytosis. The enhanced survival 
of YhcR overproducing S. aureus is partially the result of direct transcriptional up-
regulation of the sspABC operon which led to increased production of SspA and 
SspB, consequently opsonophagocytic clearance of the bacteria was likely 
inhibited in the blood survival assay. 
 
5.3 Materials and methods 
5.3.1 Bacterial strains, plasmids, and growth media. 
The bacterial strains and plasmids used in this study are listed in Table 5-
1. The S. aureus cells were cultured in trypticase soy broth (TSB) at 37˚C with 
shaking. E. coli strains were grown in Luria-Bertani (LB) broth. Transformants 
containing recombinant plasmids were selected on LB agar containing ampicillin 
(100 µg/ml), kanamycin (50 µg/ml), or erythromycin (300 µg/ml) for E. coli, and 
trypticase soy agar (TSA) containing chloramphenicol (10 µg/ml), tetracycline (5 
µg/ml), and/or erythromycin (5 µg/ml) for S. aureus.  
5.3.2 Blood survival assay. 
Strains were cultured in TSB with appropriate antibiotics. Inducer ATc was 
added when indicated to overnight cultures. Following 18 hours of culturing, the 
bacteria were washed twice in sterile PBS and suspended to an OD of 0.14 using 
a Behring photometer in PBS. Fresh venous human whole blood was collected 
using heparin containing Vacutainer tubes (BD) from outwardly healthy adult 
donors. The blood was then immediately used in the assay. Approximately 5x106 
CFU in 50 μl of PBS were added to 450 μl of blood per microcentrifuge tube with 
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appropriate antibiotics and ATc, where indicated. Microcentrifuge tubes were 
capped and placed in a rotisserie incubator and incubated at 37°C with end-over-
end mixing. At indicated time points a 20 μl sample was removed from each 
sample, serially diluted, and plated on TSA to determine the surviving CFU count 
for each sample. The percentage of surviving bacteria was calculated as CFUtime 
point/CFUinitial input*100.  
5.3.3 Gene deletion protocol. 
Deletion of sspB and sspAB was carried out following the pKOR1 allelic 
exchange protocol as described (191) and primers in listed in Table 5-2. Plasmid 
pJB38 is a modified version of pKOR1 (265) and pJB38-sspAB was kindly 
provided by Alex Horswill (266). All deletions were confirmed by diagnostic PCR.  
5.3.4 Cloning, expression and purification of a YhcR-His tagged fusion 
protein in Escherichia coli. 
The purification of YhcR-His was carried as described using the previously 
constructed pETyhcR plasmid described in section 4.3.3 (99). The only 
modification to the protocol was the use of Pro-LyseTM Bacterial Lysis Buffer 
(Lamda Biotech) to lyse the E. coli. 
5.3.5 SDS-PAGE analysis of exported proteins, mass spectrometry peptide-
protein identification, and western blotting. 
The culture supernatants were collected from the overnight cultures of S. 
aureus strain grown in TSB medium with 5 μg/ml of erythromycin and 250 ng/ml 
inducer ATc. Bacterial cells were pelleted by centrifugation at 3900 x g. The 
culture supernatants were then passed through a 0.2 μm syringe filter to remove 
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all bacterial cells. The exported proteins were precipitated from an equal volume 
of supernatant using ethanol as described (157). The exported protein profiles 
were detected by a sodium dodecyl sulfate (SDS)-12% polyacrylamide gel 
electrophoresis (PAGE) and Coomassie Blue staining. Five prominent 
overproduced protein bands (JH1-JH5) were cut from the gel and in-gel digested 
(267). Samples were submitted to the University of Minnesota, College of 
Biological Sciences Mass Spectrometry Core where they were processed for 
peptide identification by mass spectrometry. Western blotting for SspB was 
conducted as described previously (117) using a SspB antibody kindly provided 
by Alex Horswill (266) and an alkaline phosphatase conjugated anti-chicken 
secondary antibody (Sigma). Overnight cultures grew to similar OD600nm values 
and equal volume of precipitated protein from each culture supernatant was 
loaded rather than equal protein concentration so that differences in protein 
concentration could be observed.  
5.3.6 Zymography analysis. 
A 12% resolving SDS-PAGE gel with 0.1% final gelatin concentration was 
used for zymography analysis. Each sample was mixed with protein solubilisation 
buffer (5X, 50% glycerol, 10% (w/v) SDS, and 0.5 M Tris-HCl, pH 6.8) and 
incubated at room temperature for 30 minutes. 
Each sample was loaded into the wells of the gelatin SDS-PAGE and 
electrophoresed at a constant 50V for 3 hours. After electrophoresis, the gel was 
placed in a plastic wash container and 1X SDS removal buffer (2.5% Triton X-
100, 5 mM MgCl2, 25 mM Tris-Cl, pH 7.5) was added. The gel was gently 
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washed in the SDS removal buffer for a total of 60 minutes at room temperature. 
The SDS removal buffer was replaced after 30 minutes with fresh removal buffer 
and then rinsed gently with DI water. Development buffer (0.1% Triton X-100, 5 
mm MgCl2, 25 mM Tris-Cl, and pH 7.5) was added until it covered the gel and the 
container was incubated at 37°C for 24 hours. After the development period, the 
development buffer was removed and the gel was rinsed gently with DI water. 
Stain buffer (50% DI water, 35% MetOH, 15% Glacial Acetic Acid, 0.25% 
Coomassie Blue R-250) was added to cover the gel in the container. The gel was 
incubated until it was no longer visible in the stain buffer. Stain buffer was 
removed and the gel was rinsed gently with DI water. Fixing buffer (2% Glacial 
Acetic Acid, 98% DI water) was added to the container until it covered the gel 
and incubated at room temperature for 24 hours. 
5.3.7 Analysis of transcriptional regulation using a promoter-lux reporter 
fusion system.  
To investigate if the yhcSR regulator transcriptionally regulates the 
expression of the sspABC, agrBDCA, saePQRS operons, promoter-lux reporter 
fusion plasmids were created. The agr promoter-lux reporter was provided by 
Philip Hill (117) and this plasmid served as the backbone for construction of the 
sae and ssp promoter-reporters. The upstream sae and ssp promoter regions 
were PCR amplified with primers listed in Table 5-2, digested with EcoRI and 
XmaI (NEB). The pCY1006 plasmid was digested with the same enzymes to 
remove the agr promoter fragment and the plasmid backbone was purified by 
agarose gel electrophoresis. Each PCR fragment was ligated into the gel purified 
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EcoRI/XmaI digested pCY1006 backbone with T4 DNA ligase (Promega). Re-
constructed sae- (pCY306) and ssp-lux promoter reporters were confirmed by 
diagnostic PCR using the promoter specific forward primer and a plasmid specific 
luxA reverse primer listed Table 5-2. Plasmids were purified from E. coli DC10B 
and electroporated into the WCUH29-based strains as indicated in Table 5-1.  
The promoter-lux reporter fusion strains were grown in TSB in the absence of 
ATc, at 37°C with shaking overnight. Strains were diluted 1:300 and incubated 
without or with 25 ng/ml of inducer ATc. Bioluminescence intensity and optical 
density of the cultures were measured at different times of growth. The Relative 
Light Units (RLU) were calculated by dividing the bioluminescence reading by the 
OD600nm reading (lum/OD600nm) at each time point. Each experiment was repeated 
at least three times.  
5.3.8 Electrophoretic mobility shift assay. 
The same ssp promoter primers listed in Table 5-2 used for the luciferase 
reporter were ordered with a 5’-biotin tag. The 5’-biotin labeled promoter 
fragment was obtained by high-fidelity PCR. A total of 300 μl of PCR reaction 
was prepared and processed and loaded into a 2% agarose gel. The sample was 
electrophoresed, stained with ethidium bromide and the promoter fragment was 
removed from the gel and purified using a NucleoSpin Gel Clean-up kit 
(Macherey-Nagel). The purified probe was subjected to electrophoresis in a 5% 
native Tris-borate EDTA (TBE) PAGE gel for further purification. The fragment 
was cut from the gel and re-purified according to the NucleoSpin Gel Clean-up kit 
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protocol. Lastly, a sample of the purified probe was electrophoresed on a 1.2% 
agarose gel to verify the size and purity of the biotin labeled Pssp probe.  
The Electrophoretic mobility shift sssay (EMSA) was performed essentially 
as described in the manufacturer’s protocol. The LightShift Chemiluminescent 
EMSA Kit (Thermo Scientific) was used to perform the assay. All samples 
contained 1X LightShift Binding Buffer, 50 ng/μl Poly (dI•dC), and 2.5% glycerol. 
The labeled probe, YhcR-His, non-labeled specific probe, BSA, and non-specific 
non-labeled probe were all added to concentrations as outlined in the Fig. 5-12 
and ultrapure water was added so that all reaction volumes totaled 20 μl. The 
reactions were incubated at room temperature for 20 minutes followed by 
addition of 5 μl of 5X loading buffer to each reaction. 20 μl of each reaction were 
loaded into the wells of a pre-run 8% TBE native polyacrylamide gel and 
electrophoresed at 75V for three hours at 4°C. The samples were transferred to 
nylon membrane and processed as outlined in the manufacturer’s protocol. 
BioMax Light Film (Kodak) was used to detect the chemiluminescent reaction.  
5.3.9 Construction of overproduction plasmids. 
Gene ORFs were obtained using Q5 high-fidelity polymerase (NEB) PCR 
using the primers (YhcROE-for/YhcROE-rev; sspB-For/sspB-Rev-AscI; sspABC-
For/sspABC-Rev-AscI) in Table 5-2. Purified PCR fragments were digested with 
AscI. The pYH4 plasmid carrying the TetR regulated, anhydrotetracycline (ATc) 
inducible promoter was digested with PmeI and AscI. Digested PCR fragments 
were ligated into the digested pYH4 plasmid with T4 DNA ligase (Promega) and 
confirmed by diagnostic PCR using the Tetfor/TTrev primer pair listed in Table 5-
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2 that are specific for regions upstream and downstream of the TetR regulated 
promoter.  
5.3.10 HL-60 opsonophagocytic killing assay. 
HL-60 pluripotent cells were differentiated to granulocytic cells and 
cultured for 5 days as described (268). The basic assay consisted of 
approximately 1,000 CFU of S. aureus WCUH29 placed in duplicate of a 96 well 
microtiter plate. Twenty and 10 μl of human serum and complement from 3-4 
week of white rabbits (Life Technologies), respectively, were added to each well. 
Lastly, 4×105 differentiated HL-60 granulocytes were added to each well to 
initiate the assay. The plates were incubated for 60 minutes at 37°C and with a 
concentration of 5% level of CO2. Each well was mixed gently and 10 μl of 
sample from each well was drop plated in triplicate on TSA plates to determine 
surviving CFU. The percent survival was calculated as the number of surviving 
CFU/number of input CFU multiplied by 100, (CFUf/CFUi*100). The experiment 
was repeated at least 4 times. To determine the effect of S. aureus strains 
exported proteins on the activity of serum antibodies and complement, induced 
cultures were grown in TSB with appropriate antibiotics and 250 ng/ml of inducer 
ATc overnight at 37°C with shaking. The following day the bacterial cells were 
pelleted and the TSB culture supernatant was filter sterilized with a 0.2 μm 
syringe filter. Twenty five milliliters of each culture supernatant, along with sterile 
TSB as a vehicle control, were concentrated 50-fold using a Millipore Centrifugal 
Protein Concentrator with a 10 kD nominal molecular weight limit. Before the HL-
60 phagocytic assay, each concentrated culture supernatant and TSB was mixed 
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1:1 with the human serum or rabbit complement, incubated at 37°C for 30 
minutes, and then placed on ice. In the assay, 40 and 20 μl of the serum mixture 
and complement mixture, respectively, were added to each well. Additional buffer 
was added to the complement mixture wells so all wells were of equal 100 μl 
volume. 
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Table 5-1 Bacterial strains  
Strain Description Source 
DC10B Dam- E. coli which allows for direct electroporation 
of purified plasmid DNA into wild-type S. aureus 
(269) 
BL21(DE3) E. coli used for protein expression; IPTG inducible; 
Cmr and Kanr 
Invitrogen 
RN4220 Laboratory S. aureus strain (RsbU-) (181) 
WCUH29 Human clinical MRSA isolate NCIMB40771 
JE2 Plasmid cured derivative of LAC strain, community-
acquired MRSA isolate 
(202) 
923 Community-acquired MRSA isolate  
WCUH29/pYH3 WCUH29 antisense control strain with empty 
pYH3; Ermr 
(128) 
JSAS909 WCUH29 with pYJY909; Ermr (128) 
WCUH29/pYH4 WCUH29 protein overproduction control with 
empty pYH4; Ermr 
This Study 
WYhcR WCUH29 with pYH4-yhcR; Ermr This Study 
JE2/pYH4 JE2 with pYH4; Ermr This Study 
JE2/pYhcR JE2 with pYH4-yhcR; Ermr This Study 
923/pYH4 923 with pYH4; Ermr This Study 
923/pYhcR 923 with pYH4-yhcR; Ermr This Study 
NE1787 JE2 transposon mutant, srtA::erm; ermr NARSA 
JH1787 NE1787 with erm gene removed from transposon; 
srtA mutant 
This Study 
JH1787/pYH4 JH1787 with pYH4; Ermr This Study 
JH1787/pYhcR JH1787 with pYH4-yhcR; Ermr This Study 
WSspB WCUH29 with pYH4-sspB; Ermr This Study 
WCUH29/pYH4/ 
Pssp-lux 
WCUH29/pYH4 with Pssp-lux; Ermr 
This Study 
WYhcR/Pssp-lux WYhcR with Pssp-lux; Ermr This Study 
WYhcR/pCY1006 WYhcR with pCY1006; Ermr, Cmr This Study 
WYhcR/Psae-lux WYhcR with pCY306; Ermr, Cmr This Study 
WCUH29saeS WCUH29 transposon mutant, saeS::tc, Tcr (371) (117) 
WCUH29agrA WCUH29 transposon mutant, agrA::tc, Tcr (117) 
WCUH29saeS/ 
pYH4/ Pssp-lux 
371 with pYH4 and Pssp-lux; Ermr, Cmr 
This Study 
WCUH29saeS/ 
pYhcR/Pssp-lux 
371 with pYH4-yhcR and Pssp-lux; Ermr, Cmr 
This Study 
WCUH29agrA/ 
pYH4/ Pssp-lux 
WCUH29agrA with pYH4 and Pssp-lux; Ermr, Cmr 
This Study 
WCUH29agrA/ 
pYhcR/Pssp-lux 
WCUH29agrA with pYH4-yhcR and Pssp-lux; Ermr, 
Cmr 
This Study 
JH114 WCUH29 with in-frame deletion of sspAB  This Study 
JH214 WCUH29ΔsspAB with pYH4; Ermr This Study 
JH314 WCUH29ΔsspAB with pYhcR; Ermr This Study 
JH414 WCUH29ΔsspAB with pSspABC; Ermr  This Study 
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Table 5-2 Plasmids  
Plasmids  Description Source 
pCY1006   Shuttle vector carrying agr promoter-gfp-lux 
reporter, derives from pSB2019; Cmr, Ampr 
(117) 
pETyhcR pET24b based for production of YhcR in E.coli 
BL21(DE3) 
(99) 
pYH3 Shuttle vector with a TetR regulated inducible 
promoter; Ermr 
(128) 
pSAS909 pYH3 with yhcS antisense downstream of TetR 
promoter; Ampr, Ermr 
(128) 
pYH4 pYH3 with Ampr removed; Ermr (270) 
pYhcR yhcR cloned downstream of pYH4 TetR promoter 
for overproduction; Ermr 
This Study 
pTnT Allelic exchange plasmid; allows for removal of erm 
gene in NE1787 
(265) 
pSspB sspB cloned downstream of pYH4 TetR promoter 
for overproduction; Ermr 
This Study 
Pssp-lux sspABC promoter cloned upstream of promoterless 
luxABCDE; derived from pCY1006; Cmr, Ampr 
This Study 
pCY306 Sae promoter cloned upstream of promoterless 
luxABCDE; derived from pCY1006; Cmr, Ampr 
This Study 
pKOR1 Temp. sensitive inducible allelic exchange plasmid 
for S. aureus; Cmr 
(191) 
pKOR1-sspB pKOR1 with in-frame sspB upstream/downstream 
deletion region 
This Study 
pJB38-sspAB pJB38 with in-frame sspAB upstream/downstream 
deletion region 
(266) 
pSspABC sspABC operon cloned downstream of pYH4 TetR 
promoter for overproduction; Ermr 
This Study 
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Table 5-3 Oligonucleotide sequences 
Primers Sequence 
srtA-For 5'-ATGAAAAAATGGACAAATCGATTAATGAC-3' 
srtA-Rev 5'-TTATTTGACTTCTGTAGCTACAAAG-3' 
ssp Pro For 
EcoRI 
5'-TAGCGAATTCGATATGTTGAACTGGACGTCGTGAAC-3' 
ssp Pro Rev 
XmaI 
5'-TTCCCGGGCTAAAAACCTCCAAAAAATTTATTTACAAGTTAAATA 
TAACAC-3' 
sspB-For  
5'-AGGAGGTTTAAACTATGAATAGTTCATATAAATCTAGAGTATTCA 
ATATTATAAGC-3' 
sspB-Rev-
AscI 
5'-TTGGCGCGCCTTAGTAACCTATCATTGAACCATACCAG-3' 
sspABC-For 
5'-AGGAGGTTTAAACTATGAAAGGTAAATTTTTAAAAGTTAGTTC 
TTTATTCG-3' 
sspABC-
Rev-AscI 
5'-TT GGCGCGCCTTATACTAAGCGCTCATAAACGATTGG-3' 
YhcROE-
for 
5'-AAACTATGGAACAAAGGACGCGAC-3' 
YhcROE-
rev 
5'-TTGGCGCGCCCTATTTTATAGGAATTGTGAATTG-3' 
sspB ORF-
L-F-pKOR1 
5'-GGGGACAAGTTTGTACAAAAAAGCAGGCTCGCGTTATCAT 
CAAAAGCTATGGAC-3' 
sspB ORF-
L-R-pKOR1 
5'-CATATAATACCCTCCATTTAAATCAAAATATTTTGC-3' 
sspB ORF-
R-F-pKOR1 
5’-Phos-GATTATAACTGGTATGGTTCAATGATAGGTTAC-3' 
sspB ORF-
R-R-pKOR1 
5'-GGGGACCACTTTGTACAAGAAAGCTGGGTCAT TTGATGCAGGT 
TATGGTTCAGG 
pJB38-ssp 
For 
5’-GAATATGATATTAAGTCACTTGCGTCG-3’ 
pJB38-ssp 
Rev 
5’-GCTTATGAAATGGATGTTTTAAAAGAAGGTATG-3’ 
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5.4 Results 
5.4.1 Perturbation of yhcSR expression alters the survival of 
Staphylococcus aureus in human blood. 
It is important to validate the in vivo essentiality of any gene as some 
genes found to be essential in vitro may not be essential in vivo (271, 272). The 
essentiality of yhcSR makes a direct comparison of a wild-type strain and mutant 
impossible. As with our previous TSB medium studies, a yhcS antisense RNA 
and an a overproduction plasmid were used to examine the effects of YhcSR on 
survival in human whole blood. 
Survival of the yhcS antisense RNA strain (JSAS909) in human blood was 
assayed as an initial step to determine the importance of yhcSR for survival in 
the host. Using a defined volume of blood allowed for the efficient and sufficient 
concentration of antisense RNA inducer, ATc to be added to the assay. As seen 
in Fig. 5-1A, as a percentage of the initial inoculum, depletion of YhcSR by yhcS 
antisense RNA (128) resulted in significantly decreased survival in the first hour 
of incubation in human blood and continued for the second hour of incubation. 
Similar numbers of colony forming units (CFUs) survive in the controls and 
uninduced yhcS antisense RNA strain whereas fewer CFUs survived in the blood 
for the induced yhcS antisense RNA strain throughout the experiment (Fig. 5-
1B). The data suggest yhcSR are important for survival in blood and perhaps 
essential for survival in the broader host environment. 
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Figure 5-1 yhcSR are important for survival in human blood. (A) Percent 
survival of the S. aureus yhcS antisense strain (JSAS909) in human blood during 
ATc induction. Percent survival = CFUt/CFUi*100. Data represents the mean and 
standard deviation of four experiments. Statistical analysis conducted with 
Student’s T-Test; p = ≤0.05. (B) CFU counts of each strain. Cultures of S. aureus 
strains were cultured overnight with or without the inducer ATc (500 ng/ml) and 
the following day diluted and inoculated into 500 ml of fresh blood with 
erythromycin and with or without the inducer ATc (500 ng/ml).  
 
 The depletion of YhcSR in S. aureus appeared to decrease the survival of 
the bacteria in human blood. To further investigate the importance of YhcSR for 
survival in blood an YhcR overproduction strain (WYhcR, Fig. 5-2) was used to 
determine if the overproduction of the response regulator could promote survival 
in blood.  
 
Figure 5-2 Induction of YhcR in S. aureus WCUH29. 
Cultures were induced overnight with 250 ng/ml of 
inducer ATc. The next day they were adjusted to an 
equal OD600nm. The bacteria were incubated with 
lysostaphin to weaken the cell wall and then lysed with 
Pro-Lyse lysis solution. The insoluble portion was 
pelleted and soluble supernatant transferred to a fresh 
tube. Each fraction was subjected to SDS-PAGE. YhcR 
(White arrow) is induced and found in the soluble 
(cytoplasmic) portion of the bacteria 
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As seen in Fig. 5-3A, overproduction of YhcR promotes survival of S. aureus 
over the course of the three hour experiment as measured as a percentage of 
the initial inoculum. It was later determined that the overproduction of YhcR from 
the episomal plasmid increased the overall bacterial cell size, thus when cultures 
of each strain were adjusted to the same OD600nm the CFU/ml of the induced 
WYhcR strain was found to be somewhat lower than that of the controls (see 
section 3.4.5) so that in the first hour the total CFU survival appeared less than 
the controls (Fig 5-3B), but by percentage the survival is equal to the controls. By 
hour two of the experiment, there were twice as many surviving induced WYhcR 
CFU as the controls, further supporting the notion that YhcSR promotes survival 
of S. aureus in blood. 
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Figure 5-3 Overproduction of YhcR promotes survival of HA-MRSA S. 
aureus in human blood. (A) Percent survival of the S. aureus YhcR 
overproduction strain (WYhcR) in human blood during ATc induction. Data 
represents the mean and standard deviation of four experiments. Statistical 
analysis conducted by Student’s T-Test; p = ≤0.05 (B) CFU counts of each strain. 
Cultures of S. aureus strains were cultured overnight with or without the inducer 
ATc (250 ng/ml) and the following day diluted and inoculated into 500 ml of fresh 
blood with erythromycin and with or without the inducer ATc (250 ng/ml). 
 
 To determine if the enhanced survival of S. aureus during YhcR 
overproduction was applicable to other genetic backgrounds of S. aureus, the 
pYH4 and pYhcR plasmids were transformed into community-acquired methicillin 
resistant S. aureus (CA-MRSA) strains, JE2 and 923. During the initial tests with 
WCUH29, no difference in percent survival between the control strain with or 
without inducer ATc and the uninduced WYhcR strain was observed. For this 
reason, the control and YhcR overproduction strain for JE2 and 923 were only 
assayed with inducer ATc. Furthermore, I found that, in general, only a small 
percentage of the WCUH29 cells survived beyond two hours, thus survival after 
30 minutes to two hours after inoculation for the CA-MRSA and future assays 
was analyzed. Fig. 5-4 shows that overproduction of YhcR enhanced the survival 
of strains JE2 (Fig. 5-4A) and 923 (Fig. 5-4B) in blood. The data indicated 
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overproduction of YhcR enhanced survival in blood across several genetic 
backgrounds of S. aureus and suggested YhcSR contributes to S. aureus 
pathogenesis and survival in the host.  
 
Figure 5-4 Overproduction of YhcR contributes to survival of CA-MRSA in 
human blood. Percent survival of the CA-MRSA S. aureus (A) JE2 and (B) 923 
during YhcR overproduction. Data represents the mean and standard deviation 
of at least three experiments. Statistical analysis conducted by Student’s T-Test; 
p = ≤0.05. CFU counts of each strain, (C) JE2 and (D) 923. Cultures of S. aureus 
strains were cultured overnight with inducer ATc (250 ng/ml) and the following 
day diluted and inoculated into 500 ml of fresh blood with erythromycin and with 
inducer ATc (250 ng/ml) and incubated at 37°C.  
 
5.4.2 Sortase A attached cell-wall proteins likely do not contribute to 
enhanced survival in human blood during YhcR overproduction. 
Some virulence factors of S. aureus are cell surface-associated proteins 
collectively termed, “microbial surface components recognizing adhesive matrix 
molecules” or MSCRAMMs, that mediate binding to a multitude of host factors as 
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well as promote intracellular adhesion (273). This group of proteins include the 
immunoglobulin binding proteins, protein A and Sbi, and the intracellular 
adhesion and fibrinogen-binding proteins, Efb and FnbA/B (274, 275), and the 
platelet aggregation factors ClfA/B (143). This group of proteins mediate a 
multitude of functions involved in tissue attachments, complement and cellular 
inhibition.  
 Many of these proteins are synthesized as a longer precursor protein with 
an N-terminal signal sequence that directs the protein into the sorting pathway. 
Protein sorting is mediated by the sortase pathway which recognizes a C-
terminal LPXTG motif. Sortase A (srtA) cleaves the peptide bond between 
threonine and glycine and subsequently attaches the processed protein to the 
pentaglycine cross-bridge of newly synthesized peptidoglycan (276–280).  
To determine if the factor(s) that promote bacterial survival during YhcR 
overproduction are Sortase A mediated cell-wall associated virulence factors, a 
srtA transposon mutant, NE1787, was obtained from the Network on 
Antimicrobial Resistance of S. aureus (NARSA) (202, 281). The transposon used 
for gene disruption carries an erythromycin resistance cassette which is 
incompatible with the erythromycin cassette carrying pYhcR expression plasmid. 
The pTnT plasmid was obtained from NARSA and the protocol that allowed for 
the removal of the erythromycin gene was followed. The rest of the transposon 
was left in place for continued gene disruption (265). Several colonies were 
screened by PCR for removal of the erm gene (Fig. 5-5A). Two colonies (#11 
and #13) were identified to have lost the erm gene. Streaking colony #11 to TSA 
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without and with erythromycin showed that the strain was sensitive to 
erythromycin when compared to NE1787 and was labeled strain JH1787 (Fig 5-
5B). To verify that the srtA gene was inactivated in the JH1787 strain, the protein 
content of different fractions of the parental wild-type JE2 strain, srtA::erm 
(NE1787), and srtA::tn (JH1787) strains (Fig. 5-5D) were separated by SDS-
PAGE. Protein samples were transferred to a nitrocellulose membrane. An IgG 
secondary antibody was used for immunoblot detection of the S. aureus 
produced non-specific IgG binding protein, protein A, a sortase A cell-wall 
attached protein (282, 283). As seen in Fig. 5-5E, the immunoblot detects 
expression of protein A in all strains as seen in the lanes for the whole-cell 
analysis. Protein A can be cleaved from the bacterial cell wall by staphopain B 
and shed to the surround environment (138) and importantly protein A is not 
detected in the culture supernatant of JH1787 (or NE1787). Most convincing, 
protein A is not detected in the JH1787 cell-wall fraction, while it is readily 
detected in the cell-wall fraction of the parental JE2 strain (Fig 5-5E). The data 
highly suggest that the srtA gene is inactivated in JH1787 (and NE1787) and 
would suggest that sortase A attached cell-wall virulence factors are not attached 
to the pentaglycine crosslinks of staphylococcal peptidoglycan.  
Once srtA was determined to be inactivated, the control and pYhcR 
plasmids where electroporated into the JH1787 strain. To determine if sortase A 
attached virulence factors are involved in YhcSR mediated survival of S. aureus 
the strains were assayed for survival in human blood. If sortase A attached 
virulence factor(s) are involved in YhcR mediated survival, inactivation of srtA 
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should eliminate the enhanced survival of the JH1787/YhcR-overproduction 
strain as over-produced cell surface virulence factors will no longer be 
translocated to and attached to the cell wall (283). As seen in Fig. 5-6, 
inactivation of srtA does not eliminate or impact the enhanced survival resulting 
from YhcR overproduction in strain JH1787 indicating sortase A attached cell 
surface virulence factors are likely not involved in YhcR mediated survival in 
human blood. 
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Figure 5-5 Deletion of erm gene in JH1787 and analysis of cellular protein A 
distribution. (A) Diagnostic PCR detection for loss of the erm gene from the 
transposon in srtA. (B) Streak plate of parental JE2 (erms), NE1787 (ermr), and 
JH1787 (erms) on TSA and TSA/erythromycin showing JH1787 is now sensitive 
to erythromycin. (C) Diagram of strains streaked on TSA and TSA/Erm plates. 
(D) SDS-PAGE and (E) immunoblot of the cellular distribution of protein A in JE2, 
NE1787, and JH1787. 
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Figure 5-6 Inactivation of srtA does not prevent YhcR mediated enhanced 
survival. Percent survival of the S. aureus JE2 and JH1787 control and YhcR 
overproduction strains in human blood during ATc induction. The data represent 
the mean and standard deviation of two experiments. Strains were cultured 
overnight with the inducer ATc (250 ng/ml) and the following day diluted and 
inoculated into 500 ml of fresh blood with erythromycin, the inducer ATc (250 
ng/ml) and incubated at 37°C.  
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5.4.3 Culture supernatants of YhcR overproducing S. aureus inhibit 
opsonophagocytic killing. 
Long-term cell-mediated memory to S. aureus is minimal at best and the 
reasons for this are poorly understood (284). Thus, the humoral (antibody-
mediated) and non-specific innate immunity (complement and phagocytic cells) 
are the primary and most important part of the immune system for controlling S. 
aureus infections (257–260). While the Gram-positive bacteria are believed to be 
relatively resistant to the complement-mediated membrane attack complex (285) 
because of their thick peptidoglycan cell-wall relative to Gram-negative bacteria, 
they are susceptible to opsonin- and antibody-mediated phagocytosis by 
neutrophils (258, 260).  
In response to these phagocytic-mediating factors, S. aureus produces 
many factors that inhibit or degrade many of these components and aid in the 
dissemination of the bacteria (258, 284, 286). One mechanism of resistance is 
the proteolytic cleavage of complement and antibody factors, ultimately 
preventing phagocytosis (139, 286). To investigate if YhcSR regulated exported 
proteins contribute to the anti-phagocytic mechanisms of S. aureus; complement 
and serum were pre-incubated with concentrated culture supernatants of control 
and YhcR overproduction strains before being used in a modified 
opsonophagocytic killing assay.  
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Figure 5-7 YhcSR regulated exported proteins inhibit complement and 
antibody mediated phagocytosis. Sterile TSB culture supernatants (Cult. Sup) 
of control and YhcR overproducing S. aureus (WYhcR) were concentrated 50-
fold. The serum (A) and complement (B) components of the assay were pre-
incubated 30 minutes with each culture supernatant and sterile concentrated 
TSB to allow S. aureus exported factors to act upon the immune system 
components before addition to the assay. Data presents the mean and standard 
deviation of 4 individual experiments.   
 
Pre-incubating the serum fraction of the assay with the concentrated TSB vehicle 
control or culture supernatant of the control strain allowed for a similar 
percentage (~60%) of bacterial survival while pre-incubation of serum with the 
concentrated culture supernatant of the YhcR overproduction strain (WYhcR) 
resulted in a significant increase in the percentage of S. aureus that survived 
(~90%) in the assay compared to both the concentrated TSB and concentrated 
control culture supernatant (Fig. 5-7A). The data indicated that overproduction of 
YhcR resulted in inhibition of serum antibody-mediated phagocytosis. Pre-
incubation of the complement fraction of the assay with the concentrated control 
culture supernatants produced an overall mean increase in the percentage of 
bacteria that survived compared to the concentrated TSB control (75% to 60%), 
but this increase was not significant. This is not unexpected, as S. aureus is 
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known to produce several complement inhibiting proteins (139, 260). The 
overproduction of YhcR resulted in a further, significant, increase of bacterial 
survival compared to concentrated TSB control (~90% to 60%) and concentrated 
control supernatant (~90% to 75%) (Fig. 5-7B). The data indicated that 
overproduction of YhcR contributed to complement inhibition and anti-phagocytic 
mechanisms of S. aureus. Taken together, the data indicate the YhcSR TCS is 
involved in regulation of exported proteins that inhibit opsonization and classical 
activation of the complement pathway.   
5.4.4 Identification of over-produced exported proteins resulting from YhcR 
overexpression in S. aureus. 
Inactivation of srtA revealed that it is unlikely that LPXTG cell-wall 
associated virulence factors are involved in the increased survival of the WYhcR 
strain. Furthermore, the opsonophagocytic assay revealed S. aureus exported 
proteins were involved in the YhcR mediated enhanced survival of S. aureus. As 
the second broad category of S. aureus virulence factors, exported proteins are 
secreted into the environment surrounding the bacterium. Many of these proteins 
are exported by the general secretion system (287, 288). Deletion of the main 
secretion protein, SecY, and some associated Sec proteins is not possible due to 
their essential nature in S. aureus (225, 281, 289–292), thus, examining how the 
Sec pathway contributes to YhcR mediated survival is problematic. To solve the 
issue of essentiality and directly identify which exported proteins were 
overproduced during YhcR overproduction, the exported proteins of the ATc 
induced control and WYhcR strains were precipitated from cell-free culture 
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supernatants. After denaturation and size separation by SDS-PAGE 
electrophoresis the exported proteins were visually compared (Fig. 5-8) and five 
proteins bands that were over-produced or bands that only appeared in the 
WYhcR lane were designated JH1-JH5 and processed for identification by mass 
spectrometry (See Material and Methods 5.3.5).  
 
Figure 5-8 Comparative analysis of the exported 
protein profiles of the control and WYhcR strains. 
Each strain was induced with 250 ng/ml of inducer ATc 
overnight. The following day the bacterial cells were 
pelleted and the culture supernatant was filter sterilized. 
Proteins were precipitated with 100% EtOH overnight at 
4°C. Precipitated proteins were separated by SDS-
PAGE. Samples JH1-JH5 were chosen as the five most 
prominent bands relative the control.  
 
 
Each processed sample had one protein that 
was the major component of the band (data not shown).  
The identified proteins were cross-referenced with 
published studies to identify proteins involved in innate 
immune suppression via inhibition of the humoral 
and/or innate cellular response. The parameters of the whole blood survival 
assay – human whole blood, defined volume, and a short assay period – 
suggested the YhcR-mediated enhanced survival mechanism likely inhibited the 
innate immune system response and not the adaptive immune system response. 
Published studies describing the immune system evasion properties of the 
predominant protein of sample JH2, the cysteine endopeptidase, staphopain B 
(SspB,) fell within this parameters. SspB is a known secreted protease of S. 
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aureus (293) and the sspB gene is co-transcribed in the same operon as sspA 
(V8 Protease) (294), a protease found to be up-regulated during growth in serum 
(295). More than 80% of the processed active form of SspB was identified by 
mass spectrometry.  
 To confirm the finding that SspB was up-regulated during YhcR 
overproduction, cell-free culture supernatants were prepared and the exported 
proteins were precipitated from the control and WYhcR strains without and with 
inducer ATc. As seen in Fig. 5-9A, the addition of ATc affects the protein profile 
of the control strain very little, while the addition of ATc to the WYhcR results in 
the appearance of a protein band that is similar in size to the processed active 
form of SspB, 27kD. Additionally, many protein bands are absent in the SDS-
PAGE gel from the induced WYhcR strain which is consistent with previous 
reports that up-regulation of SspB (and SspA) resulted in degradation of other 
exported proteins (138, 293). As a positive control, the sspB gene was cloned 
into the same inducible expression vector (pYH4-sspB, WSspB). Very little 
extracellular protein is found in the supernatants of this strain as visualized by 
SDS-PAGE Coomassie Blue staining. Further confirmation of SspB up-regulation 
was carried out by immunoblot using chicken egg antibody specific for SspB 
(kindly provided by Alex Horswill (296)). In the control strain, SspB expression 
was low and appeared unaffected by the addition of ATc (Fig 5-9B). As 
increasing concentrations of ATc were added to to induce YhcR production, 
staphopain B was up-regulated in an ATc dependent manner in the WYhcR 
strain (Fig 5-9B). SspB was readily detectable in the induced WSspB strain as 
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well. The SspB specific antibody detected the various processed and degraded 
forms of the protein (297, 298). The data suggested a regulatory link between 
YhcSR and SspB production and indicated that the induced dose dependent 
increase in YhcR production resulted in a dose dependent increase in staphopain 
B production. 
 
Figure 5-9 Induction of YhcR leads to up-regulation of SspB. (A) SDS-PAGE 
analysis of precipitated culture supernatant proteins from control and WYhcR 
without and with ATc and WSspB with ATc. (B) Western blot detection of SspB 
from precipitated culture supernatant proteins showing up-regulation of SspB 
with increasing induction of YhcR by inducer ATc. 
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5.4.5 Functional analysis of staphopain B expression. 
To determine if the overproduced SspB was functional, the cell-free culture 
supernatants were assayed gelatin zymography, as SspB degrades collagen. 
Coomassie staining of the SDS-PAGE revealed the appearance of a single 
prominent band in the WYhcR lane and the disappearance of other proteins from 
supernatant (compare Fig 5-10A to B), similar to the finding in Fig. 5-9A. Gelatin 
zymogram analysis of the same samples revealed very little gelatin degradation 
in the control strain while a large, prominent band of gelatin degradation 
appeared in the WYhcR strain (Fig 5-10B). Importantly, the protein band that 
appeared in the WYhcR strain was at the same molecular weight as the band of 
gelatin degradation in the zymogram, suggesting the gelatin degradation is the 
result of this protein. The data highly suggested that the YhcR-mediated 
overproduction of the cysteine endopeptidase, SspB, is active and resulted in a 
large amount of protein degradation relative to the control strain culture 
supernatant. Taken together, the data indicated that overproduction of YhcR 
resulted in the functional overproduction of staphopain B.  
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Figure 5-10 Coomassie stain and zymographic analysis of control and 
WYhcR. (A) Equal volumes of concentrated culture supernatant were resolved 
by 12% SDS-PAGE and proteins stained with Coomassie Blue. (B) Equal 
volumes of concentrated culture supernatant were resolved by 12% SDS-PAGE 
plus 0.1% gelatin and processed to remove SDS to allow for protein refolding. 
Following incubation the gel was stained with Coomassie Blue to reveal bands of 
gelatin degradation.  
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5.4.6 The ssp promoter is up-regulated during YhcR overproduction. 
Staphopain B is produced from the middle gene of a three gene operon 
and is bordered downstream by sspA, encoding the V8 serine endopeptidase 
and upstream by sspC which encodes staphostatin B, a cytoplasmic inhibitor of 
SspB (294). To determine if the up-regulation of SspB occurs post-
transcriptionally or if the entire ssp operon is up-regulated at the transcriptional 
level, the ssp promoter was cloned upstream of a promoterless-luciferase 
(luxABCDE) reporter cassette and electroporated into the control and WYhcR 
strain. As seen in Fig. 5-11, induction of YhcR expression with inducer ATc 
results in a 3-fold maximal increase in bioluminescence output from the Pssp-lux 
reporter relative to the control culture. Furthermore, Pssp-lux output was greater 
and sustained throughout the growth of WYhcR demonstrating that YhcR 
overproduction resulted in increased transcription from the ssp promoter. 
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Figure 5-11 Promoter-reporter analysis of the ssp promoter during YhcR 
overproduction. The Pssp-lux reporter plasmid was electroporated into the 
control and WYhcR strains. Uninduced overnight cultures of each strain were 
diluted 1:300, incubated at 37°C with 25 ng/ml of inducer ATc. OD600nm and 
luminescence readings were measured every 30 minutes with 1 minute of mixing 
before each reading in a BioTek Synergy II spectrophotometer. The light intensity 
values for each time point are given as relative light units, Lum reading/OD600nm 
reading = RLU. The data presented are the mean of three independent 
experiments.  
 
   
5.4.7 Up-regulation of the ssp promoter does not result from YhcR 
mediated regulation of agr and sae. 
The sspABC promoter is regulated by several transcriptional regulators. 
Positive transcriptional regulation of the ssp promoter by the Agr TCS has 
previously been demonstrated (293, 298). Negative transcriptional regulation is 
mediated by virulence factor regulators SarA and the SaeRS two-component 
system as well as the alternative stress response sigma factor, σB (12, 293, 298, 
299). A recent report on the YhcSR TCS provided evidence that YhcR binds the 
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promoter regions of sae and agr (129) and represses their expression in 
anaerobic culture conditions. Considering this information data experiments were 
developed to determine if overproduction of YhcR altered transcription from the 
sae and agr promoters in an aerobic luciferase-reporter plate assay. Induction of 
YhcR overproduction resulted in increased transcriptional reporter activity from 
the agr promoter (pCY1006) (Fig. 5-12A) and the sae promoter (pCY306) (Fig. 5-
12B). Reporter activity for both promoters in the induced WYhcR strain relative to 
the control was increased from the mid-exponential phase onward. The data 
suggested YhcR positively regulates these two promoters in aerobic conditions.  
To determine if up-regulation of the sspABC promoter was mediated by 
sae or agr, the control and pYhcR plasmids were electroporated into 
WCUH29saeS and WCUH29agrA mutants. These two strains were then 
electroporated with the Pssp-lux reporter plasmid. To confirm that regulation of 
the sspABC promoter in S. aureus WCUH29 was similar to previously published 
results for S. aureus SH1000 and UAMS-1 (12, 298), the basal reporter activity in 
the control strain for WCUH29 WT, WCUH29saeS and WCUH29agr in the 
absence of ATc was determined (Fig. 5-13A).   
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Figure 5-12 Promoter-reporter analysis of the agr and sae promoters during 
YhcR overproduction. (A) pCY1006 (Pagr-lux) and (B) pCY306 (Psae-lux) 
were separately electroporated into the control and WYhcR strains. Uninduced 
overnight cultures of each strain were diluted 1:300, incubated at 37°C with 25 
ng/ml of inducer ATc. OD600nm and luminescence readings were measured 
every 30 minutes with 1 minute of mixing before each reading in a BioTek 
Synergy II spectrophotometer. The light intensity values for each time point are 
given as relative light units, Lum reading/OD600nm reading = RLU. The data are 
the mean of three independent experiments.  
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Decreased and increased transcription of the sspABC promoter in the agrA 
mutant and saeS mutant, respectively, is consistent with published reports that 
Agr activated and Sae repressed transcription of the sspABC operon. The data 
suggested YhcSR are an activator of both agr and sae (Fig 5-12A and B), which 
are positive and negative regulators, respectively, of sspABC. If YhcR is solely 
responsible for increasing transcription of sspABC via indirect positive regulation 
of AgrA, deletion of agrA will eliminate any YhcR mediated increased 
transcription of sspABC. As indicated by the WCUH29agr/Pssp-lux reporter data 
in Fig. 5-13C, increased Pssp transcription continues to occur when YhcR is 
overproduced relative to the control, but maximal transcription of the sspABC 
promoter is slightly reduced in WCUH29agrA. The deletion of agrA does alter the 
growth phase expression pattern of the reporter, with maximal expression 
occurring earlier in the growth cycle of WCUH29agrA, suggesting that YhcR 
dependent up-regulation of the agr TCS may contribute to sspABC up-regulation 
in the late and post-exponential growth phases (compare 5-13B to C) (300). The 
incomplete loss of sspABC expression in WCUH29agrA suggested another 
transcription factor is involved or the sspABC up-regulation is mediated by direct 
YhcR positive regulation. As a known repressor of sspABC, deletion of sae 
should result in increased sspABC transcription and YhcR dependent up-
regulation of sae should decrease expression of sspABC. To verify Sae is acting 
as a negative regulator, and not a positive regulator in WCUH29, the Pssp-lux 
plasmid reporter expression was monitored in the WCUH29saeS strain during 
YhcR overproduction.  
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Figure 5-13 Pssp-lux plasmid reporter expression in WCUH29agrA and 
WCUH29saeS with and without YhcR overproduction. (A) Expression of 
Pssp-lux reporter in control WCUH29 WT, WCUH29agrA and WCUH29saeS 
strains in the absence of inducer ATc. Pssp-lux reporter expression without and 
with 25 ng/ml inducer ATc in control and YhcR overproduction (YhcR-OP) strains 
of (B) WCUH29 WT, (C) WCUH29agrA, (D) WCUH29saeS.  
 
As seen in Fig. 5-13D, deletion of saeS resulted in a dramatic increase in 
Pssp-lux reporter expression, even without ATc induction of YhcR production, 
confirming that sae is indeed a repressor of sspABC. Furthermore, the high level 
of reporter expression in WCUH29saeS indicated that in the WCUH29 WT strain, 
Pssp-lux expression is intermediate, a likely result of direct YhcR positive 
regulation on the sspABC promoter and secondary YhcR regulation of agr and 
sae, which in turn regulate Pssp positively and negatively, respectively, yielding 
an intermediate level of sspABC transcription overall in the wild-type S. aureus 
WCUH29. 
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5.4.8 YhcR binds the sspABC promoter. 
The Pssp-reporter analysis indicated positive regulation of agr by YhcR 
had a minor impact on the up-regulation of sspABC, but it could not account for 
all of the sspABC up-regulation that is produced during YhcR overproduction. 
Thus, it is likely that YhcR directly binds the sspABC promoter. To investigate 
this hypothesis an electrophoretic mobility shift assay (EMSA) was performed 
with purified YhcR-his and a Pssp probe. It was found that the mobility of the 
Pssp probe during native PAGE electrophoresis was increasingly retarded as the 
concentration of YhcR-his increased (Fig. 5-14, lanes 1-5), which indicated that 
YhcR bound the sspABC promoter probe. To determine the specificity of this 
binding, 100-fold excess of non-labeled specific Pssp probe was added to the 
reaction which caused incomplete labeled probe retardation, indicating that the 
non-labeled specific probe was competing with the labeled probe for the limited 
amount of YhcR-his (Fig. 5-14, compare lanes 4 and 6). To further confirm the 
specificity of the binding, a non-specific protein control was added (Fig 5-14, lane 
7) and no apparent shift was seen, indicating the mere presence of protein did 
not inhibit the mobility of the Pssp probe. Lastly, the presence of 100-fold excess 
non-labeled, non-specific probe in the reaction of from two different internal DNA 
fragments of the sspABC operon did not interfere with the mobility of the YhcR-
his/Pssp complex (Fig. 5-14, compare lanes 4 and 8-9). Taken together, the data 
indicated that YhcR specifically bound the upstream promoter region of the 
sspABC operon. 
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Figure 5-14 Electrophoretic mobility shift analysis of the sspABC promoter 
regulated by YhcR. The promoter region of the sspABC gene was obtained by 
PCR using 5’ biotin-labeled primers. The mobility of the labeled promoter 
fragment without addition of YhcR is shown in the first lane. Different amounts of 
YhcR (0.25, 0.5, 1, 2 μg) were incubated with each labeled sspABC promoter 
probe in a 20 μl reaction volume. ―, incubation with unlabeled specific 
competitor; +, incubation in the presence of 100-fold excess unlabeled specific 
competitor. BSA (1 μg) and a nonspecific internal gene probe (A) sspA and (B) 
sspB were used as nonspecific binding controls. Approximately 20 fmol of biotin-
labeled sspABC promoter probe was used in each reaction mixture. 
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5.4.9 Deletion of sspAB partially eliminated YhcR-mediated enhanced 
survival in blood. 
 
SspAB are involved in inhibiting many aspects of the innate immune 
response (139, 140, 262–264, 286). Furthermore, the data indicated that the 
YhcSR TCS regulated sspABC expression by direct positive transcriptional 
regulation. Lastly, overproduction of YhcR led to increased inhibition of 
opsonophagocytic killing by the exported proteins of S. aureus, of which SspAB 
are part of the exported S. aureus repertoire. Using an in-frame sspAB deletion 
plasmid (266), kindly provided by Alex Horswill, the sspAB genes were deleted 
from the S. aureus WCUH29 chromosome. The control plasmid, pYH4, and 
YhcR overproduction plasmid, pYhcR, were electroporated into S. aureus 
WCUH29ΔsspAB (JH114) creating JH214 (WCUH29ΔsspAB/pYH4) and JH314 
(WCUH29ΔsspAB/pYhcR), respectively. Additionally, the sspABC operon was 
cloned in-frame downstream of the TetR inducible promoter in the pYH4 
expression vector, creating pSspABC, and electroporated into JH114 to create 
JH414 (WCUH29ΔsspAB/pSspABC) for complementation and overproduction.  
The wild-type strains and sspAB mutant strains were assayed for their survival in 
human blood with ATc induction. As seen previously, overproduction of YhcR 
increased the percentage of CFU that survived throughout the 2 hour experiment 
(Fig 5-15, control vs. WYhcR). Deletion of sspAB had very little impact on the 
survival of S. aureus compared to the wild-type control (Fig 5-15, control vs. 
JH214). This was not unexpected as endogenous expression of individual 
proteases contribute only slight benefits to the overall survival of S. aureus and a 
significant decrease in fitness in blood and animal models is only seen when all 
152 
 
known proteases are deleted in S. aureus (296). That said, overproduction of 
YhcR in the sspAB deletion background did result in a significant decrease in the 
percentage of CFU that survived in the first half hour of the assay (Fig 5-15, 
WYhcR vs. JH314). After the first half hour, deletion of sspAB had minimal 
impact on the enhanced survival mediated by YhcR overproduction and by two 
hours, WYhcR and JH314 had similar percentage of surviving CFU. The data 
indicated that YhcR mediated overproduction of SspAB does contribute to the 
enhanced survival of YhcR over-producing S. aureus (WYhcR), but they 
contributed to survival early in the assay. The result further indicated other 
factors are involved in the enhanced survival of induced WYhcR over longer 
periods of incubation in human whole blood. The JH414 and WYhcR have similar 
percentage of CFU survival by hour 2 of the assay.  
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Figure 5-15 Deletion of sspAB partially eliminated YhcR-mediated 
enhanced survival in blood. Percent survival of the S. aureus WCUH29 wild-
type and sspAB mutant strain with control and YhcR overproduction plasmids in 
human blood during ATc induction. The data is the mean and standard deviation 
of four experiments. Statistical analysis conducted with Student’s T-Test; P ≤ 
0.05. Cultures of S. aureus strains were cultured overnight with the inducer ATc 
(250 ng/ml) and the following day diluted and inoculated into 500 ml of fresh 
blood with erythromycin and the inducer ATc (250 ng/ml) and incubated at 37°C.
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5.5 Discussion 
 To investigate and determine if a relationship between pathogenesis and 
the YhcSR TCS existed, the inducible yhcS antisense RNA and YhcR 
overproduction mutants were analyzed for how well they survived in human 
whole blood. It was not unexpected to find depletion of YhcSR inhibited survival 
in human blood. The decreased survival is likely related to inhibited cell growth 
from YhcSR depletion, as shown to occur in vitro (128). Conversely, 
overproduction of YhcR enhanced the survival of S. aureus. This was unlikely to 
be related to growth rate, as we know that YhcR overproduction does not 
increase the growth rate of S. aureus, at least in TSB cultures.  
 Staphylococcus aureus produces numerous LPXTG cell-surface 
associated and exported virulence factors (8, 301). To determine which group of 
factors was involved in the enhanced survival mediated by YhcR overproduction 
a srtA mutant/YhcR-overproduction strain was analyzed and it was found to 
survive well as the wild-type JE2/YhcR-overproduction strain in human blood 
which suggested srtA attached virulence factors were not involved in the 
enhanced survival phenotype. To assess the contribution of exported proteins to 
the enhanced survival phenotype, a modified HL-60 opsonophagocytic killing 
assay was developed. Pre-incubation of culture supernatant from the induced 
WYhcR strain with complement components and human serum significantly 
enhanced survival of S. aureus in the assay relative to the TSB control alone and 
control strain culture supernatant, which suggested YhcR-regulated exported 
proteins were inhibiting opsonin-based phagocytosis of S. aureus in blood.  
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 Comparative analysis of the exported protein profile of the induced control 
and WYhcR strains revealed several protein bands to be highly overproduced in 
the WYhcR culture supernatant. Using mass spectrometry for peptide analysis 
and immunoblotting, staphopain B, was identified as one of the highly enriched 
proteins in the WYhcR culture supernatant. The operon of sspABC encodes the 
V8 protease and staphopain B, both of which are known to promote survival and 
inhibit opsonophagocytosis (139, 140, 263, 264). This information corresponded 
well with the finding that WYhcR culture supernatants inhibited opsonophagocytic 
killing of S. aureus relative to the control supernatants. 
 Using a Pssp-luxABCDE reporter plasmid it was shown that transcription 
from the sspABC promoter was up-regulated relative to the control by 
overproduction of YhcR which led to overproduction of SspB, as detected by 
immunoblotting. Furthermore, the transcriptional up-regulation is a direct result of 
YhcR binding to the Pssp, as confirmed by gel-shift analysis, and not through sae 
or agr, other known direct regulators of Pssp.  
 Overproduction of YhcR in the absence of sspAB (WCUH29ΔsspAB) only 
significantly decreased survival of S. aureus in the first 30 minutes of incubation 
in human blood, which was unexpected as YhcR overproduction promoted 
survival throughout the 2 to 3 hour experiment time-frame. An explanation for this 
observation lies in the fact that proteases, including SspA and SspB, modulate 
the stability and abundance of staphylococcal extracellular and cell-associated 
virulence factors through proteolytic cleavage (138, 296). Therefore, it is possible 
other virulence factors involved in opsonophagocytic inhibition, protein A for 
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example, may have accumulated in the absence of the proteases during the 
assay period in the defined volume of blood and possibly complemented the loss 
of the SspAB proteases.  
The YhcSR TCS system regulates gene expression in response to the presence 
or absence of oxygen, and possible reactive oxygen species (129). The 
regulation of sspABC by YhcSR if of interest in the context of biofilm formation 
and stability and abscess formation, in addition to its apparent role in survival in 
blood. Biofilms and wound sites are known to have varying degrees of hypoxia 
(302–304) thus, it is conceivable that YhcSR may regulate expression of SspAB 
in response to the oxygen pressure levels in the microenvironment. This 
regulation likely has implications in biofilm formation and stability, extracellular 
matrix destruction and wound healing, as well as neutrophil infiltration and 
response to infections (139, 261–263, 266, 296, 305, 306). Further investigation 
is needed to define the role of YhcSR in relation to SspAB production in these 
microenvironments and how YhcSR regulation of sspABC impacts the 
pathogenesis of S. aureus in these environments. 
 The data presented in this chapter indicate the YhcSR TCS of S. aureus 
positively regulates the expression of sppABC at the transcriptional level. Using 
an YhcR overproduction mutant, it was identified that the sspABC promoter is up-
regulated and at least one protease of the operon, SspB, is overproduced. The 
protease overproduction that resulted from YhcR overproduction partially 
enhanced survival of S. aureus in human whole blood; linking the YhcSR TCS to 
anti-opsonophagocytic killing mechanisms of S. aureus.  
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Chapter 6 :  The YhcSR two-component system likely 
positively regulates the staphyloxanthin biosynthetic 
operon, crtOPQMN
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6.1 Overview 
The golden pigment of Staphylococcus aureus distinguishes the species 
from other staphylococcal species and is the product of a series of biosynthetic 
steps that produce a unique C(30) golden carotenoid, staphyloxanthin. 
Staphyloxanthin acts as an antioxidant and impairs reactive oxygen species 
mediated killing within the phagosome of professional phagocytes and thus, 
promotes virulence and survival of S. aureus.  
It was observed that the golden pigment of a strain of S. aureus 
ectopically expressing YhcR from a chromosomally integrated spac-promoter 
cassette was noticeably increased compared to the wild-type strain. Subsequent 
analysis revealed that depletion of YhcSR by yhcS antisense RNA and 
overproduction of YhcR decreased and increased by 50%, respectively, the 
amount of staphyloxanthin produced by S. aureus. Staphyloxanthin is important 
for hydrogen peroxide resistance of S. aureus. Depletion of YhcSR and 
overproduction of YhcR decreased and increased, respectively, the hydrogen 
peroxide susceptibility of S. aureus significantly. Furthermore, using a whole 
blood survival assay, the genetic elimination of staphyloxanthin during YhcR 
overproduction abolished the protective phenotype of increased staphyloxanthin 
production, which is consistent with staphyloxanthin’s role in impairing reactive 
oxygen species mediated killing of S. aureus by neutrophils. 
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6.2 Introduction 
 The distinctive golden pigment of Staphylococus aureus is the biosynthetic 
product of crtOPQMN and aldH (307, 308). This six enzyme biosynthetic 
pathway’s final product is the golden C(30) triterpenoid carotenoid, α-D-
glucopyranosyl 1-O-(4,4’-diaponeurosporen-4-oate) 6-O-(12- 
methyltetradecanoate), or more simply, staphyloxanthin (STX) (309). The 
antioxidant properties of STX were first reported by Clauditz et al. (310) and 
several follow-up studies have confirmed this initial report and identified STX as 
an important virulence factor for intracellular phagocyte survival of S. aureus 
(311) and is linked to resistance to reactive oxygen species (ROS) produced by 
the NADPH oxidase system within the phagocyte phagosome (312).  
Currently, it is known that the stress response alternative sigma factor B 
regulates STX production, as a σB deletion mutant is white and lacks STX. This 
regulation is likely direct as a consensus σB DNA binding motif was identified in 
the crt promoter, but direct interaction has not been confirmed (313). Additionally, 
the cold shock protein A, CspA, is a positive regulator, likely in a σB dependent 
manner (314). The metabolism of S. aureus is also known to influence pigment 
production, as mutants with a defective tricarboxylic acid cycle or inability to 
perform oxidative phosphorylation showed increased pigmentation and the 
response was dependent on expression of σB (315).  
 In this chapter data are presented that show the YhcSR TCS directly 
transcriptionally activates the crtOPQMN operon and modulates STX carotenoid 
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production. Moreover, YhcSR’s regulation of staphyloxanthin influences S. 
aureus susceptibility to hydrogen peroxide and survival in human whole blood.  
6.3 Materials and methods 
6.3.1 Bacterial strains, plasmids and growth media. 
The bacterial strains and plasmids used in this study are listed in Table 6-
1. The S. aureus cells were cultured in trypticase soy broth (TSB) at 37˚C with 
shaking. Transformants containing recombinant plasmids were selected on 
trypticase soy agar (TSA) containing chloramphenicol (10 µg/ml) or erythromycin 
(5 µg/ml) for S. aureus. Sheep’s blood agar plates were obtained from BD. For 
anaerobic growth, TSA plates were placed in an oxygen-free, nitrogen-hydrogen 
gas mixture COY chamber and incubated room temperature. 
6.3.2 Construction of S. aureus WCUH29 Pspac-yhcS and –yhcR strains. 
S. aureus WCUH29 Pspac-yhcS and –yhcR were constructed by phage 
transducing the pFF71-yhcS or –yhcR chromosomal fragment from SASJ104 
and SASJ204, respectively (128, 316). Briefly, SASJ104 and SASJ204 were 
cultured and used to make separate φ11 lysates. The lysates were then used to 
infect wild-type S. aureus WCUH29 and transductants were selected on TSA 
with chloramphenicol. The pFF71 plasmid site-specifically integrates into the S. 
aureus chromosome at the φL54α attB site located in the lipase (geh) gene 
(317). Transductants that were Cmr and lipase negative on Spirit Blue Agar 
plates with Lipase Reagent (BD) were cultured and genomic DNA was extracted 
and screened by diagnostic PCR using the PspacFor/YhcROE-Rev primer set, 
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listed in Table 6-2, to specifically identify colonies that had recombined the 
pFF71-yhcS or –yhcR chromosomal fragment into the genome.  
6.3.3 Extraction of staphyloxanthin from S. aureus strains. 
The S. aureus strains were cultured in 5 ml of TSB in a 50 ml conical vial at 37°C 
and shaking at 220 RPM with respective inducers; 200 μM IPTG or 500 ng/ml 
ATc. After 24 hours the OD600nm of each culture was read in 200 μl duplicates 
using a BioTek Synergy II spectrophotometer. One ml of culture was carefully 
washed twice in PBS. The pelleted cells were resuspended in one ml of 100% 
methanol with pipetting and vortexing until all large clumps of cells were 
dispersed. The extractions were placed in a rotisserie incubator and rotated end-
over-end at room temperature for 1 hour. Cellular debris was pelleted and the 
OD450nm for each methanol extraction was measured using 200 μl aliquots in 
duplicate on the BioTek spectrophotometer. The fold change was calculated as 
Normalized Mutant/Normalized control. To normalize STX concentration, the 
OD450nm reading was divided by the respective OD600nm reading for each 
sample (normalized STX concentration = OD450nm/OD600nm). The experiment 
was repeated at least three times.  
6.3.4 Hydrogen peroxide susceptibility assay. 
Hydrogen peroxide (H2O2) was added to 1.5% final concentration in PBS 
and 2x108 CFU were incubated at 37°C for 1 hour. Serial dilutions were plated on 
trypticase soy agar (TSA) for enumeration of surviving CFU. Percent survival was 
calculated as surviving #CFU/ input #CFU multiplied by 100, (#CFUf/#CFUi)*100. 
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6.3.5 Electrophoretic mobility shift assay. 
The crt promoter primers are listed in Table 5-2. The promoter fragment 
was obtained by high-fidelity PCR. The PCR was loaded into a 2% agarose gel. 
The sample was electrophoresed, and the gel was stained with ethidium 
bromide. The promoter fragment was removed from the gel and purified using a 
NucleoSpin Gel Clean-up kit (Macherey-Nagel).  
For the electrophoretic mobility shift assay (EMSA) a 5% native TBE 
PAGE gel was prepared and pre-run using 0.5X TBE. Samples were prepared in 
1X PBS, with 50 ng of total crt or ssp promoter probe, 50 ng/μl poly (dI•dC), and 
2.5% glycerol. 1 μg of YhcR-His, specific binding protein, and 10 μg of BSA, non- 
specific binding protein, was added where indicated .Ultrapure water was added 
so that all reaction volumes totaled 20 μl. The reactions were incubated at room 
temperature for 20 minutes and then 5 μl of 5X loading buffer was added to each 
reaction. 20 μl of each reaction was loaded in a pre-run 5% TBE native 
polyacrylamide gel and electrophoresed at 100V for two hours at 4°C. After 
electrophoresis, the gel was incubated in DI water containing 5 μg/ml ethidium 
bromide for 10 minutes. The gel was washed three times with DI water and the 
mobility of DNA probes was visualized with a long wave UV light and 
photographed. 
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Table 6-1 Bacterial strains and plasmids 
Strain Description Source 
SASJ104 RN4220 geh::pFF71-yhcS; Cmr (128) 
SASJ204 RN4220 geh::pFF71-yhcR; Cmr (128) 
WJH104 WCUH29 geh::pFF71-yhcS; Cmr This Study 
WJH204  WCUH29 geh::pFF71-yhcR; Cmr This Study 
WCUH29/pYH3 WCUH29 antisense control strain with empty 
pYH3; Ermr (128) 
JSAS909 WCUH29 with pYJY909; Ermr (128) 
WCUH29/pYH4 WCUH29 protein overproduction control with 
empty pYH4; Ermr 
This Study 
WYhcR WCUH29 with pYH4-yhcR; Ermr This Study 
JH113 WCUH29 with in-frame deletion of crtM This Study 
JH213 
WCUH29ΔcrtM with pYH4; Ermr 
 
This Study 
JH313 WCUH29ΔcrtM with pYhcR; Ermr This Study 
   
Plasmids  Description Source 
pYH3 Shuttle vector with a TetR regulated inducible 
promoter; Ermr (128) 
pSAS909 pYH3 with yhcS antisense downstream of TetR 
promoter; Ampr, Ermr (128) 
pYH4 pYH3 with Ampr removed; Ermr (270) 
pYhcR yhcR cloned downstream of pYH4 TetR 
promoter; Ermr This Study 
pKOR1 Temperature sensitive inducible allelic exchange 
plasmid for S. aureus; Cmr 
(191) 
pKOR1-crtM pKOR1 with in-frame crtM upstream/downstream 
deletion region; Cmr 
This Study 
 
Table 6-2 Oligonucleotide sequences 
Primers Sequence 
Pspacfor 5'-GCTTGAATTCATTCAGAACGCTCGGTTGCC-3' 
YhcROE-rev 5'-TTGGCGCGCCCTATTTTATAGGAATTGTGAATTG-3' 
crtM-pKOR1-L-
For 
5'-GGGG ACAAGTTTGTACAAAAAAGCAGGCT 
CAGCAAGTTCCAGTAGATGTCATTG-3' 
crtM-pKOR1-L-
Rev 
5'-CATACTAGTCCTCCTATATTGAAATGCC-3' 
crtM-pKOR1-R-
For 
5’-Phos- CATAGAATATAGGTGGTTGAATAATGAAGATTG-3' 
crtM-pKOR1-R-
Rev 
5'-GGGGACCACTTTGTACAAGAAAGCTGGGTCTTG 
ATCTGTCACATCAATATCTATACCG-3' 
Pcrt For 5’-CTAATGGTTATGCATCAGGAAGTAAC-3’ 
Pcrt Rev 5’-CTAAATTGAATCACTCTCAATCATACTGAC-3’ 
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6.4 Results 
6.4.1 Ectopic yhcR expression made S. aureus colonies more golden in 
color. 
During the construction of what were intended to be IPTG inducible Pspac 
regulated yhcS (WJH104) and yhcR (WJH204) S. aureus WCUH29 strains (128, 
200) it was observed that the golden color of the ectopically expressing yhcR 
colony was remarkably enhanced relative to the wild-type S. aureus WCUH29 
strain and ectopically expressing yhcS strain. This phenotype was seen on TSA 
plates (Fig. 6-1A) and sheep’s blood agar plates (Fig. 6-1B). The enhanced 
golden pigment of the WJH204 strain was observed when the strain was grown 
aerobically; when grown anaerobically, the golden pigment was absent in all 
strains (Fig. 6-1C).  
Figure 6-1 Ectopic 
expression of YhcR 
enhances the golden 
color of S. aureus. 
Overnight cultures of the 
strains were serially diluted 
and 10 μl of the 10-3, 10-5, 
and 10-7 dilutions were 
plated on (A) TSA and (B) 
5% sheep’s blood agar 
plates and incubated 24 
hours at 37°C. (C) Each 
strain was streaked on TSA 
plates and incubated 
aerobically or anaerobically. 
The diagram on the right 
outlines the placement of 
the strains on the plates.  
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6.4.2 Altering the expression levels of YhcR altered the amount of golden 
pigment, staphyloxanthin, produced by S. aureus WCUH29. 
Synthesis of the golden pigment of S. aureus is encoded by the 
crtOPQMN operon plus the aldH gene (308). These six enzymes synthesize the 
golden carotenoid, staphyloxanthin (STX), of S. aureus in a multistep 
biosynthetic pathway (307, 309, 318). The STX pigment has shown to be 
important for cellular protection from UV radiation and oxidants (310) and to be a 
virulence factor, protecting the bacterium from oxidants during phagocytosis 
(312) 
To confirm that alteration of the level of YhcSR production modifies the 
amount of STX produced in S. aureus cells, the carotenoid was extracted using 
methanol after 24 hours of aerobic growth and STX production was compared 
from YhcSR deplete cells and cells ectopically producing YhcR relative to the 
respective control cells. Depletion of YhcSR by induction of yhcS antisense RNA 
(128) resulted in a 50% decrease in the amount of STX compared to control cells 
(Fig. 6-2A). Conversely, ectopic expression of YhcR (WJH204) produces a 50% 
increase in the amount of STX produced by the bacteria compared to the control 
cells (Fig. 6-2B). The data indicated that altering the level of YhcSR produced 
altered the amount of STX produced in S. aureus cells. 
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Figure 6-2 Altering the expression level of YhcR altered the amount of 
staphyloxanthin produced by S. aureus. (A) WCUH29/pYH3 and (B) 
WCUH29/yhcS antisense RNA (JSAS909) (B) WCUH29 and WCUH29::Pspac-
yhcR (WJH204); induced with 500 ng/ml ATc and 200 μM IPTG, respectively. 
The data represent the mean ± standard deviation of at least three experiments. 
 
6.4.3 Altering the expression levels of YhcR altered susceptibility of S. 
aureus WCUH29 to killing by hydrogen peroxide. 
  The membrane bound staphyloxanthin carotenoid protects S. aureus from 
ROS, such as hydrogen peroxide (310, 312). To determine if altering the 
production of YhcR alters susceptibility of S. aureus to hydrogen peroxide killing, 
the strains were assay for survival in a H2O2 susceptibility assay. It was found 
that depleting S. aureus of YhcSR by yhcS antisense RNA significantly reduced 
survival after one hour of incubation in 1.5% H2O2 (Fig.6-3A). Conversely, 
overproduction of YhcR resulted in significant protection from killing by H2O2 (Fig 
6-3B). The data indicated that YhcSR contributed to protection from ROS, likely 
through regulation of STX biosynthesis. 
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Figure 6-3 Altering the expression of YhcR alters S. aureus susceptibility to 
H2O2. (A) control and yhcSR antisense RNA strains; induced with 500 ng/ml ATc. 
(B) control and YhcR overproduction strain (WYhcR); induced with 250 ng/ml 
ATc. Approximately 5x108 CFU were incubated in PBS with 1.5% hydrogen 
peroxide at 37°C for 1 hour. The percent survival was calculated as 
(#CFUf/#CFUi)*100. Statistical analysis conducted with Student’s T.Test. The 
data represents the mean ± standard deviation of three experiments. 
 
 
6.4.4 YhcR likely directly binds the upstream promoter region of 
crtOPQMN. 
To determine if the increased production of STX was due to direct positive 
regulation by YhcR, an electrophoretic mobility shift assay (EMSA) with ethidium 
bromide staining was performed to determine if YhcR was capable of binding the 
upstream promoter region of crtOPQMN. As seen in Fig. 6-4, the addition of 
YhcR-His to the reaction resulted in electrophoretic mobility retardation of the 
Pcrt probe. The addition of a non-specific protein, BSA, caused no such 
retardation. The previously determined YhcR regulated promoter of sspABC was 
used as a positive control and shows a similar retardation pattern. The data 
suggested that YhcR binds the crt promoter and that the YhcSR TCS is a 
positive regulator of the crtOPQMN operon. 
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Figure 6-4 Electrophoretic mobility shift analysis of the crtPQOMN 
promoter regulated by YhcR. 50 ng of each promoter probe was added to 
reactions. Either no protein was added (―), 1 μg of YhcR-His, or 10 μg of BSA 
was added to each reaction and incubated for 20 minutes at room temperature. 
Reactions were then electrophoresed on a 5% native 0.5X TBE PAGE gel for 2 
hours at 100V followed by staining with ethidium bromide to visualize the DNA. 
 
6.4.5 Elimination of staphyloxanthin in S. aureus during YhcR 
overproduction eliminateed YhcR-mediated enhanced survival in human 
blood. 
The presence of STX has been shown to decrease the killing of S. aureus 
by purified neutrophils and in whole blood. The decreased susceptibility was 
linked to protection against ROS produced by the phagocyte NADPH oxidase 
system (312, 319). Circulating neutrophils are a major component of blood 
phagocytes. Previously, it was identified that YhcR overproduction significantly 
enhanced the percentage of S. aureus that survived in human whole blood. To 
determine if the YhcR mediated overproduction of STX was, at least partially, 
responsible for the increased survival of the WYhcR strain the first gene in the 
STX biosynthetic operon, crtM, was deleted. The deletion created an S. aureus 
strain that lacked capability of producing any carotenoid intermediates or STX 
(Fig. 6-5A, JH113). The pYH4 and pYhcR plasmids were subsequently 
electroporated into the JH113 creating JH213 and JH313, respectively.   
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The deletion of crtM, resulting in STX-less S. aureus resulted in a slight 
decrease, on average, in survival for the mutant throughout the experiment, but 
was only significant at the one hour time point of incubation (Fig 6-5B, control vs. 
JH213). As seen previously, induction of YhcR overproduction resulted in 
significantly enhanced survival of S. aureus during incubation in human blood 
(Fig 6-5B, WYhcR). The enhanced survival that resulted from YhcR 
overproduction was completely eliminated in the crtM mutant (Fig 6-5B, JH213 
vs. JH313). The data indicated that YhcR mediated overproduction of STX 
significantly contributed to the enhanced survival of S. aureus during YhcR 
overproduction. The data also suggested that the enhanced survival of the 
WYhcR strain is the result of improved phagocyte oxidative burst resistance due 
to overproduction of STX as a direct transcriptional result of YhcR 
overproduction.  
 
170 
 
 
Figure 6-5 Lack of staphyloxanthin eliminates the enhanced of S. aureus 
survival resulting from YhcR overproduction. (A) comparison of STX 
carotenoid color production from 24 hour aerobic cultures of S. aureus WCUH29 
wild-type and WCUH29ΔcrtM (JH113). (B) Percent survival of the S. aureus 
WCUH29 control, WYhcR, JH213, and JH313 strains in human blood during ATc 
induction. The data represents the mean and standard deviation of four 
experiments. Statistical analysis was conducted with a Student’s T-Test, P ≤ 
0.05. Cultures of S. aureus strains were cultured overnight with the inducer ATc 
(250 ng/ml) and the following day diluted and inoculated into 500 ml of fresh 
blood with erythromycin and the inducer ATc (250 ng/ml) and incubated at 37°C. 
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6.5 Discussion 
 The data presented in this chapter indicated the YhcSR TCS of S. aureus 
modulates the production of STX and subsequently, sensitivity or resistance to 
hydrogen peroxide. This modulation is likely to occur at the transcriptional level 
as YhcR binds the crt promoter as determined by a gel-shift assay. Construction 
of a Pcrt-luxABCDE promoter-reporter and/or qPCR is needed to verify 
transcriptional regulation during depletion or overproduction of Yhc(S)R. 
 The YhcS sensor kinase uses a [2Fe-2S] containing GAF domain to sense 
oxygen and phosphorylates YhcR under normal atmospheric oxygen 
concentrations (129). In the presence of oxygen or mild oxidants, YhcS likely 
phosphorylates YhcR and promotes production of STX as an antioxidant 
protection measure. The observation of the lack of pigment production during 
anaerobic growth on TSA plates is supportive of this, for in the absence of any 
oxidants, YhcS would be fully reduced (kinase inactive) and YhcR is not 
phosphorylated (129), therefore YhcR does would not promote Pcrt transcription. 
The YhcS kinase function is inactivated by strong oxidation, such as in the 
presence of millimolar concentrations of H2O2 in vitro (129), but modeling of the 
neutrophil phagosome suggests H2O2 concentration is only in the low micromolar 
range (320). It is therefore suggested, mild oxidation of the YhcS [2Fe-2S] cluster 
may occur, even under anaerobic conditions such as those that may perhaps 
occur in the phagosomes of neutrophils within an anaerobic wound site (302). 
Oxidation of YhcS may up-regulate crt transcription and promote STX 
biosynthesis as way to counter-act oxidative killing by the neutrophil. If oxygen is 
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present in the phagosome, it too, would promote YhcSR mediated up-regulation 
of STX and antioxidant protection. In support of this suggestion, STX has been 
shown to be important for bacterial survival when S. aureus is cultured with 
neutrophils or in human and mouse whole blood. Furthermore, genetic mutations 
or pharmacological inhibition of the NADPH oxidase pathway in neutrophils 
eliminated the necessity for STX by S. aureus in both of these assays (312). 
Likewise, the data presented here showed that the genetic disruption of STX 
biosynthesis completely eliminated the enhanced survival of S. aureus due to 
YhcR-mediated STX overproduction. Investigations of this possibility are 
ongoing, and if supported, would implicate the YhcSR TCS as an important 
virulence factor for modulating expression of antioxidants and survival within 
phagosomes.
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Chapter 7 : Thesis conclusions and future work 
7.1 Conclusions 
The overarching goal of this thesis research was to characterize and 
understand novel cis- and trans-acting factors that affect gene expression in S. 
aureus. To that end, the data presented in this thesis is the result of studies 
measuring the effect of cis-acting single nucleotide polymorphisms in a promoter 
and their influence on gene transcription and gene product expression. 
Furthermore, characterization of a novel trans-acting essential two-component 
system revealed the TCS transcriptionally regulates genes involved in cellular 
metabolism, homeostasis, and well-known virulence factors.  
In chapter two studies, the α-toxin hyperproducing phenotype of the S. 
aureus RF122 was investigated and single nucleotide polymorphisms in the 
promoter region of the hla were identified that promote increased transcription of 
the gene and this was linked to the positive regulator, SarZ. Furthermore, RF122 
has increased and decreased transcriptional expression of hla positive regulators 
and negative regulators, respectively, which appear to synergize and 
dramatically increase the expression of α-toxin. RF122 is of the predominant 
bovine mastitis ET3 clone. Alpha-toxin is an important for virulence factor in 
mastitis pathogenesis and the genetic and transcriptional changes that occur in 
RF122 that produce the α-toxin hyper-production phenotype likely contribute to 
its success as a mastitis pathogen.  
The first goal of the studies on the yhcSR TCS was to confirm the 
essentiality of the TCS in the clinically relevant WCUH29 strain because, 
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although useful, the RN4220 laboratory strain is genetically mutated and, as a 
result, findings must be confirmed in a relevant clinical strain. Data presented in 
chapter three studies support the hypothesis that the yhcSR TCS is essential for 
S. aureus aerobic and anaerobic viability and that it is likely essential in other 
strains of clinical relevant S. aureus. In an effort to characterize and begin to 
identify the underlying mechanism for YhcSR essentiality the cellular morphology 
of inducible mutants was observed. YhcSR depletion resulted in extremely large 
bacterial cells that appear as if they’re incapable of dividing properly, while the 
overproduction of YhcR produced uniformly enlarged cells, which may have 
thickened cell walls. Future analysis is needed to confirm the recent report linking 
YhcSR to cell-wall synthesis (137) and identify additional cell-wall synthesis 
genes regulated by YhcSR and investigate their relationship with YhcSR’s 
essentiality.  
Chapter four presents data on the positive transcriptional regulation of the 
lacABCDE and opuCABC operons by the YhcSR TCS. YhcR directly and 
specifically binds the promoter region of each operon and the depletion of yhcSR 
down regulates transcription from the respective promoters. The partial 
complementation of growth by expression of lacABC in trans shuttles 
intermediates into glycolysis suggesting the growth defect from yhcSR depletion 
is due to loss of expression of upstream glycolytic enzymes or the bacterial cell is 
starved for ATP, as the lac operon yields glyceraldehyde 3-phosphate which then 
can be catabolized for substrate level phosphorylation in glycolysis. While the 
exact link between the cellular osmotic regulatory opuC operon and the oxygen 
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sensing YhcSR TCS remains unclear, it is perhaps possible that YhcSR up-
regulates opuC during aerobic logarithmic growth when bacterial growth is rapid 
and proper turgor pressure is important to maintain sustained cellular division, 
particularly in salt rich environments.  
 In an effort determine if a relationship existed between YhcSR and 
pathogenesis, the inducible mutants were assayed for survival in human whole 
blood. It was of little surprise to find the yhcS antisense mutant did not survive 
well in the blood and was killed faster than wild-type control or non-induced 
strains. The interesting finding was that overproduction of YhcR promoted 
survival of S. aureus. As outlined in chapters five and six, the survival of an YhcR 
overproduction strain is linked to the increased expression of exported proteases 
and biosynthesis of staphyloxanthin, respectively. YhcSR directly regulates each 
operon and promotes transcription of the respective operon. The overproduction 
of YhcR bypasses any sensory input from YhcS and promotes almost continuous 
transcription of YhcR regulated genes. The relationship between YhcSR, anti-
phagocytosis, and survival within neutrophils needs to be further investigated as 
both virulence operons found so far to be regulated by YhcSR converge on this 
part of the innate immune system and suggest YhcSR has a prominent and 
important role for S. aureus in evading and escaping phagocytosis.  
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7.2 Future work 
7.2.1 Analysis of Staphylococcus aureus NCTC8235 yhcSR::erm mutant 
Of great interest and importance is the recent report of an antibiotic gene 
replacement of yhcSR in S. aureus NCTC8235 (321, 322). As discussed in 
chapter 3, the strain harbors a genetic mutation that inactivates the rsbU genes 
and does not have a functional alternative ςB, thus many transcription factors, 
stress induced genes, and virulence factors are not expressed or their 
expression is dramatically altered. In an effort to understand how the rsbU 
mutation may affect the essentiality of yhcSR, in a suppressive manner, phage 
transduction or gene replacement with the original plasmid should be undertaken 
in an rsbU+ strain, such as WCUH29 or even the rsbU+ restored, NCTC8235 
derivative, SH1000. Additionally, a mutation in rsbU should be made in WCUH29 
followed by the attempt to delete the native yhcSR locus. If a 
WCUH29ΔrsbUΔyhcSR is successfully created, a large-scale comparative 
transcriptional analysis, likely RNA-seq, of the parental WCUH29, 
WCUH29ΔrsbU, WCUH29ΔrsbUΔyhcSR strains should be conducted to identify 
differentially expressed genes. The rsbU mutation is likely to lead to the aberrant 
up-regulation one or more essential genes or pathways that is normally regulated 
by YhcSR, so initial focus should center on genes or pathways that are known to 
be essential. To determine which genes are responsible for the suppressor 
ability, identified genes should be chromosomally integrated and ectopically 
expressed followed by an attempt to delete the native yhcSR locus. 
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7.2.2 Whole genome ChIP-seq analysis 
To comprehensively identify YhcR binding sites in the S. aureus genome, 
chromosome immunoprecipitation coupled with massively parallel DNA 
sequencing (ChIP-seq) should be carried out. The use of ChIP-seq has been 
used extensively in bacteria to confirm and identify novel binding sites for 
transcriptional regulators (323–326). The data garnered from ChIP-seq will 
provide the likely DNA recognition sequence of YhcR and genes transcriptionally 
regulated by YhcSR. The analysis is static therefore subsequent analysis using 
DNA footprinting and qPCR or promoter-reporter assays can confirm the binding 
site sequence and transcriptional regulation. Since YhcSR is essential for aerobic 
and anaerobic growth, ChIP-seq should be done for both conditions and a 
comparative analysis between the data sets can be used to identify differential 
binding sites between the two conditions. At one point during my thesis research 
I attempted to perform this assay, but technical issues prohibited the completion 
of the assay. After retrospective analysis, it is suggested that a three times 
repeated human influenza hemagglutinin (3×HA) epitope tag be placed in-frame 
on the carboxy terminal of YhcR for this assay. The use of a ChIP grade antibody 
recognizing the 3×HA would be essential to the assay. Once YhcR binding sites 
and potentially regulated genes are identified, a systemic analysis can be 
undertaken to identify genes in involved in the essentiality of YhcSR and 
determine how each of these genes is involved YhcSR mediated S. aureus 
fitness and pathogenesis.  
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7.2.3 Analysis of the importance of YhcS iron-sulfur cluster formation 
during phagocytosis and resistance to oxidants 
It is known that STX is important for its antioxidant capacity and helps S. 
aureus survive within phagosomes. While a direct transcriptional link and an 
increase in STX production was shown because of YhcR overproduction, it would 
be of interest to determine the role of the YhcS [2Fe-2S] cluster in up-regulation 
of crtOPQMN, and possibly other virulence factors, during phagocytosis. It is 
unlikely that an allelic mutation of the cysteines that coordinate the iron-sulfur 
cluster could be obtained, as they are essential to the kinase activity of YhcS and 
likely to the TCS as a whole (129), instead an inducible-dominant negative strain 
should be constructed by cloning the yhcS ORF into the TetR inducible pYH4 
plasmid. Using site-directed mutagenesis four cysteine  serine mutations at the 
four cysteine amino acid sites of YhcS can constructed. The uninduced and 
induced wild-type YhcS and YhcS mutant would then be assayed for their ability 
to promote STX synthesis in vitro and assayed for the ability to survive in the HL-
60 opsonophagocytic killing assay. Further detailed analysis using isolated 
neutrophils from wild-type and gp91Phox-/- (Oxidative burst mutant, X-linked GCD 
model) mice could be used. If the induced CS YhcS mutant strain survived 
worse than the induced wild-type YhcS strain in normal mouse neutrophils, but 
similar in the gp91Phox-/- neutrophils it would indicate the iron-sulfur cluster is 
important for virulence factor regulation during phagocytosis and suggest the 
iron-sulfur cluster is sensitive to oxidants within the phagosome.  
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7.2.4 Preliminary screening for YhcR inhibitors 
The identification of novel antibiotics to combat the pervasive multi-drug 
resistance in S. aureus is of utmost importance. Novel essential proteins and 
pathways are excellent candidates for the development of new antibiotics. The 
thought behind this thinking is: the development of resistance will be slower, as 
the bacteria will have never encountered the new drug, and if used properly, 
resistance can be maintained to a low level.  
To that end, the described screening assay was used to identify two novel 
inhibitors of the only other essential two-component response regulator in S. 
aureus, WalR (111). Briefly, the screening assay is a single plasmid based assay 
that contains an enhanced green fluorescent protein (egfp) reporter fused 
downstream of the iclR promoter. On a separate area of the plasmids, YhcR is 
cloned downstream of the DNA-binding domain of IclR, creating a chimeric 
protein. In the absence of the YhcR-IclR chimeric protein, the eGFP protein is 
expressed and the E. coli cells fluoresce. As the mode of transcriptional 
regulation for helix-turn-helix response regulators, homodimerization of the 
chimeric YhcR-IclR protein is facilitated by the dimerization domain of YhcR, 
which brings together the DNA-binding domain of IclR, resulting in the YhcR-IclR 
chimeric protein dependent repression of eGFP production. The introduction of 
compounds that inhibit the YhcR dimerization event will cause the E. coli cells to 
fluoresce relative to the no compound control (no fluorescence). Our laboratory 
currently has access to a library of 5,000 compounds, with the ability to expand 
the library through collaborations based at the University of Minnesota.  
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 The work presented in this dissertation identified cis-acting SNPs and a 
trans-acting transcription factor that promote an α-toxin hyperproduction 
phenotype that is likely involved in increased bovine mastitis pathogenesis of S. 
aureus strain RF122. Additionally, the essentiality of the trans-acting YhcSR TCS 
was confirmed. The YhcSR TCS was identified to transcriptionally activate four 
operons that are involved in lactose catabolism (lacABCD), cellular osmotic 
homeostasis (opuCABC), and virulence factor production (sspABC and 
crtOPQMN). These operons contribute to in vitro S. aureus viability and survival 
of S. aureus in human blood.  
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